Olaparib Clinical Trials (2026): 409 Studies for Ovarian Cancer & Breast Cancer

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

409 Olaparib clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 229 indications (including Ovarian Cancer & Breast Cancer) and 87,625 total planned enrollment. 41 Phase 3 Olaparib trials and 206 Phase 2, 6 Phase 4 are listed. 93 Olaparib clinical trials are actively recruiting at 2,053 U.S. sites across 51 states. Most recent activity: NCT03486873 (Aug 2043).

Where to Participate: All Olaparib Trial Sites in the U.S. (2,053 sites across 51 states)

Every actively recruiting Olaparibtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

StateFacilityCityTrialMap
ALO'Neal Comprehensive Cancer Center at UABBirmingham35294NCT05952453Map
ALUniversity of Alabama at BirminghamBirmingham35294NCT04711824Map
ALUniversity of Alabama at BirminghamBirmingham35294NCT01042379Map
ALUniversity of Alabama at Birmingham Cancer CenterBirmingham35233NCT05554328Map
ALUniversity of Alabama at Birmingham Cancer CenterBirmingham35233NCT05564377Map
ALUniversity of Alabama at Birmingham Cancer CenterBirmingham35233NCT06580314Map
ALUniversity of Alabama at Birmingham Comprehensive Cancer CenterBirmingham35294NCT02693535Map
ALUniversity of South Alabama Mitchell Cancer InstituteMobile36688NCT05554328Map
ALUniversity of South Alabama Mitchell Cancer InstituteMobile36688NCT05564377Map
AKAlaska Breast Care and Surgery LLCAnchorage99508NCT06580314Map
AKAlaska Oncology and Hematology LLCAnchorage99508NCT06580314Map
AKAlaska Women's Cancer CareAnchorage99508NCT05554328Map
AKAlaska Women's Cancer CareAnchorage99508NCT05564377Map
AKAlaska Women's Cancer CareAnchorage99508NCT06580314Map
AKAnchorage Associates in Radiation MedicineAnchorage98508NCT06580314Map
AKKatmai Oncology GroupAnchorage99508NCT06580314Map
AKProvidence Alaska Medical CenterAnchorage99508NCT06580314Map
AZBanner MD Anderson Cancer Center ( Site 0066)Gilbert85234NCT06966700Map
AZCTCA at Western Regional Medical CenterGoodyear85338NCT05554328Map
AZCTCA at Western Regional Medical CenterGoodyear85338NCT05564377Map
AZKingman Regional Medical CenterKingman86401NCT05554328Map
AZKingman Regional Medical CenterKingman86401NCT05564377Map
AZKingman Regional Medical CenterKingman86401NCT04858334Map
AZCancer Center at Saint Joseph'sPhoenix85004NCT06580314Map
AZCancer Treatment Centers of America-PhoenixPhoenix85338NCT02693535Map
AZMayo Clinic Cancer Center ( Site 0034)Phoenix85054NCT06966700Map
AZMayo Clinic Hospital in ArizonaPhoenix85054NCT06580314Map
AZArizona Cancer Center at UMC North ( Site 0018)Tucson85719NCT03486873Map
AZUniversity of Arizona Cancer Center ( Site 0035)Tucson85719NCT06966700Map
ARHighlands Oncology Group - FayettevilleFayetteville72703NCT06580314Map
ARMercy Hospital Fort SmithFort Smith72903NCT06580314Map
ARNEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro72401NCT05564377Map
ARNEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro72401NCT04858334Map
ARCARTI Cancer CenterLittle Rock72205NCT06580314Map
ARUniversity of Arkansas for Medical SciencesLittle Rock72205NCT06580314Map
ARHighlands Oncology Group - RogersRogers72758NCT06580314Map
ARHighlands Oncology GroupSpringdale72762NCT06580314Map
CAKaiser Permanente-Deer Valley Medical CenterAntioch94531NCT06580314Map
CAMission Hope Medical Oncology - Arroyo GrandeArroyo Grande93420NCT06580314Map
CAPCR OncologyArroyo Grande93420NCT05554328Map
CAPCR OncologyArroyo Grande93420NCT05564377Map
CASutter AuburnAuburn95602NCT02693535Map
CASutter Auburn Faith HospitalAuburn95602NCT06580314Map
CASutter Cancer Centers Radiation Oncology Services-AuburnAuburn95603NCT06580314Map
CAComprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054)Bakersfield93309NCT03486873Map
CAKaiser Permanente-BellflowerBellflower90706NCT06580314Map
CAAlta Bates Summit Medical Center-Herrick CampusBerkeley94704NCT04858334Map
CAAlta Bates Summit Medical Center-Herrick CampusBerkeley94704NCT06580314Map
CASutter Alta BatesBerkeley94705NCT02693535Map
CAProvidence Saint Joseph Medical Center/Disney Family Cancer CenterBurbank91505NCT06580314Map
CARoy and Patricia Disney Family Cancer Center ( Site 0055)Burbank91505NCT06966700Map
CAMills-Peninsula Medical CenterBurlingame94010NCT06580314Map
CASutter Cancer Centers Radiation Oncology Services-Cameron ParkCameron Park95682NCT06580314Map
CAMercy Cancer Center - CarmichaelCarmichael95608NCT05564377Map
CAMercy Cancer Center - CarmichaelCarmichael95608NCT06580314Map
CAMercy San Juan Medical CenterCarmichael95608NCT05564377Map
CAMercy San Juan Medical CenterCarmichael95608NCT06580314Map
CAEden Hospital Medical CenterCastro Valley94546NCT06580314Map
CASutter Davis HospitalDavis95616NCT06580314Map
CAUniversity of California - Davis, Comprehensive Cancer CenterDavis95817NCT01042379Map
CACity of HopeDuarte91010NCT01042379Map
CACity of Hope Medical CenterDuarte91010NCT05238922Map
CAKaiser Permanente DublinDublin94568NCT06580314Map
CAMercy Cancer Center - Elk GroveElk Grove95758NCT05564377Map
CAMercy Cancer Center - Elk GroveElk Grove95758NCT06580314Map
CAStanford Cancer Center EmeryvilleEmeryville94608NCT06580314Map
CAUC San Diego Health System - EncinitasEncinitas92024NCT05564377Map
CAMemorialCare Orange Coast Medical CenterFountain Valley92708NCT06785636Map
CAKaiser Permanente-FremontFremont94538NCT06580314Map
CAPalo Alto Medical Foundation-FremontFremont94538NCT04858334Map
CAPalo Alto Medical Foundation-FremontFremont94538NCT06580314Map
CAFresno Cancer CenterFresno93720NCT06580314Map
CAKaiser Permanente Fresno Orchard PlazaFresno93720NCT06580314Map
CAKaiser Permanente-FresnoFresno93720NCT06580314Map
CAProvidence Medical Foundation ( Site 0080)Fullerton92835NCT06966700Map
CAKaiser Permanente South BayHarbor City90710NCT06580314Map
CACity of Hope-Lennar Foundation Cancer CenterIrvine92618NCT05238922Map
CAKaiser Permanente-IrvineIrvine92618NCT06580314Map
CAUCI Health - Chao Family Comprehensive Cancer Center and Ambulatory CareIrvine92612NCT04633239Map
CAUC San Diego Moores Cancer CenterLa Jolla92093NCT05564377Map
CAUC San Diego Moores Cancer CenterLa Jolla92093NCT06580314Map
CAUCSD Moores Cancer Center ( Site 0039)La Jolla92037NCT06353386Map
CAUniversity of California San DiegoLa Jolla92093-0698NCT01042379Map
CAUniversity of California San Diego - Moores Cancer CenterLa Jolla92093NCT05498272Map
CACancer and Blood Research CenterLos Alamitos90720NCT06785636Map
CACedars Sinai Medical CenterLos Angeles90048NCT06580314Map
CACedars-Sinai Medical CenterLos Angeles90048NCT05554328Map
CACedars-Sinai Medical CenterLos Angeles90048NCT05564377Map
CAKaiser Permanente Los Angeles Medical CenterLos Angeles90027NCT06580314Map
CAKaiser Permanente West Los AngelesLos Angeles90034NCT06580314Map
CALos Angeles General Medical CenterLos Angeles90033NCT04633239Map
CAThe Angeles Clinic and Research Institute - West Los Angeles OfficeLos Angeles90025NCT05564377Map
CAThe Angeles Clinic and Research Institute, A Cedars-Sinai AffiliateLos Angeles90025NCT02693535Map
CAUCLA Hematology/Oncology - Santa Monica ( Site 0044)Los Angeles90404NCT06353386Map
CAUCLA Hematology/Oncology - Westwood (Building 100) ( Site 0009)Los Angeles90095NCT03486873Map
CAUniversity of Southern CaliforniaLos Angeles90033NCT01042379Map
CAUSC / Norris Comprehensive Cancer CenterLos Angeles90033NCT04633239Map
CAValkyrie Clinical TrialsLos Angeles90067NCT05238922Map
CAMercy Cancer CenterMerced95340NCT06580314Map
CAKaiser Permanente- Modesto MOB IIModesto95356NCT06580314Map
CAKaiser Permanente-ModestoModesto95356NCT06580314Map
CAMemorial Medical CenterModesto95355NCT04858334Map
CAMemorial Medical CenterModesto95355NCT06580314Map
CAPalo Alto Medical Foundation-Camino DivisionMountain View94040NCT06580314Map
CAPalo Alto Medical Foundation-Gynecologic OncologyMountain View94040NCT06580314Map
CAProvidence Queen of The ValleyNapa94558NCT06580314Map
CAHOAG Memorial Hospital PresbyterianNewport Beach92663NCT01042379Map
CAHoag Memorial Hospital Presbyterian ( Site 0010)Newport Beach92663NCT06966700Map
CASutter Cancer Research ConsortiumNovato94945NCT06580314Map
CAKaiser Permanente - Oakland Medical CenterOakland94611NCT02693535Map
CAKaiser Permanente Oakland-BroadwayOakland94611NCT06580314Map
CAKaiser Permanente-OaklandOakland94611NCT06580314Map
CAChildren's Hospital of Orange CountyOrange92868NCT05564377Map
CASaint Joseph Hospital - OrangeOrange92868NCT05554328Map
CASaint Joseph Hospital - OrangeOrange92868NCT05564377Map
CASaint Joseph Hospital - OrangeOrange92868NCT04858334Map
CAUC Irvine Health/Chao Family Comprehensive Cancer CenterOrange92868NCT04633239Map
CAPalo Alto Medical Foundation Health CarePalo Alto94301NCT06580314Map
CAStanford Cancer Center ( Site 0086)Palo Alto94304NCT03486873Map
CAStanford Cancer Institute Palo AltoPalo Alto94304NCT05554328Map
CAStanford Cancer Institute Palo AltoPalo Alto94304NCT05564377Map
CAStanford Cancer Institute Palo AltoPalo Alto94304NCT06580314Map
CASutter Palo Alto Medical Foundation: Palo AltoPalo Alto94301NCT02693535Map
CAKaiser Permanente - Panorama CityPanorama City91402NCT06580314Map
CAHuntington Memorial HospitalPasadena91105NCT06580314Map
CAKaiser Permanente-Rancho Cordova Cancer CenterRancho Cordova95670NCT06580314Map
CAKaiser Permanente- Marshall Medical OfficesRedwood City94063NCT06580314Map
CAKaiser Permanente-RichmondRichmond94801NCT06580314Map
CAKaiser Permanente-RiversideRiverside92505NCT06580314Map
CAMercy Cancer Center - RocklinRocklin95765NCT05564377Map
CAMercy Cancer Center - RocklinRocklin95765NCT06580314Map
CARohnert Park Cancer CenterRohnert Park94928NCT06580314Map
CAKaiser Permanente - Roseville Medical CenterRoseville95661NCT02693535Map
CAKaiser Permanente-RosevilleRoseville95661NCT06580314Map
CASutter Cancer Centers Radiation Oncology Services-RosevilleRoseville95661NCT06580314Map
CASutter RosevilleRoseville95661NCT02693535Map
CASutter Roseville Medical CenterRoseville95661NCT04858334Map
CASutter Roseville Medical CenterRoseville95661NCT06580314Map
CAThe Permanente Medical Group-Roseville Radiation OncologyRoseville95678NCT06580314Map
CAKaiser Permanente - Sacramento Medical CenterSacramento95814NCT02693535Map
CAKaiser Permanente Downtown CommonsSacramento95814NCT06580314Map
CAKaiser Permanente-South SacramentoSacramento95823NCT06580314Map
CAMercy Cancer Center - SacramentoSacramento95816NCT05564377Map
CAMercy Cancer Center - SacramentoSacramento95816NCT06580314Map
CASouth Sacramento Cancer CenterSacramento95823NCT06580314Map
CASutter Medical Center SacramentoSacramento95816NCT04858334Map
CASutter Medical Center SacramentoSacramento95816NCT06580314Map
CASutter SacramentoSacramento95816NCT02693535Map
CAKaiser Permanente-San Diego ZionSan Diego92120NCT06580314Map
CASharp Memorial HospitalSan Diego92123NCT05564377Map
CAUC San Diego Medical Center - HillcrestSan Diego92103NCT05564377Map
CACalifornia Pacific Medical Center Research InstituteSan Francisco94115NCT02693535Map
CACalifornia Pacific Medical Center-Pacific CampusSan Francisco94115NCT04858334Map
CACalifornia Pacific Medical Center-Pacific CampusSan Francisco94115NCT06580314Map
CAKaiser Permanente - San Francisco Medical CenterSan Francisco94115NCT02693535Map
CAKaiser Permanente - South San Francisco Medical CenterSan Francisco94080NCT02693535Map
CAKaiser Permanente-San FranciscoSan Francisco94115NCT06580314Map
CASutter Cancer Research ConsortiumSan Francisco94115NCT02693535Map
CAUCSF Helen Diller Family Comprehensive Cancer Center ( Site 0004)San Francisco94158NCT03486873Map
CAUniversity of California San Francisco (UCSF)San Francisco94115NCT01042379Map
CAUniversity of California, San FranciscoSan Francisco94143NCT06177171Map
CAKaiser Permanente - San Jose Medical CenterSan Jose95119NCT02693535Map
CAKaiser Permanente-Santa Teresa-San JoseSan Jose95119NCT06580314Map
CAStanford Cancer Center South BaySan Jose95124NCT06580314Map
CAKaiser Permanente - San Leandro Medical CenterSan Leandro94577NCT02693535Map
CAKaiser Permanente San LeandroSan Leandro94577NCT06580314Map
CAPacific Central Coast Health Center-San Luis ObispoSan Luis Obispo93401NCT06580314Map
CAKaiser Permanente-San MarcosSan Marcos92078NCT06580314Map
CAMills Health CenterSan Mateo94401NCT04858334Map
CAMills Health CenterSan Mateo94401NCT06580314Map
CAKaiser San Rafael-GallinasSan Rafael94903NCT06580314Map
CARidley-Tree Cancer CenterSanta Barbara93105NCT06580314Map
CASutter Sansum ClinicSanta Barbara93105NCT02693535Map
CAKaiser Permanente - Santa Clara Medical CenterSanta Clara95051NCT02693535Map
CAKaiser Permanente Medical Center - Santa ClaraSanta Clara95051NCT06580314Map
CAPalo Alto Medical Foundation-Santa CruzSanta Cruz95065NCT04858334Map
CAPalo Alto Medical Foundation-Santa CruzSanta Cruz95065NCT06580314Map
CASanta Cruz Radiation Oncology Medical GroupSanta Cruz95065NCT06580314Map
CASutter Palo Alto Medical Foundation: FremontSanta Cruz994538NCT02693535Map
CASutter Palo Alto Medical Foundation: Santa CruzSanta Cruz95065NCT02693535Map
CAMission Hope Medical Oncology - Santa MariaSanta Maria93444NCT06580314Map
CAProvidence Saint John's Health Center ( Site 0059)Santa Monica90404NCT03486873Map
CASaint John's Cancer InstituteSanta Monica90404NCT05564377Map
CAUCLA Hematology/Oncology - Parkside ( Site 0021)Santa Monica90404NCT06797635Map
CAKaiser Permanente-Santa RosaSanta Rosa95403NCT06580314Map
CAProvidence Medical Foundation - Santa RosaSanta Rosa95403NCT04858334Map
CAProvidence Medical Foundation - Santa RosaSanta Rosa95403NCT06580314Map
CAProvidence Santa Rosa Memorial HospitalSanta Rosa95405NCT06580314Map
CASutter Pacific Medical FoundationSanta Rosa95403NCT04858334Map
CASutter Pacific Medical FoundationSanta Rosa95403NCT06580314Map
CAKaiser Permanente Cancer Treatment CenterSouth San Francisco94080NCT06580314Map
CAKaiser Permanente-South San FranciscoSouth San Francisco94080NCT06580314Map
CAKaiser Permanente-StocktonStockton95210NCT06580314Map
CASaint Joseph's Medical CenterStockton95204NCT06580314Map
CAPalo Alto Medical Foundation-SunnyvaleSunnyvale94086NCT04858334Map
CAPalo Alto Medical Foundation-SunnyvaleSunnyvale94086NCT06580314Map
CASutter Palo Alto Medical Foundation: SunnyvaleSunnyvale94086NCT02693535Map
CATorrance Memorial Physician Network - Cancer CareTorrance90505NCT06580314Map
CAKaiser Permanente Medical Center-VacavilleVacaville95688NCT06580314Map
CANorthbay Cancer CenterVacaville95687NCT04858334Map
CAKaiser Permanente - Vallejo Medical CenterVallejo94589NCT02693535Map
CAKaiser Permanente-VallejoVallejo94589NCT06580314Map
CASutter Solano Medical Center/Cancer CenterVallejo94589NCT06580314Map
CAJohn Muir Medical Center-Walnut CreekWalnut Creek94598NCT06580314Map
CAKaiser Permanente - Walnut Creek Medical CenterWalnut Creek94596NCT02693535Map
CAKaiser Permanente-Walnut CreekWalnut Creek94596NCT06580314Map
CAVA Greater Los Angeles Healthcare System, West Los Angeles, CAWest Los Angeles90073NCT04038502Map
CAHelios Clinical Research ( Site 0061)Whittier90602NCT06966700Map
CAWoodland Memorial HospitalWoodland95695NCT05564377Map
CAWoodland Memorial HospitalWoodland95695NCT06580314Map
CAKaiser Permanente-Woodland HillsWoodland Hills91367NCT06580314Map
COCall for Information (Investigational Site 2041)Aurora80045NCT02861573Map
COCU Medicine ClinicsAurora80045NCT06856499Map
CORocky Mountain Regional VA Medical Center, Aurora, COAurora80045NCT04038502Map
COUCHealth University of Colorado HospitalAurora80045NCT05564377Map
COUCHealth University of Colorado HospitalAurora80045NCT06580314Map
COUniversity of Colorado Cancer CenterAurora80045NCT01042379Map
COUniversity of Colorado Cancer Center ( Site 0021)Aurora80045NCT03486873Map
COUniversity of Colorado HealthAurora80045NCT06785636Map
COUniversity of Colorado HospitalAurora80045NCT05887609Map
COUniverstiy of Colorado HospitalAurora80045NCT06856499Map
COMemorial Hospital NorthColorado Springs80920NCT06580314Map
COPenrose-Saint Francis HealthcareColorado Springs80907NCT06580314Map
CORocky Mountain Cancer Centers-PenroseColorado Springs80907NCT06580314Map
COSaint Francis Cancer CenterColorado Springs80923NCT06580314Map
COUCHealth Memorial Hospital CentralColorado Springs80909NCT06580314Map
COIntermountain Health Cancer Center Saint Joseph ( Site 0062)Denver80218NCT06966700Map
CORocky Mountain Cancer Centers (RMCC) ( Site 8006)Denver80220NCT06966700Map
COUCHealth - Cherry CreekDenver80206NCT06580314Map
COCommonSpirit Cancer Center MercyDurango81301NCT06580314Map
COMercy Medical CenterDurango81301NCT06580314Map
COCancer Care and Hematology-Fort CollinsFort Collins80528NCT05564377Map
COCancer Care and Hematology-Fort CollinsFort Collins80528NCT06580314Map
COPoudre Valley HospitalFort Collins80524NCT05564377Map
COPoudre Valley HospitalFort Collins80524NCT06580314Map
COIntermountain Health St. Mary's Regional Hospital ( Site 0054)Grand Junction81501NCT06966700Map
COUCHealth Greeley HospitalGreeley80631NCT05564377Map
COUCHealth Greeley HospitalGreeley80631NCT06580314Map
COUCHealth Highlands Ranch HospitalHighlands Ranch80129NCT06580314Map
COSaint Anthony HospitalLakewood80228NCT06580314Map
CORocky Mountain Cancer Centers-Sky RidgeLone Tree80124NCT05238922Map
COLongmont United HospitalLongmont80501NCT06580314Map
COMedical Center of the RockiesLoveland80538NCT05564377Map
COMedical Center of the RockiesLoveland80538NCT06580314Map
COSaint Mary Corwin Medical CenterPueblo81004NCT06580314Map
COSaint Anthony North HospitalWestminster80023NCT06580314Map
CTSaint Vincent's Medical Center (SVMC)Bridgeport06606NCT02693535Map
CTDanbury HospitalDanbury06810NCT06580314Map
CTSmilow Cancer Hospital Care Center-FairfieldFairfield06824NCT06580314Map
CTSmilow Cancer Hospital Care Center at GreenwichGreenwich06830NCT06580314Map
CTHartford Healthcare Alliance (Data Collection Only)Hartford06102NCT05188508Map
CTHartford HospitalHartford06102NCT02693535Map
CTSmilow Cancer Hospital Care Center at Saint FrancisHartford06105NCT06580314Map
CTMidstate Medical Center (MSMC)Meriden06451NCT02693535Map
CTThe Hospital of Central Connecticut (HOCC) Cancer CenterNew Britain06053NCT02693535Map
CTSmilow Cancer Center/Yale-New Haven HospitalNew Haven06510NCT06580314Map
CTYale Cancer CenterNew Haven06510NCT01042379Map
CTYale UniversityNew Haven06520NCT06580314Map
CTNorwalk HospitalNorwalk06856NCT06580314Map
CTWilliam W. Backus HospitalNorwich06360NCT02693535Map
CTSmilow Cancer Hospital Care Center at Long RidgeStamford06902NCT06580314Map
CTCharlotte HungerfordTorrington06790NCT02693535Map
CTSmilow Cancer Hospital Care Center-TrumbullTrumbull06611NCT06580314Map
CTSmilow Cancer Hospital-Waterbury Care CenterWaterbury06708NCT06580314Map
CTSmilow Cancer Hospital Care Center - WaterfordWaterford06385NCT06580314Map
CTWindham Hospital (WH)Willimantic06226NCT02693535Map
DEBeebe Medical CenterLewes19958NCT06580314Map
DEBeebe South Coastal Health CampusMillville19967NCT06580314Map
DEChristiana Care Health System-Christiana HospitalNewark19718NCT06580314Map
DEHelen F Graham Cancer CenterNewark19713NCT05564377Map
DEHelen F Graham Cancer CenterNewark19713NCT06580314Map
DEMedical Oncology Hematology Consultants PANewark19713NCT05564377Map
DEMedical Oncology Hematology Consultants PANewark19713NCT06580314Map
DEBeebe Health CampusRehoboth Beach19971NCT06580314Map
DEChristiana Care Health System-Wilmington HospitalWilmington19801NCT06580314Map
DCGeorgetown University Medical CenterWashington D.C.20007NCT01042379Map
DCSibley Memorial HospitalWashington D.C.20016NCT04858334Map
DCWashington DC VA Medical Center, Washington, DCWashington D.C.20422-0001NCT04038502Map
FLAdventHealth AltamonteAltamonte Springs32701NCT04858334Map
FLAdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044)Altamonte Springs32701NCT06966700Map
FLUM Sylvester Comprehensive Cancer Center at AventuraAventura33180NCT05554328Map
FLUM Sylvester Comprehensive Cancer Center at AventuraAventura33180NCT05564377Map
FLUniversity of Miami/Sylvester Cancer Institute - AventuraAventura33180NCT02693535Map
FLUM Sylvester Comprehensive Cancer Center at Coral GablesCoral Gables33146NCT05554328Map
FLUM Sylvester Comprehensive Cancer Center at Coral GablesCoral Gables33146NCT05564377Map
FLUM Sylvester Comprehensive Cancer Center at Coral GablesCoral Gables33146NCT04858334Map
FLUniversity of Miami/Sylvester Cancer Institute - LennarCoral Gables33146NCT02693535Map
FLUM Sylvester Comprehensive Cancer Center at Deerfield BeachDeerfield Beach33442NCT05554328Map
FLUM Sylvester Comprehensive Cancer Center at Deerfield BeachDeerfield Beach33442NCT05564377Map
FLUM Sylvester Comprehensive Cancer Center at Deerfield BeachDeerfield Beach33442NCT04858334Map
FLUniversity of Miami/Sylvester Cancer Institute - Deerfield BeachDeerfield Beach33442NCT02693535Map
FLBroward Health Medical CenterFort Lauderdale33316NCT05564377Map
FLBroward Health Medical CenterFort Lauderdale33316NCT06580314Map
FLHoly Cross HospitalFort Lauderdale33308NCT02693535Map
FLHoly Cross HospitalFort Lauderdale33308NCT06580314Map
FLHoly Cross Hospital, Michael & Dianne Bienes Comp Cancer Ctr ( Site 0022)Fort Lauderdale33308NCT03486873Map
FLFlorida Cancer Specialists - South ( Site 7004)Fort Myers33901NCT06966700Map
FLUF Health Cancer Institute - GainesvilleGainesville32610NCT05564377Map
FLUF Health Cancer Institute - GainesvilleGainesville32610NCT06580314Map
FLUniversity of Florida HealthGainesville32610NCT02693535Map
FLBioresearch Partner ( Site 0072)Hialeah33013NCT06966700Map
FLMemorial Healthcare SystemHollywood33028NCT04711824Map
FLExelixis Clinical Site #15Jacksonville32224NCT05932862Map
FLMayo Clinic Hospital ( Site 0013)Jacksonville32224NCT06966700Map
FLMayo Clinic in FloridaJacksonville32224-9980NCT05554328Map
FLMayo Clinic in FloridaJacksonville32224-9980NCT05564377Map
FLMayo Clinic in FloridaJacksonville32224-9980NCT04585958Map
FLOrlando Health Cancer Institute - Lake MaryLake Mary32746NCT06580314Map
FLBAPTIST ALLIANCE - MCI (Data Collection Only)Miami33143NCT05188508Map
FLMount Sinai Medical CenterMiami33140NCT06785636Map
FLUM Sylvester Comprehensive Cancer Center at KendallMiami33176NCT05554328Map
FLUM Sylvester Comprehensive Cancer Center at KendallMiami33176NCT05564377Map
FLUM Sylvester Comprehensive Cancer Center at KendallMiami33176NCT04858334Map
FLUniversity of Miami Hospital and Clinics, Sylvester Cancer Center-Cancer Research Services ( Site 0051)Miami33136NCT06353386Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT05554328Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT05564377Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT04858334Map
FLUniversity of Miami Sylvester Comprehensive Cancer CenterMiami33136NCT02693535Map
FLUniversity of Miami/Sylvester Cancer Institute - Alex's PlaceMiami33136NCT02693535Map
FLUniversity of Miami/Sylvester Cancer Institute - Griffin Cancer Research BuildingMiami33136NCT02693535Map
FLUniversity of Miami/Sylvester Cancer Institute - KendallMiami33176NCT02693535Map
FLUniversity of Miami/Sylvester Cancer Institute - Sole MiaMiami33181NCT02693535Map
FLMount Sinai Medical Center Comprehensive Cancer CenterMiami Beach33140NCT05238922Map
FLMount Sinai Medical Center Comprehensive Cancer Center ( Site 0031)Miami Beach33140NCT03486873Map
FLUniversity of Miami Sylvester Comprehensive Cancer Center at Sole MiaNorth Miami33181NCT05554328Map
FLUniversity of Miami Sylvester Comprehensive Cancer Center at Sole MiaNorth Miami33181NCT05564377Map
FLHealth CentralOcoee34761NCT06580314Map
FLAdvent HealthOrlando32804NCT06915025Map
FLAdventHealth OrlandoOrlando32803NCT04858334Map
FLExelixis Clinical Site #8Orlando32827NCT05932862Map
FLOrlando Health Cancer InstituteOrlando32806NCT06580314Map
FLOrlando VA Medical Center, Orlando, FLOrlando32827NCT04038502Map
FLSacred Heart HospitalPensacola32504NCT06580314Map
FLUM Sylvester Comprehensive Cancer Center at PlantationPlantation33324NCT05554328Map
FLUM Sylvester Comprehensive Cancer Center at PlantationPlantation33324NCT05564377Map
FLUM Sylvester Comprehensive Cancer Center at PlantationPlantation33324NCT04858334Map
FLUniversity of Miami/Sylvester Cancer Institute - PlantationPlantation33324NCT02693535Map
FLFlorida Cancer Specialists - North ( Site 7002)St. Petersburg33701NCT06966700Map
FLExelixis Clinical Site #16Tampa33612NCT05932862Map
FLH. Lee Moffitt Cancer Center and Research InstituteTampa33612NCT01042379Map
FLMoffitt Cancer CenterTampa33612NCT05524935Map
FLMoffitt Cancer CenterTampa33612NCT01042379Map
GAUniversity Cancer and Blood Center LLCAthens30607NCT06580314Map
GACancer Treatment Centers of America - AtlantaAtlanta30265NCT02693535Map
GAEmory Saint Joseph's HospitalAtlanta30342NCT06580314Map
GAEmory University HospitalAtlanta30322NCT06785636Map
GAEmory University Hospital MidtownAtlanta30308NCT04585958Map
GAEmory University Hospital MidtownAtlanta30308NCT06580314Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT04585958Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT06580314Map
GAEmory University Winship Cancer InstituteAtlanta30322NCT02693535Map
GAGrady Health SystemAtlanta30303NCT06580314Map
GANorthside HospitalAtlanta30342NCT06580314Map
GAWinship Cancer Institute of Emory UniversityAtlanta30322NCT01042379Map
GAAugusta University ( Site 0077)Augusta30912NCT03486873Map
GAAugusta University Medical CenterAugusta30912NCT06580314Map
GAAtlanta VA Medical and Rehab Center, Decatur, GADecatur30033NCT04038502Map
GAEmory Decatur HospitalDecatur30033NCT06580314Map
GANorthwest Georgia Oncology Centers PC ( Site 0061)Marietta30060NCT03486873Map
GACity of Hope Cancer Center - Atlanta ( Site 0102)Newnan30265NCT06966700Map
GAGynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research PavilionSavannah31405NCT02693535Map
GALewis Cancer & Research PavilionSavannah31405NCT02693535Map
GALewis Cancer & Research Pavilion at the Melanoma, Skin Cancer & Sarcoma InstituteSavannah31405NCT02693535Map
GASummit Cancer CareSavannah31405NCT02693535Map
HIHawaii Cancer Care - Westridge‘Aiea96701NCT05564377Map
HIHawaii Cancer Care - Westridge‘Aiea96701NCT04858334Map
HIHawaii Cancer Care - Westridge‘Aiea96701NCT06580314Map
HIPali Momi Medical Center‘Aiea96701NCT05564377Map
HIPali Momi Medical Center‘Aiea96701NCT04858334Map
HIPali Momi Medical Center‘Aiea96701NCT06580314Map
HIQueen's Cancer Center - Pearlridge‘Aiea96701NCT06580314Map
HIThe Cancer Center of Hawaii-Pali Momi‘Aiea96701NCT06580314Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT02693535Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT05554328Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT05564377Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT04858334Map
HIThe Queen's Medical Center - West Oahu‘Ewa Beach96706NCT06580314Map
HIHawaii Cancer Care Inc - Waterfront PlazaHonolulu96813NCT05564377Map
HIHawaii Cancer Care Inc - Waterfront PlazaHonolulu96813NCT04858334Map
HIHawaii Cancer Care Inc - Waterfront PlazaHonolulu96813NCT06580314Map
HIKaiser Permanente Moanalua Medical CenterHonolulu96819NCT06580314Map
HIKaiser Permanente Moanalua Medical Center ( Site 0063)Honolulu96813NCT03486873Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT05554328Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT05564377Map
HIKapiolani Medical Center for Women and ChildrenHonolulu96826NCT06580314Map
HIKuakini Medical CenterHonolulu96817NCT06580314Map
HIQueen's Cancer Cenrer - POB IHonolulu96813NCT05554328Map
HIQueen's Cancer Cenrer - POB IHonolulu96813NCT05564377Map
HIQueen's Cancer Cenrer - POB IHonolulu96813NCT04858334Map
HIQueen's Cancer Cenrer - POB IHonolulu96813NCT06580314Map
HIQueen's Cancer Center - KuakiniHonolulu96817NCT05554328Map
HIQueen's Cancer Center - KuakiniHonolulu96817NCT05564377Map
HIQueen's Cancer Center - KuakiniHonolulu96817NCT04858334Map
HIQueen's Cancer Center - KuakiniHonolulu96817NCT06580314Map
HIQueen's Medical CenterHonolulu96813NCT05554328Map
HIQueen's Medical CenterHonolulu96813NCT05564377Map
HIQueen's Medical CenterHonolulu96813NCT04858334Map
HIQueen's Medical CenterHonolulu96813NCT06580314Map
HIStraub Clinic and HospitalHonolulu96813NCT05564377Map
HIStraub Clinic and HospitalHonolulu96813NCT04858334Map
HIStraub Clinic and HospitalHonolulu96813NCT06580314Map
HIThe Cancer Center of Hawaii-LilihaHonolulu96817NCT06580314Map
HIThe Queen's Medical Center - KuakiniHonolulu96817NCT02693535Map
HIThe Queen's Medical Center - POB IHonolulu96813NCT02693535Map
HIThe Queen's Medical Center - PunchbowlHonolulu96813NCT02693535Map
HIUniversity of Hawaii Cancer CenterHonolulu96813NCT05564377Map
HIUniversity of Hawaii Cancer CenterHonolulu96813NCT06580314Map
HIWilcox Memorial Hospital and Kauai Medical ClinicLihue96766NCT06580314Map
IDBoise VA Medical Center, Boise, IDBoise83702NCT04038502Map
IDSaint Alphonsus Cancer Care Center-BoiseBoise83706NCT05554328Map
IDSaint Alphonsus Cancer Care Center-BoiseBoise83706NCT05564377Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT05554328Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT05564377Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT04858334Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT06580314Map
IDSaint Alphonsus Cancer Care Center-CaldwellCaldwell83605NCT05554328Map
IDSaint Alphonsus Cancer Care Center-CaldwellCaldwell83605NCT05564377Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT05554328Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT05564377Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT04858334Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT06580314Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT05554328Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT05564377Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT04858334Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT06580314Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT05554328Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT05564377Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT04858334Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT06580314Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT05554328Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT05564377Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT04858334Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT05554328Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT05564377Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT04858334Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT06580314Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT05554328Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT05564377Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT04858334Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT06580314Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT05554328Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT05564377Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT04858334Map
IDKootenai Clinic Cancer Services - SandpointSandpoint83864NCT06580314Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT05554328Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT05564377Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT04858334Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT06580314Map
ILOSF Saint Anthony's Health CenterAlton62002NCT06580314Map
ILAdvocate Outpatient Center - AuroraAurora60506NCT06580314Map
ILRush-Copley Medical CenterAurora60504NCT06580314Map
ILAdvocate Good Shepherd HospitalBarrington60010NCT05554328Map
ILAdvocate Good Shepherd HospitalBarrington60010NCT05564377Map
ILAdvocate Good Shepherd HospitalBarrington60010NCT06580314Map
ILCarle BroMenn Outpatient CenterBloomington61704NCT06580314Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT05554328Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT05564377Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT04858334Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT06580314Map
ILIllinois CancerCare-CantonCanton61520NCT05554328Map
ILIllinois CancerCare-CantonCanton61520NCT05564377Map
ILIllinois CancerCare-CantonCanton61520NCT04858334Map
ILIllinois CancerCare-CantonCanton61520NCT06580314Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT06580314Map
ILSIH Cancer InstituteCarterville62918NCT05564377Map
ILSIH Cancer InstituteCarterville62918NCT06580314Map
ILIllinois CancerCare-CarthageCarthage62321NCT05554328Map
ILIllinois CancerCare-CarthageCarthage62321NCT05564377Map
ILIllinois CancerCare-CarthageCarthage62321NCT04858334Map
ILIllinois CancerCare-CarthageCarthage62321NCT06580314Map
ILCentralia Oncology ClinicCentralia62801NCT05554328Map
ILCentralia Oncology ClinicCentralia62801NCT05564377Map
ILCentralia Oncology ClinicCentralia62801NCT04858334Map
ILCentralia Oncology ClinicCentralia62801NCT06580314Map
ILAdvocate Illinois Masonic Medical CenterChicago60657NCT05554328Map
ILAdvocate Illinois Masonic Medical CenterChicago60657NCT05564377Map
ILAdvocate Illinois Masonic Medical CenterChicago60657NCT06580314Map
ILCancer Treatment Centers of America-ChicagoChicago60099NCT02693535Map
ILJohn H Stroger Jr Hospital of Cook CountyChicago60612NCT05554328Map
ILJohn H Stroger Jr Hospital of Cook CountyChicago60612NCT05564377Map
ILJohn H Stroger Jr Hospital of Cook CountyChicago60612NCT06580314Map
ILMount Sinai Hospital Medical CenterChicago60608NCT05564377Map
ILNorthwestern Memorial HospitalChicago60611NCT05887609Map
ILNorthwestern UniversityChicago60611NCT05564377Map
ILThe University of Chicago ( Site 0020)Chicago60637NCT03486873Map
ILUniversity of ChicagoChicago60453NCT01042379Map
ILUniversity of ChicagoChicago60637NCT06785636Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT05554328Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT05564377Map
ILUniversity of Chicago Comprehensive Cancer CenterChicago60637NCT06580314Map
ILUniversity of Chicago Medical CenterChicago60615NCT04515836Map
ILUniversity of IllinoisChicago60612NCT05554328Map
ILUniversity of IllinoisChicago60612NCT05564377Map
ILUniversity of IllinoisChicago60612NCT04858334Map
ILUniversity of IllinoisChicago60612NCT06580314Map
ILAMG Crystal Lake - OncologyCrystal Lake60014NCT05554328Map
ILAMG Crystal Lake - OncologyCrystal Lake60014NCT05564377Map
ILAMG Crystal Lake - OncologyCrystal Lake60014NCT06580314Map
ILCarle at The RiverfrontDanville61832NCT05554328Map
ILCarle at The RiverfrontDanville61832NCT05564377Map
ILCarle at The RiverfrontDanville61832NCT04858334Map
ILCarle at The RiverfrontDanville61832NCT06580314Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT05554328Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT05564377Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT04858334Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT06580314Map
ILDecatur Memorial HospitalDecatur62526NCT05554328Map
ILDecatur Memorial HospitalDecatur62526NCT05564377Map
ILDecatur Memorial HospitalDecatur62526NCT04858334Map
ILDecatur Memorial HospitalDecatur62526NCT06580314Map
ILNorthwestern Medicine Cancer Center KishwaukeeDeKalb60115NCT05564377Map
ILIllinois CancerCare-DixonDixon61021NCT05554328Map
ILIllinois CancerCare-DixonDixon61021NCT05564377Map
ILIllinois CancerCare-DixonDixon61021NCT04858334Map
ILIllinois CancerCare-DixonDixon61021NCT06580314Map
ILAdvocate Good Samaritan HospitalDowners Grove60515NCT05554328Map
ILAdvocate Good Samaritan HospitalDowners Grove60515NCT05564377Map
ILAdvocate Good Samaritan HospitalDowners Grove60515NCT06580314Map
ILCarle Physician Group-EffinghamEffingham62401NCT05554328Map
ILCarle Physician Group-EffinghamEffingham62401NCT05564377Map
ILCarle Physician Group-EffinghamEffingham62401NCT04858334Map
ILCarle Physician Group-EffinghamEffingham62401NCT06580314Map
ILCrossroads Cancer CenterEffingham62401NCT05554328Map
ILCrossroads Cancer CenterEffingham62401NCT05564377Map
ILCrossroads Cancer CenterEffingham62401NCT04858334Map
ILCrossroads Cancer CenterEffingham62401NCT06580314Map
ILAdvocate Sherman HospitalElgin60123NCT05554328Map
ILAdvocate Sherman HospitalElgin60123NCT05564377Map
ILAdvocate Sherman HospitalElgin60123NCT06580314Map
ILElmhurst Memorial HospitalElmhurst60126NCT04858334Map
ILElmhurst Memorial HospitalElmhurst60126NCT06580314Map
ILIllinois CancerCare-EurekaEureka61530NCT05554328Map
ILIllinois CancerCare-EurekaEureka61530NCT05564377Map
ILIllinois CancerCare-EurekaEureka61530NCT04858334Map
ILIllinois CancerCare-EurekaEureka61530NCT06580314Map
ILNorthShore University HealthSystem-Evanston HospitalEvanston60201NCT05554328Map
ILNorthShore University HealthSystem-Evanston HospitalEvanston60201NCT05564377Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT05554328Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT05564377Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT04858334Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT06580314Map
ILNorthwestern Medicine Cancer Center DelnorGeneva60134NCT05564377Map
ILNorthShore University HealthSystem-Glenbrook HospitalGlenview60026NCT05554328Map
ILNorthShore University HealthSystem-Glenbrook HospitalGlenview60026NCT05564377Map
ILNorthwestern Medicine Glenview Outpatient CenterGlenview60026NCT05564377Map
ILNorthwestern Medicine Grayslake Outpatient CenterGrayslake60030NCT05564377Map
ILIngalls Memorial HospitalHarvey60426NCT05564377Map
ILAdvocate South Suburban HospitalHazel Crest60429NCT05554328Map
ILAdvocate South Suburban HospitalHazel Crest60429NCT05564377Map
ILAdvocate South Suburban HospitalHazel Crest60429NCT06580314Map
ILNorthShore University HealthSystem-Highland Park HospitalHighland Park60035NCT05554328Map
ILNorthShore University HealthSystem-Highland Park HospitalHighland Park60035NCT05564377Map
ILUChicago Medicine AdventHealth Cancer Institute HinsdaleHinsdale60521NCT06580314Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT05554328Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT05564377Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT04858334Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT06580314Map
ILNorthwestern Medicine Lake Forest HospitalLake Forest60045NCT05564377Map
ILAMG Libertyville - OncologyLibertyville60048NCT05554328Map
ILAMG Libertyville - OncologyLibertyville60048NCT05564377Map
ILAMG Libertyville - OncologyLibertyville60048NCT06580314Map
ILCondell Memorial HospitalLibertyville60048NCT05554328Map
ILCondell Memorial HospitalLibertyville60048NCT05564377Map
ILCondell Memorial HospitalLibertyville60048NCT06580314Map
ILIllinois CancerCare-MacombMacomb61455NCT05554328Map
ILIllinois CancerCare-MacombMacomb61455NCT05564377Map
ILIllinois CancerCare-MacombMacomb61455NCT04858334Map
ILIllinois CancerCare-MacombMacomb61455NCT06580314Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT05554328Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT05564377Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT04858334Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT06580314Map
ILLoyola UniversityMaywood60153NCT01042379Map
ILLoyola University Medical CenterMaywood60153NCT05564377Map
ILSSM Health Good SamaritanMount Vernon62864NCT06580314Map
ILEdward Hospital/Cancer CenterNaperville60540NCT04858334Map
ILEdward Hospital/Cancer CenterNaperville60540NCT06580314Map
ILUC Comprehensive Cancer Center at Silver CrossNew Lenox60451NCT05554328Map
ILUC Comprehensive Cancer Center at Silver CrossNew Lenox60451NCT05564377Map
ILUC Comprehensive Cancer Center at Silver CrossNew Lenox60451NCT06580314Map
ILCarle BroMenn Medical CenterNormal61761NCT05554328Map
ILCarle BroMenn Medical CenterNormal61761NCT05564377Map
ILCarle BroMenn Medical CenterNormal61761NCT06580314Map
ILCarle Cancer Institute NormalNormal61761NCT05554328Map
ILCarle Cancer Institute NormalNormal61761NCT05564377Map
ILCarle Cancer Institute NormalNormal61761NCT06580314Map
ILCancer Care Center of O'FallonO'Fallon62269NCT05554328Map
ILCancer Care Center of O'FallonO'Fallon62269NCT05564377Map
ILCancer Care Center of O'FallonO'Fallon62269NCT04858334Map
ILCancer Care Center of O'FallonO'Fallon62269NCT06580314Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT06580314Map
ILAdvocate Christ Medical CenterOak Lawn60453-2699NCT05554328Map
ILAdvocate Christ Medical CenterOak Lawn60453-2699NCT05564377Map
ILAdvocate Christ Medical CenterOak Lawn60453-2699NCT06580314Map
ILAdvocate Outpatient Center - Oak LawnOak Lawn60453NCT06580314Map
ILNorthwestern Medicine Orland ParkOrland Park60462NCT05564377Map
ILUniversity of Chicago Medicine-Orland ParkOrland Park60462NCT05554328Map
ILUniversity of Chicago Medicine-Orland ParkOrland Park60462NCT05564377Map
ILUniversity of Chicago Medicine-Orland ParkOrland Park60462NCT06580314Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT05554328Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT05564377Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT04858334Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT06580314Map
ILAdvocate High Tech Medical ParkPalos Heights60463NCT06580314Map
ILAdvocate Lutheran General HospitalPark Ridge60068NCT05554328Map
ILAdvocate Lutheran General HospitalPark Ridge60068NCT05564377Map
ILAdvocate Lutheran General HospitalPark Ridge60068NCT06580314Map
ILIllinois CancerCare-PekinPekin61554NCT05554328Map
ILIllinois CancerCare-PekinPekin61554NCT05564377Map
ILIllinois CancerCare-PekinPekin61554NCT04858334Map
ILIllinois CancerCare-PekinPekin61554NCT06580314Map
ILIllinois CancerCare-PeoriaPeoria61615NCT05554328Map
ILIllinois CancerCare-PeoriaPeoria61615NCT05564377Map
ILIllinois CancerCare-PeoriaPeoria61615NCT04858334Map
ILIllinois CancerCare-PeoriaPeoria61615NCT06580314Map
ILMethodist Medical Center of IllinoisPeoria61636NCT06580314Map
ILIllinois CancerCare-PeruPeru61354NCT05554328Map
ILIllinois CancerCare-PeruPeru61354NCT05564377Map
ILIllinois CancerCare-PeruPeru61354NCT04858334Map
ILIllinois CancerCare-PeruPeru61354NCT06580314Map
ILValley Radiation OncologyPeru61354NCT06580314Map
ILEdward Hospital/Cancer Center?PlainfieldPlainfield60585NCT04858334Map
ILEdward Hospital/Cancer Center?PlainfieldPlainfield60585NCT06580314Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT05554328Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT05564377Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT04858334Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT06580314Map
ILMercyhealth Cancer Institute - RockfordRockford61114NCT05564377Map
ILUW Health Carbone Cancer Center RockfordRockford61114NCT06580314Map
ILMemorial Hospital EastShiloh62269NCT05564377Map
ILOrchard Healthcare Research Inc. ( Site 0006)Skokie60077NCT06797635Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT05554328Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT05564377Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT04858334Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT06580314Map
ILSpringfield ClinicSpringfield62702NCT05554328Map
ILSpringfield ClinicSpringfield62702NCT05564377Map
ILSpringfield ClinicSpringfield62702NCT04858334Map
ILSpringfield ClinicSpringfield62702NCT06580314Map
ILSpringfield Memorial HospitalSpringfield62781NCT05554328Map
ILSpringfield Memorial HospitalSpringfield62781NCT05564377Map
ILSpringfield Memorial HospitalSpringfield62781NCT04858334Map
ILSpringfield Memorial HospitalSpringfield62781NCT06580314Map
ILCarle Cancer CenterUrbana61801NCT05554328Map
ILCarle Cancer CenterUrbana61801NCT05564377Map
ILCarle Cancer CenterUrbana61801NCT04858334Map
ILCarle Cancer CenterUrbana61801NCT06580314Map
ILNorthwestern Medicine Cancer Center WarrenvilleWarrenville60555NCT05564377Map
ILIllinois CancerCare - WashingtonWashington61571NCT05554328Map
ILIllinois CancerCare - WashingtonWashington61571NCT05564377Map
ILIllinois CancerCare - WashingtonWashington61571NCT04858334Map
ILIllinois CancerCare - WashingtonWashington61571NCT06580314Map
ILRush-Copley Healthcare CenterYorkville60560NCT06580314Map
INIU Health North HospitalCarmel46032NCT06580314Map
INNorthwest Cancer Center - Main CampusCrown Point46307NCT06580314Map
INUChicago Medicine Northwest IndianaCrown Point46307NCT05554328Map
INUChicago Medicine Northwest IndianaCrown Point46307NCT06580314Map
INNorthwest Oncology LLCDyer46311NCT06580314Map
INFort Wayne Medical Oncology and Hematology ( Site 0084)Fort Wayne46804NCT06966700Map
INParkview Regional Medical CenterFort Wayne46845NCT06580314Map
INGoshen Center for Cancer CareGoshen46526NCT06580314Map
INNorthwest Cancer Center - HobartHobart46342NCT06580314Map
INSaint Mary Medical CenterHobart46342NCT06580314Map
INAscension Saint Vincent Indianapolis HospitalIndianapolis46260NCT06580314Map
INCommunity Health NetworkIndianapolis46250NCT06785636Map
INCommunity Health Network (The University of Texas MD Anderson Cancer Center)Indianapolis46250NCT02693535Map
INFranciscan Health ( Site 0077)Indianapolis46237NCT06966700Map
INIndiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis46202NCT04711824Map
INIndiana University/Melvin and Bren Simon Cancer CenterIndianapolis46202NCT06580314Map
INSaint Catherine HospitalIndianapolis46312NCT06580314Map
INSidney and Lois Eskenazi HospitalIndianapolis46202NCT06580314Map
INWoodland Cancer Care CenterMichigan City46360NCT05564377Map
INThe Community HospitalMunster46321NCT06580314Map
INWomen's Diagnostic Center - MunsterMunster46321NCT06580314Map
INMemorial Hospital of South BendSouth Bend46601NCT06580314Map
INNorthwest Cancer Center - ValparaisoValparaiso46383NCT06580314Map
IAMary Greeley Medical CenterAmes50010NCT04858334Map
IAMary Greeley Medical CenterAmes50010NCT06580314Map
IAMcFarland Clinic - AmesAmes50010NCT04858334Map
IAMcFarland Clinic - AmesAmes50010NCT06580314Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT05554328Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT05564377Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT04858334Map
IASaint Anthony Regional HospitalCarroll51401NCT04858334Map
IAMercy HospitalCedar Rapids52403NCT05564377Map
IAMercy HospitalCedar Rapids52403NCT06580314Map
IAOncology Associates at Mercy Medical CenterCedar Rapids52403NCT05564377Map
IAOncology Associates at Mercy Medical CenterCedar Rapids52403NCT06580314Map
IAMercy Cancer Center-West LakesClive50325NCT04858334Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT05554328Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT04858334Map
IAMethodist Jennie Edmundson HospitalCouncil Bluffs51503NCT06580314Map
IANebraska Cancer Specialists/Oncology Hematology West PC - MEJCouncil Bluffs51503NCT06580314Map
IAGreater Regional Medical CenterCreston50801NCT04858334Map
IABroadlawns Medical CenterDes Moines50314NCT04858334Map
IAIowa Methodist Medical CenterDes Moines50309NCT04858334Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT05554328Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT05564377Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT04858334Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT05554328Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT05564377Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT04858334Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT05554328Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT05564377Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT04858334Map
IAMcFarland Clinic - Trinity Cancer CenterFort Dodge50501NCT04858334Map
IAMcFarland Clinic - Trinity Cancer CenterFort Dodge50501NCT06580314Map
IAUI Healthcare Mission Cancer and Blood - Fort DodgeFort Dodge50501NCT04858334Map
IAUniversity of Iowa Hospital and Clinics ( Site 0026)Iowa City52242NCT03486873Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT06580314Map
IAMcFarland Clinic - MarshalltownMarshalltown50158NCT04858334Map
IAMcFarland Clinic - MarshalltownMarshalltown50158NCT06580314Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT05554328Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT05564377Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT04858334Map
IAMercy Medical Center-West LakesWest Des Moines50266NCT04858334Map
KSUniversity of Kansas Clinical Research CenterFairway66205NCT04633239Map
KSCentral Care Cancer Center - Garden CityGarden City67846NCT06580314Map
KSCentral Care Cancer Center - Great BendGreat Bend67530NCT06580314Map
KSHaysMedHays67601NCT04858334Map
KSUniversity of Kansas Cancer CenterKansas City66160NCT04858334Map
KSLawrence Memorial HospitalLawrence66044NCT04858334Map
KSThe University of Kansas Cancer Center - OlatheOlathe66061NCT04858334Map
KSUniversity of Kansas Cancer Center-Overland ParkOverland Park66210NCT04858334Map
KSUniversity of Kansas Hospital-Indian Creek CampusOverland Park66211NCT04858334Map
KSFreeman Physician Group of PittsburgPittsburg66762NCT04858334Map
KSMercy Hospital PittsburgPittsburg66762NCT06580314Map
KSSalina Regional Health CenterSalina67401NCT04858334Map
KSUniversity of Kansas Health System Saint Francis CampusTopeka66606NCT04858334Map
KSUniversity of Kansas Hospital-Westwood Cancer CenterWestwood66205NCT04858334Map
KYFlaget Memorial HospitalBardstown40004NCT06580314Map
KYBaptist Health CorbinCorbin40701NCT06580314Map
KYCommonwealth Cancer Center-CorbinCorbin40701NCT06580314Map
KYBaptist Health LexingtonLexington40503NCT06580314Map
KYSaint Joseph HospitalLexington40504NCT06580314Map
KYSaint Joseph Hospital EastLexington40509NCT05564377Map
KYSaint Joseph Hospital EastLexington40509NCT06580314Map
KYSaint Joseph Radiation Oncology Resource CenterLexington40504NCT06580314Map
KYUniversity of KentuckyLexington40536NCT05568550Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT05554328Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT05564377Map
KYSaint Joseph LondonLondon40741NCT06580314Map
KYBaptist Health LouisvilleLouisville40207NCT06580314Map
KYJames Graham Brown Cancer Center ( Site 0058)Louisville40202NCT03486873Map
KYThe James Graham Brown Cancer Center at University of LouisvilleLouisville40202NCT06580314Map
KYUofL Health Medical Center NortheastLouisville40245NCT06580314Map
KYSaint Joseph Mount SterlingMount Sterling40353NCT06580314Map
KYBaptist Health PaducahPaducah42003NCT06580314Map
KYMercy Health-Paducah Cancer Center ( Site 0084)Paducah42003NCT03486873Map
LALSU Health Baton Rouge-North ClinicBaton Rouge70805NCT06580314Map
LAMary Bird Perkins Cancer CenterBaton Rouge70809NCT04858334Map
LAOur Lady of The LakeBaton Rouge70808NCT06580314Map
LAOur Lady of the Lake Medical OncologyBaton Rouge70817NCT06580314Map
LAOur Lady of the Lake Physician GroupBaton Rouge70808NCT06580314Map
LAWomen's Cancer Care ( Site 0088)Covington70433NCT03486873Map
LAOchsnerJefferson70121NCT06785636Map
LAWest Jefferson Medical CenterMarrero70072NCT06580314Map
LAEast Jefferson General HospitalMetairie70006NCT06580314Map
LALSU Healthcare Network / Metairie Multi-Specialty ClinicMetairie70006NCT06580314Map
LAOchsner Baptist Medical CenterNew Orleans70115NCT05554328Map
LAOchsner Baptist Medical CenterNew Orleans70115NCT06580314Map
LAOchsner Clinic Foundation ( Site 0021)New Orleans70121NCT06966700Map
LAOchsner Medical Center JeffersonNew Orleans70121NCT05554328Map
LAOchsner Medical Center JeffersonNew Orleans70121NCT05564377Map
LAOchsner Medical Center JeffersonNew Orleans70121NCT06580314Map
LAUniversity Medical Center New OrleansNew Orleans70112NCT06580314Map
LALouisiana State University Health Sciences Shreveport ( Site 0053)Shreveport71103NCT06966700Map
MEHarold Alfond Center for Cancer CareAugusta04330NCT02693535Map
MEHarold Alfond Center for Cancer CareAugusta04330NCT05554328Map
MEHarold Alfond Center for Cancer CareAugusta04330NCT05564377Map
MEJackson Laboratory - Maine Cancer Genomics InitiativeAugusta04330NCT02693535Map
MEWaldo County General HospitalBelfast04915NCT02693535Map
MESMHC Cancer Care and Blood Disorders -BiddefordBiddeford04005NCT02693535Map
MELafayette Family Cancer Center-EMMCBrewer04412NCT05554328Map
MELafayette Family Cancer Center-EMMCBrewer04412NCT05564377Map
MENorthern Light Cancer CareBrewer04412NCT02693535Map
MERaish Peavey Haskell Children's Cancer and Treatment CenterBrewer04412NCT02693535Map
MEMaineHealth Cancer Care -BrunswickBrunswick04011NCT02693535Map
MENew England Cancer SpecialistKennebunk04043NCT02693535Map
MEYork Hopsital Oncology & Infusion Care in KitteryKittery03904NCT02693535Map
MEStephens Memorial HospitalNorway04268NCT02693535Map
MEPenobscot Bay Medical CenterRockport04856NCT02693535Map
MESMHC Cancer Care and Blood Disorders -SandfordSanford04073NCT02693535Map
MEMaine Children's Cancer ProgramScarborough04074NCT02693535Map
MEMaine Medical Partner's Women's HealthScarborough04074NCT02693535Map
MEMaineHealth Maine Medical Center- ScarboroughScarborough04074NCT05554328Map
MEMaineHealth Maine Medical Center- ScarboroughScarborough04074NCT05564377Map
MEMaineHealth Maine Medical Center- ScarboroughScarborough04074NCT06580314Map
MENew England Cancer SpecialistScarborough04074NCT02693535Map
MEMaineHealth Cancer Care -South PortlandSouth Portland04106NCT02693535Map
MEMaineHealth Cancer Care and IV Therapy - South PortlandSouth Portland04106NCT05564377Map
MENew England Cancer SpecialistTopsham04086NCT02693535Map
MEYork Hospital Oncology & Infusion Care in WellsWells04090NCT02693535Map
MENew England Cancer Specialists ( Site 0051)Westbrook04092NCT06966700Map
MEYork Hospital Oncology & Infusion Care in YorkYork Village03909NCT02693535Map
MDJohns Hopkins HospitalBaltimore21287NCT06785636Map
MDJohns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimore21287NCT05498272Map
MDJohns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimore21228NCT03786796Map
MDJohns Hopkins University/Sidney Kimmel Cancer CenterBaltimore21287NCT06580314Map
MDMedStar Franklin Square Medical Center ( Site 0046)Baltimore21237NCT03486873Map
MDMercy Medical Center - Baltimore ( Site 0015)Baltimore21202NCT06966700Map
MDSidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore21287NCT06245889Map
MDSidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore21287NCT06245889Map
MDSidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056)Baltimore21287NCT03486873Map
MDUniversity of Maryland/Greenebaum Cancer CenterBaltimore21201NCT05554328Map
MDUniversity of Maryland/Greenebaum Cancer CenterBaltimore21201NCT05564377Map
MDNational Institutes of Health Clinical CenterBethesda20892NCT05554328Map
MDNational Institutes of Health Clinical CenterBethesda20892NCT05564377Map
MDNational Institutes of Health Clinical CenterBethesda20892NCT04086485Map
MDWalter Reed National Military Medical CenterBethesda20889-5600NCT05554328Map
MDWalter Reed National Military Medical CenterBethesda20889-5600NCT05564377Map
MDWalter Reed National Military Medical CenterBethesda20889-5600NCT06580314Map
MDMaryland Oncology Hematology (MOH) ( Site 8000)Columbia21044NCT03486873Map
MDUPMC Western MarylandCumberland21502NCT05554328Map
MDUPMC Western MarylandCumberland21502NCT05564377Map
MDChristiana Care - Union HospitalElkton21921NCT06580314Map
MABeth Israel Deaconess Medical CenterBoston02215NCT05463848Map
MABeth Israel Deaconess Medical CenterBoston02215NCT06488378Map
MABrigham and Women's HospitalBoston02215NCT06488378Map
MADana-Farber Cancer InstituteBoston02215NCT05463848Map
MADana-Farber Cancer InstituteBoston02215NCT05564377Map
MADana-Farber Cancer InstituteBoston02215NCT04585958Map
MADana-Farber Cancer InstituteBoston02215NCT06488378Map
MAMassachusetts General HospitalBoston02114NCT05463848Map
MATufts Medical CenterBoston02111NCT05554328Map
MATufts Medical CenterBoston02111NCT05564377Map
MABaystate Medical CenterSpringfield01199NCT05554328Map
MABaystate Medical CenterSpringfield01199NCT05564377Map
MABaystate Medical CenterSpringfield01199NCT06580314Map
MATufts Medical Center Cancer Center StonehamStoneham02180NCT05554328Map
MATufts Medical Center Cancer Center StonehamStoneham02180NCT05564377Map
MIMyMichigan Medical Center GratiotAlma48801NCT06580314Map
MIMyMichigan Medical Center AlpenaAlpena49707NCT06580314Map
MITrinity Health Ann Arbor HospitalAnn Arbor48106NCT02693535Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT05554328Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT05564377Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT04858334Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT06580314Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT05554328Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT05564377Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT04858334Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT06580314Map
MIVA Ann Arbor Healthcare System, Ann Arbor, MIAnn Arbor48105NCT04038502Map
MIBronson Battle CreekBattle Creek49017NCT05564377Map
MIBronson Battle CreekBattle Creek49017NCT06580314Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT05554328Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT05564377Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT04858334Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT06580314Map
MITrinity Health Medical Center - BrightonBrighton48114NCT05554328Map
MITrinity Health Medical Center - BrightonBrighton48114NCT05564377Map
MITrinity Health Medical Center - BrightonBrighton48114NCT04858334Map
MITrinity Health Medical Center - BrightonBrighton48114NCT06580314Map
MIUniversity of Michigan - Brighton Center for Specialty CareBrighton48116NCT05554328Map
MIUniversity of Michigan - Brighton Center for Specialty CareBrighton48116NCT05564377Map
MIUniversity of Michigan - Brighton Center for Specialty CareBrighton48116NCT06580314Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT05554328Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT05564377Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT04858334Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT06580314Map
MITrinity Health Medical Center - CantonCanton48188NCT05554328Map
MITrinity Health Medical Center - CantonCanton48188NCT05564377Map
MITrinity Health Medical Center - CantonCanton48188NCT04858334Map
MITrinity Health Medical Center - CantonCanton48188NCT06580314Map
MIChelsea HospitalChelsea48118NCT05554328Map
MIChelsea HospitalChelsea48118NCT05564377Map
MIChelsea HospitalChelsea48118NCT04858334Map
MIChelsea HospitalChelsea48118NCT06580314Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT05554328Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT05564377Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT04858334Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT06580314Map
MIHematology Oncology Consultants-ClarkstonClarkston48346NCT04858334Map
MIHematology Oncology Consultants-ClarkstonClarkston48346NCT06580314Map
MINewland Medical Associates-ClarkstonClarkston48346NCT06580314Map
MICorewell Health Dearborn HospitalDearborn48124NCT05554328Map
MICorewell Health Dearborn HospitalDearborn48124NCT05564377Map
MICorewell Health Dearborn HospitalDearborn48124NCT04858334Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT02693535Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT04858334Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT06580314Map
MIKarmanos Cancer InstituteDetroit48201NCT06785636Map
MIKarmanos Cancer Institute ( Site 0047)Detroit48201NCT03486873Map
MIHenry Ford River District HospitalEast China Township48054NCT04858334
MIHenry Ford River District HospitalEast China Township48054NCT06580314
MIOSF Saint Francis Hospital and Medical GroupEscanaba49829NCT05564377Map
MIOSF Saint Francis Hospital and Medical GroupEscanaba49829NCT06580314Map
MICorewell Health Farmington Hills HospitalFarmington Hills48336NCT05554328Map
MICorewell Health Farmington Hills HospitalFarmington Hills48336NCT05564377Map
MICorewell Health Farmington Hills HospitalFarmington Hills48336NCT04858334Map
MICancer Hematology Centers - FlintFlint48503NCT05554328Map
MICancer Hematology Centers - FlintFlint48503NCT05564377Map
MICancer Hematology Centers - FlintFlint48503NCT04858334Map
MICancer Hematology Centers - FlintFlint48503NCT06580314Map
MIGenesee Hematology Oncology PCFlint48503NCT06580314Map
MIGenesys Hurley Cancer InstituteFlint48503NCT02693535Map
MIGenesys Hurley Cancer InstituteFlint48503NCT05554328Map
MIGenesys Hurley Cancer InstituteFlint48503NCT05564377Map
MIGenesys Hurley Cancer InstituteFlint48503NCT04858334Map
MIGenesys Hurley Cancer InstituteFlint48503NCT06580314Map
MIHurley Medical CenterFlint48503NCT05554328Map
MIHurley Medical CenterFlint48503NCT05564377Map
MIHurley Medical CenterFlint48503NCT06580314Map
MIMyMichigan Medical Center GladwinGladwin48624NCT06580314Map
MICancer Research Consortium of West MichiganGrand Rapids49503NCT02693535Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT05564377Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT06580314Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT06580314Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT05564377Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT06580314Map
MIHenry Ford Saint John Hospital - AcademicGrosse Pointe Woods48236NCT04858334Map
MIHenry Ford Saint John Hospital - AcademicGrosse Pointe Woods48236NCT06580314Map
MIHenry Ford Saint John Hospital - BreastGrosse Pointe Woods48236NCT06580314Map
MIHenry Ford Saint John Hospital - Van ElslanderGrosse Pointe Woods48236NCT04858334Map
MIHenry Ford Saint John Hospital - Van ElslanderGrosse Pointe Woods48236NCT06580314Map
MIBeacon KalamazooKalamazoo49048NCT05564377Map
MIBeacon KalamazooKalamazoo49048NCT06580314Map
MIBeacon Kalamazoo Cancer CenterKalamazoo49009NCT05564377Map
MIBeacon Kalamazoo Cancer CenterKalamazoo49009NCT06580314Map
MIBronson Methodist HospitalKalamazoo49007NCT05564377Map
MIBronson Methodist HospitalKalamazoo49007NCT06580314Map
MIWest Michigan Cancer CenterKalamazoo49007NCT05564377Map
MIWest Michigan Cancer CenterKalamazoo49007NCT06580314Map
MIHerbert-Herman Cancer Center, Sparrow HospitalLansing48912NCT01042379Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT02693535Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT05554328Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT05564377Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT06580314Map
MITrinity Health Livonia HospitalLivonia48154NCT02693535Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT05554328Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT05564377Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT04858334Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT06580314Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT05554328Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT05564377Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT04858334Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT06580314Map
MIHenry Ford Warren Hospital - Breast MacombMacomb48044NCT06580314Map
MIMyMichigan Medical Center MidlandMidland48670NCT06580314Map
MIMyMichigan Medical Center Mount PleasantMount Pleasant48858NCT06580314Map
MITrinity Health Muskegon HospitalMuskegon49444NCT05564377Map
MITrinity Health Muskegon HospitalMuskegon49444NCT06580314Map
MICorewell Health Lakeland Hospitals - Niles HospitalNiles49120NCT05564377Map
MICorewell Health Lakeland Hospitals - Niles HospitalNiles49120NCT06580314Map
MICancer and Hematology Centers of Western Michigan - Norton ShoresNorton Shores49444NCT05564377Map
MICancer and Hematology Centers of Western Michigan - Norton ShoresNorton Shores49444NCT06580314Map
MIHenry Ford Health Providence Novi HospitalNovi48374NCT04858334Map
MIHope Cancer CenterPontiac48341NCT06580314Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT05564377Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT04858334Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT06580314Map
MINewland Medical Associates-PontiacPontiac48341NCT04858334Map
MINewland Medical Associates-PontiacPontiac48341NCT06580314Map
MITrinity Health Oakland HospitalPontiac48341NCT02693535Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT05554328Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT05564377Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT04858334Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT06580314Map
MICorewell Health Reed City HospitalReed City49677NCT05564377Map
MICorewell Health Reed City HospitalReed City49677NCT06580314Map
MICorewell Health Children'sRoyal Oak48073NCT05564377Map
MICorewell Health William Beaumont University HospitalRoyal Oak48073NCT05554328Map
MICorewell Health William Beaumont University HospitalRoyal Oak48073NCT05564377Map
MICorewell Health William Beaumont University HospitalRoyal Oak48073NCT04858334Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT02693535Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT05564377Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT04858334Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT06580314Map
MICorewell Health Lakeland Hospitals - Marie Yeager Cancer CenterSaint Joseph49085NCT05564377Map
MICorewell Health Lakeland Hospitals - Marie Yeager Cancer CenterSaint Joseph49085NCT06580314Map
MICorewell Health Lakeland Hospitals - Saint Joseph HospitalSaint Joseph49085NCT05564377Map
MICorewell Health Lakeland Hospitals - Saint Joseph HospitalSaint Joseph49085NCT06580314Map
MIHenry Ford Health Providence Southfield HospitalSouthfield48075NCT04858334Map
MIMyMichigan Medical Center TawasTawas City48764NCT05564377Map
MIMyMichigan Medical Center TawasTawas City48764NCT04858334Map
MIMyMichigan Medical Center TawasTawas City48764NCT06580314Map
MIMichigan Cancer Research ConsortiumTraverse City48341NCT02693535Map
MIMunson Medical CenterTraverse City49684NCT05564377Map
MIMunson Medical CenterTraverse City49684NCT06580314Map
MICorewell Health Beaumont Troy HospitalTroy48085NCT05554328Map
MICorewell Health Beaumont Troy HospitalTroy48085NCT05564377Map
MICorewell Health Beaumont Troy HospitalTroy48085NCT04858334Map
MIHenry Ford Health Warren HospitalWarren48093NCT02693535Map
MIHenry Ford Health Warren HospitalWarren48093NCT04858334Map
MIHenry Ford Health Warren HospitalWarren48093NCT06580314Map
MIHenry Ford Madison Heights Hospital - BreastWarren48093NCT06580314Map
MIHenry Ford Warren Hospital - GLCMSWarren48093NCT04858334Map
MIHenry Ford Warren Hospital - GLCMSWarren48093NCT06580314Map
MIUniversity of Michigan Health - WestWyoming49519NCT05564377Map
MIUniversity of Michigan Health - WestWyoming49519NCT06580314Map
MIHuron Gastroenterology PCYpsilanti48106NCT05554328Map
MIHuron Gastroenterology PCYpsilanti48106NCT05564377Map
MIHuron Gastroenterology PCYpsilanti48106NCT04858334Map
MIHuron Gastroenterology PCYpsilanti48106NCT06580314Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT05554328Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT05564377Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT04858334Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT06580314Map
MNRiverwood Healthcare CenterAitkin56431NCT06580314Map
MNEssentia Health - Baxter ClinicBaxter56425NCT06580314Map
MNSanford Joe Lueken Cancer CenterBemidji56601NCT05564377Map
MNSanford Joe Lueken Cancer CenterBemidji56601NCT04858334Map
MNSanford Joe Lueken Cancer CenterBemidji56601NCT06580314Map
MNEssentia Health Saint Joseph's Medical CenterBrainerd56401NCT06580314Map
MNMinnesota Oncology - BurnsvilleBurnsville55337NCT06580314Map
MNCambridge Medical CenterCambridge55008NCT06580314Map
MNMercy HospitalCoon Rapids55433NCT05554328Map
MNMercy HospitalCoon Rapids55433NCT05564377Map
MNMercy HospitalCoon Rapids55433NCT04858334Map
MNMercy HospitalCoon Rapids55433NCT06580314Map
MNEssentia Health - Saint Joseph's Crosslake ClinicCrosslake56442NCT06580314Map
MNEssentia Health - Deer River ClinicDeer River56636NCT05554328Map
MNEssentia Health - Deer River ClinicDeer River56636NCT05564377Map
MNEssentia Health - Deer River ClinicDeer River56636NCT06580314Map
MNEssentia Health Saint Mary's - Detroit Lakes ClinicDetroit Lakes56501NCT06580314Map
MNEssentia Health Cancer CenterDuluth55805NCT05554328Map
MNEssentia Health Cancer CenterDuluth55805NCT05564377Map
MNEssentia Health Cancer CenterDuluth55805NCT06580314Map
MNEssentia Health Saint Mary's Medical CenterDuluth55805NCT06580314Map
MNMiller-Dwan HospitalDuluth55805NCT06580314Map
MNSaint Luke's Hospital of DuluthDuluth55805NCT04858334Map
MNFairview Southdale HospitalEdina55435NCT05554328Map
MNFairview Southdale HospitalEdina55435NCT05564377Map
MNFairview Southdale HospitalEdina55435NCT06580314Map
MNEssentia Health - Ely ClinicEly55731NCT06580314Map
MNEssentia Health - FosstonFosston56542NCT06580314Map
MNEssentia Health Hibbing ClinicHibbing55746NCT05554328Map
MNEssentia Health Hibbing ClinicHibbing55746NCT05564377Map
MNEssentia Health Hibbing ClinicHibbing55746NCT06580314Map
MNEssentia Health - International Falls ClinicInternational Falls56649NCT06580314Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT05554328Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT05564377Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT06580314Map
MNMinnesota Oncology Hematology PA-MaplewoodMaplewood55109NCT06580314Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT05564377Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT06580314Map
MNAvera Cancer Institute at MarshallMarshall56258NCT06580314Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT05554328Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT05564377Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT04858334Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT06580314Map
MNHealth Partners IncMinneapolis55454NCT06580314Map
MNHennepin County Medical CenterMinneapolis55415NCT06580314Map
MNMinneapolis VA Health Care System, Minneapolis, MNMinneapolis55417-2309NCT04038502Map
MNUniversity of MinnesotaMinneapolis55455NCT01042379Map
MNUniversity of Minnesota/Masonic Cancer CenterMinneapolis55455NCT06580314Map
MNMonticello Cancer CenterMonticello55362NCT06580314Map
MNEssentia Health - Moose Lake ClinicMoose Lake55767NCT06580314Map
MNNew Ulm Medical CenterNew Ulm56073NCT06580314Map
MNEssentia Health - Park RapidsPark Rapids56470NCT06580314Map
MNEssentia Health - Saint Joseph's Pequot Lakes ClinicPequot Lakes56472NCT06580314Map
MNEssentia Health - Saint Joseph's Pine River ClinicPine River56474NCT06580314Map
MNFairview Northland Medical CenterPrinceton55371NCT06580314Map
MNNorth Memorial Medical Health CenterRobbinsdale55422NCT06580314Map
MNExelixis Clinical Site #14Rochester55905NCT05932862Map
MNMayo ClinicRochester55905NCT01042379Map
MNMayo Clinic in RochesterRochester55905NCT05554328Map
MNMayo Clinic in RochesterRochester55905NCT05564377Map
MNMayo Clinic in RochesterRochester55905NCT04633239Map
MNMayo Clinic in RochesterRochester55905NCT04585958Map
MNMayo Clinic in RochesterRochester55905NCT06580314Map
MNMayo Clinic in Rochester, Minnesota ( Site 0002)Rochester55905NCT03486873Map
MNMetro Minnesota Community Oncology Research Consortium, Hennepin County Medical CenterSaint Louis Park55416NCT01042379Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT05554328Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT05564377Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT04858334Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT06580314Map
MNRegions HospitalSaint Paul55101NCT05554328Map
MNRegions HospitalSaint Paul55101NCT05564377Map
MNRegions HospitalSaint Paul55101NCT04858334Map
MNRegions HospitalSaint Paul55101NCT06580314Map
MNUnited HospitalSaint Paul55102NCT05554328Map
MNUnited HospitalSaint Paul55102NCT05564377Map
MNUnited HospitalSaint Paul55102NCT04858334Map
MNUnited HospitalSaint Paul55102NCT06580314Map
MNEssentia Health SandstoneSandstone55072NCT05554328Map
MNEssentia Health SandstoneSandstone55072NCT05564377Map
MNEssentia Health SandstoneSandstone55072NCT06580314Map
MNSaint Francis Regional Medical CenterShakopee55379NCT06580314Map
MNEssentia Health - Saint Joseph's Staples ClinicStaples56479NCT06580314Map
MNLakeview HospitalStillwater55082NCT06580314Map
MNEssentia Health Virginia ClinicVirginia55792NCT05554328Map
MNEssentia Health Virginia ClinicVirginia55792NCT05564377Map
MNEssentia Health Virginia ClinicVirginia55792NCT06580314Map
MNRidgeview Medical CenterWaconia55387NCT06580314Map
MNRice Memorial HospitalWillmar56201NCT06580314Map
MNMinnesota Oncology Hematology PA-WoodburyWoodbury55125NCT06580314Map
MNFairview Lakes Medical CenterWyoming55092NCT06580314Map
MSBaptist Memorial Hospital and Cancer Center-Golden TriangleColumbus39705NCT05564377Map
MSBaptist Memorial Hospital and Cancer Center-Golden TriangleColumbus39705NCT04858334Map
MSBaptist Cancer Center-GrenadaGrenada38901NCT05564377Map
MSBaptist Cancer Center-GrenadaGrenada38901NCT04858334Map
MSBaptist Memorial Hospital and Cancer Center-Union CountyNew Albany38652NCT05564377Map
MSBaptist Memorial Hospital and Cancer Center-Union CountyNew Albany38652NCT04858334Map
MSBaptist Memorial Hospital and Cancer Center-OxfordOxford38655NCT05564377Map
MSBaptist Memorial Hospital and Cancer Center-OxfordOxford38655NCT04858334Map
MSBaptist Memorial Hospital and Cancer Center-DesotoSouthhaven38671NCT05564377Map
MSBaptist Memorial Hospital and Cancer Center-DesotoSouthhaven38671NCT04858334Map
MOMercy Oncology and Hematology - Clayton-ClarksonBallwin63011NCT04858334Map
MOMercy Oncology and Hematology - Clayton-ClarksonBallwin63011NCT06580314Map
MOCentral Care Cancer Center - BolivarBolivar65613NCT06580314Map
MOCox Cancer Center BransonBranson65616NCT06580314Map
MOMercy Cancer Center - Cape GirardeauCape Girardeau63703NCT06580314Map
MOSaint Francis Medical CenterCape Girardeau63703NCT05554328Map
MOSaint Francis Medical CenterCape Girardeau63703NCT05564377Map
MOSaint Francis Medical CenterCape Girardeau63703NCT04858334Map
MOSaint Francis Medical CenterCape Girardeau63703NCT06580314Map
MOSaint Luke's HospitalChesterfield63017NCT05564377Map
MOSiteman Cancer Center at Saint Peters HospitalCity of Saint Peters63376NCT05564377Map
MOMU Health - University Hospital/Ellis Fischel Cancer CenterColumbia65212NCT06580314Map
MOSiteman Cancer Center at West County HospitalCreve Coeur63141NCT05564377Map
MOParkland Health Center - FarmingtonFarmington63640NCT05554328Map
MOParkland Health Center - FarmingtonFarmington63640NCT05564377Map
MOParkland Health Center - FarmingtonFarmington63640NCT04858334Map
MOParkland Health Center - FarmingtonFarmington63640NCT06580314Map
MOFreeman Health SystemJoplin64804NCT06580314Map
MOMercy Hospital JoplinJoplin64804NCT06580314Map
MOKansas City VA Medical Center, Kansas City, MOKansas City64128NCT04038502Map
MOSaint Luke's Cancer Institute ( Site 0059)Kansas City64111NCT06966700Map
MOSaint Luke's Hospital of Kansas CityKansas City64111NCT04858334Map
MOUniversity Health Truman Medical CenterKansas City64108NCT04858334Map
MOUniversity of Kansas Cancer Center - NorthKansas City64154NCT04858334Map
MOSaint Luke's East - Lee's SummitLee's Summit64086NCT04858334Map
MOUniversity of Kansas Cancer Center - Lee's SummitLee's Summit64064NCT04858334Map
MOLake Regional HospitalOsage Beach65065NCT06580314Map
MOMercy Clinic-Rolla-Cancer and HematologyRolla65401NCT06580314Map
MOPhelps Health Delbert Day Cancer InstituteRolla65401NCT05564377Map
MOPhelps Health Delbert Day Cancer InstituteRolla65401NCT06580314Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT05564377Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT06580314Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT05554328Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT05564377Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT04858334Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT06580314Map
MOCoxHealth South HospitalSpringfield65807NCT06580314Map
MOMercy Hospital SpringfieldSpringfield65804NCT05564377Map
MOMercy Hospital SpringfieldSpringfield65804NCT04858334Map
MOMercy Hospital SpringfieldSpringfield65804NCT06580314Map
MOMercy Hospital Saint LouisSt Louis63141NCT05564377Map
MOMercy Hospital Saint LouisSt Louis63141NCT04858334Map
MOMercy Hospital Saint LouisSt Louis63141NCT06580314Map
MOMercy Hospital SouthSt Louis63128NCT05564377Map
MOMercy Hospital SouthSt Louis63128NCT04858334Map
MOMercy Hospital SouthSt Louis63128NCT06580314Map
MOMercy Infusion Center - ChippewaSt Louis63109NCT06580314Map
MOMissouri Baptist Medical CenterSt Louis63131NCT05554328Map
MOMissouri Baptist Medical CenterSt Louis63131NCT05564377Map
MOMissouri Baptist Medical CenterSt Louis63131NCT04858334Map
MOMissouri Baptist Medical CenterSt Louis63131NCT06580314Map
MOSiteman Cancer CenterSt Louis63108NCT06785636Map
MOSiteman Cancer Center at Christian HospitalSt Louis63136NCT05564377Map
MOSiteman Cancer Center-South CountySt Louis63129NCT05564377Map
MOWashington University School of MedicineSt Louis63110NCT05554328Map
MOWashington University School of MedicineSt Louis63110NCT05564377Map
MOWashington University School of MedicineSt Louis63110NCT06580314Map
MOWashington University School of Medicine in St. LouisSt Louis63110NCT06915025Map
MOWashington University Siteman Cancer Center ( Site 0031)St Louis63110NCT06966700Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT05554328Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT05564377Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT04858334Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT06580314Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT05554328Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT05564377Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT04858334Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT06580314Map
MOMercy Hospital WashingtonWashington63090NCT06580314Map
MTCommunity Hospital of AnacondaAnaconda59711NCT05554328Map
MTCommunity Hospital of AnacondaAnaconda59711NCT05564377Map
MTCommunity Hospital of AnacondaAnaconda59711NCT04858334Map
MTCommunity Hospital of AnacondaAnaconda59711NCT06580314Map
MTBillings Clinic Cancer CenterBillings59101NCT05554328Map
MTBillings Clinic Cancer CenterBillings59101NCT05564377Map
MTBillings Clinic Cancer CenterBillings59101NCT04858334Map
MTBillings Clinic Cancer CenterBillings59101NCT06580314Map
MTIntermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0003)Billings59102NCT06797635Map
MTIntermountain Health West End ClinicBillings59106NCT06580314Map
MTSaint Vincent Frontier Cancer CenterBillings59102NCT06580314Map
MTSaint Vincent HealthcareBillings59101NCT06580314Map
MTBozeman Health Deaconess HospitalBozeman59715NCT05554328Map
MTBozeman Health Deaconess HospitalBozeman59715NCT05564377Map
MTBozeman Health Deaconess HospitalBozeman59715NCT04858334Map
MTBozeman Health Deaconess HospitalBozeman59715NCT06580314Map
MTSaint James Community Hospital and Cancer Treatment CenterButte59701NCT06580314Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT05554328Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT05564377Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT04858334Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT06580314Map
MTGreat Falls ClinicGreat Falls59405NCT06580314Map
MTHi-Line Sletten Cancer CenterHavre59501NCT06580314Map
MTBenefis Helena Specialty CenterHelena59601NCT06580314Map
MTLogan Health Medical CenterKalispell59901NCT05554328Map
MTLogan Health Medical CenterKalispell59901NCT05564377Map
MTLogan Health Medical CenterKalispell59901NCT04858334Map
MTLogan Health Medical CenterKalispell59901NCT06580314Map
MTCommunity Medical CenterMissoula59804NCT05554328Map
MTCommunity Medical CenterMissoula59804NCT05564377Map
MTCommunity Medical CenterMissoula59804NCT04858334Map
MTCommunity Medical CenterMissoula59804NCT06580314Map
MTSaint Patrick Hospital - Community HospitalMissoula59802NCT06580314Map
NECHI Health Saint FrancisGrand Island68803NCT06580314Map
NECHI Health Good SamaritanKearney68847NCT06580314Map
NECancer Partners of Nebraska ( Site 0068)Lincoln68516NCT06966700Map
NEAlegent Health Bergan Mercy Medical CenterOmaha68124NCT06580314Map
NEAlegent Health Immanuel Medical CenterOmaha68122NCT06580314Map
NEAlegent Health Lakeside HospitalOmaha68130NCT06580314Map
NECreighton University Medical CenterOmaha68131NCT06580314Map
NENebraska Cancer SpecialistsOmaha68130NCT06785636Map
NENebraska Cancer Specialists/Oncology Hematology West PC - MECCOmaha68114NCT04858334Map
NENebraska Cancer Specialists/Oncology Hematology West PC - MECCOmaha68114NCT06580314Map
NENebraska Methodist HospitalOmaha68114NCT04858334Map
NENebraska Methodist HospitalOmaha68114NCT06580314Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT02693535Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT05564377Map
NVComprehensive Cancer Centers of Nevada ( Site 0043)Las Vegas89169NCT03486873Map
NVOptum Care Cancer Center ( Site 0050)Las Vegas89102NCT06966700Map
NVOptumCare Cancer Care at CharlestonLas Vegas89102NCT05554328Map
NVOptumCare Cancer Care at CharlestonLas Vegas89102NCT05564377Map
NVOptumCare Cancer Care at CharlestonLas Vegas89102NCT04858334Map
NVOptumCare Cancer Care at Fort ApacheLas Vegas89183NCT05554328Map
NVOptumCare Cancer Care at Fort ApacheLas Vegas89183NCT05564377Map
NVOptumCare Cancer Care at Fort ApacheLas Vegas89183NCT04858334Map
NVSummerlin Hospital Medical CenterLas Vegas89144NCT05564377Map
NVRenown Regional Medical CenterReno89502NCT04858334Map
NVRenown Regional Medical Center ( Site 0041)Reno89502NCT06966700Map
NHNH Oncology - Hematology, PAConcord03103NCT02693535Map
NHDartmouth Cancer CenterLebanon03756NCT05900895Map
NHDartmouth Hitchcock Medical Center/Dartmouth Cancer CenterLebanon03756NCT04858334Map
NHSolinsky Center for Cancer CareManchester03103NCT02693535Map
NHNew England Cancer SpecialistPortsmouth03801NCT02693535Map
NJMemorial Sloan Kettering Basking RidgeBasking Ridge07920NCT04858334Map
NJMemorial Sloan Kettering Basking RidgeBasking Ridge07920NCT06580314Map
NJMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge07920NCT04683679Map
NJMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge07920NCT05188508Map
NJSummit Medical GroupBerkeley Heights07922NCT06580314Map
NJCooper Hospital University Medical CenterCamden08103NCT04858334Map
NJCooper Hospital University Medical CenterCamden08103NCT06580314Map
NJHunterdon Medical CenterFlemington08822NCT05564377Map
NJSummit Health - Florham Park CampusFlorham Park07932NCT06580314Map
NJHackensack Univ Medical Center (HUMC) ( Site 0007)Hackensack07601NCT06966700Map
NJThe Cancer Institute of New Jersey HamiltonHamilton08690NCT06580314Map
NJJersey City Medical CenterJersey City07302NCT05554328Map
NJJersey City Medical CenterJersey City07302NCT06580314Map
NJMonmouth Medical Center Southern CampusLakewood08701NCT05554328Map
NJMonmouth Medical Center Southern CampusLakewood08701NCT05564377Map
NJSaint Barnabas Medical CenterLivingston07039NCT05564377Map
NJMonmouth Medical CenterLong Branch07740NCT05554328Map
NJMonmouth Medical CenterLong Branch07740NCT05564377Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT05554328Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT05564377Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT04858334Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT06580314Map
NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown07748NCT04683679Map
NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown07748NCT05188508Map
NJMemorial Sloan Kettering BergenMontvale07645NCT04858334Map
NJMemorial Sloan Kettering BergenMontvale07645NCT06580314Map
NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale07645NCT04683679Map
NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale07645NCT05188508Map
NJCancer Institute of New Jersey ( Site 0025)New Brunswick08901NCT03486873Map
NJExelixis Clinical Site #9New Brunswick08901NCT05932862Map
NJRutgers Cancer Institute of New JerseyNew Brunswick08903NCT05554328Map
NJRutgers Cancer Institute of New JerseyNew Brunswick08903NCT05564377Map
NJRutgers Cancer Institute of New JerseyNew Brunswick08903NCT01042379Map
NJRutgers Cancer Institute of New JerseyNew Brunswick08903NCT06580314Map
NJRutgers Cancer Institute of New Jersey ( Site 0076)New Brunswick08901NCT06966700Map
NJSidney Kimmel Cancer Center Washington TownshipSewell08080NCT05554328Map
NJSidney Kimmel Cancer Center Washington TownshipSewell08080NCT05564377Map
NJSidney Kimmel Cancer Center Washington TownshipSewell08080NCT06580314Map
NJRobert Wood Johnson University Hospital SomersetSomerville08876NCT05564377Map
NJRobert Wood Johnson University Hospital SomersetSomerville08876NCT06580314Map
NJHoly Name Medical Center /ID# 279017Teaneck07666NCT07024784Map
NJCommunity Medical CenterToms River08755NCT05564377Map
NJMD Anderson Cancer Center at Cooper-VoorheesVoorhees Township08043NCT04858334Map
NMLovelace Medical Center - Saint Joseph SquareAlbuquerque87102NCT02693535Map
NMPresbyterian Kaseman HospitalAlbuquerque87110NCT02693535Map
NMThe University of New Mexico Comprehensive Cancer CenterAlbuquerque87131NCT02693535Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87106NCT05554328Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87106NCT05564377Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87106NCT04858334Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87106NCT06580314Map
NMMemorial Medical CenterLas Cruces88011NCT02693535Map
NMPresbyterian Rust Medical CenterRio Rancho87124NCT02693535Map
NYNYU Langone Hospital - BrooklynBrooklyn11220NCT06580314Map
NYRoswell Park Cancer InstituteBuffalo14263NCT05554328Map
NYRoswell Park Cancer InstituteBuffalo14263NCT05564377Map
NYRoswell Park Cancer InstituteBuffalo14263NCT04858334Map
NYRoswell Park Cancer InstituteBuffalo14263NCT01042379Map
NYRoswell Park Cancer InstituteBuffalo14263NCT06580314Map
NYMemorial Sloan Kettering CommackCommack11725NCT05554328Map
NYMemorial Sloan Kettering CommackCommack11725NCT05564377Map
NYMemorial Sloan Kettering CommackCommack11725NCT04858334Map
NYMemorial Sloan Kettering CommackCommack11725NCT06580314Map
NYMemorial Sloan Kettering Commack (Limited Protocol Activities)Commack11725NCT04683679Map
NYMemorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities)Commack11725NCT05188508Map
NYGlens Falls HospitalGlens Falls12801NCT06580314Map
NYMemorial Sloan Kettering WestchesterHarrison10604NCT05554328Map
NYMemorial Sloan Kettering WestchesterHarrison10604NCT05564377Map
NYMemorial Sloan Kettering WestchesterHarrison10604NCT04858334Map
NYMemorial Sloan Kettering WestchesterHarrison10604NCT06580314Map
NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison10604NCT04683679Map
NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison10604NCT05188508Map
NYNorthwell Health Monter Cancer CenterLake Success11042NCT02693535Map
NYNorthwell Health/Center for Advanced MedicineLake Success11042NCT04858334Map
NYNYU Langone Hospital - Long IslandMineola11501NCT05564377Map
NYNYU Langone Hospital - Long IslandMineola11501NCT04858334Map
NYNYU Langone Hospital - Long IslandMineola11501NCT06580314Map
NYNorthern Westchester HospitalMount Kisco10549NCT02693535Map
NYCohen Children's Medical CenterNew Hyde Park11040NCT02693535Map
NYBellevue Hospital CenterNew York10016NCT06580314Map
NYColumbia University Irving Medical CenterNew York10032NCT05498272Map
NYColumbia University Medical CenterNew York10032NCT01042379Map
NYExelixis Clinical Site #5New York10029NCT05932862Map
NYLaura and Isaac Perlmutter Cancer Center / NYU Langone HealthNew York10016NCT01042379Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT05564377Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT04858334Map
NYLaura and Isaac Perlmutter Cancer Center at NYU LangoneNew York10016NCT06580314Map
NYLaura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032)New York10016NCT03486873Map
NYManhattan Campus of the VA NY Harbor Healthcare System, New York, NYNew York10010NCT04038502Map
NYManhattan Eye, Ear, and Throat HospitalNew York10065NCT02693535Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05463848Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05498272Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05554328Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05564377Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT04711824Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT04858334Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT06580314Map
NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)New York10065NCT04683679Map
NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)New York10065NCT05188508Map
NYMount Sinai ChelseaNew York10011NCT06580314Map
NYMount Sinai HospitalNew York10029NCT05564377Map
NYMount Sinai HospitalNew York10029NCT06580314Map
NYMount Sinai WestNew York10019NCT06580314Map
NYStaten Island University HospitalNew York10305NCT02693535Map
NYQueens Cancer CenterRego Park11374NCT02693535Map
NYRochester General HospitalRochester14621NCT04858334Map
NYUnity Park Ridge CampusRochester14626NCT04858334Map
NYUniversity of RochesterRochester14642NCT06580314Map
NYUniversity of Rochester Wilmot Cancer InstituteRochester14642NCT01042379Map
NYPhelps HospitalSleepy Hollow10591NCT02693535Map
NYState University of New York Upstate Medical UniversitySyracuse13210NCT05554328Map
NYState University of New York Upstate Medical UniversitySyracuse13210NCT05564377Map
NYState University of New York Upstate Medical UniversitySyracuse13210NCT06580314Map
NYMontefiore Medical CenterThe Bronx10467NCT01042379Map
NYMontefiore Medical Center - Moses CampusThe Bronx10467NCT05564377Map
NYMontefiore Medical Center-Einstein CampusThe Bronx10461NCT05564377Map
NYMontefiore Medical Center-Weiler HospitalThe Bronx10461NCT05564377Map
NYMemorial Sloan Kettering NassauUniondale11553NCT04858334Map
NYMemorial Sloan Kettering NassauUniondale11553NCT06580314Map
NYMemorial Sloan Kettering Nassau (All Protocol Activities)Uniondale11553NCT04683679Map
NYMemorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale11553NCT05188508Map
NYWilmot Cancer Institute at WebsterWebster14580NCT06580314Map
NYWhite Plains Hospital-Center for Cancer Care ( Site 0069)White Plains10601NCT03486873Map
NCCone Health MedCenter AsheboroAsheboro27205NCT05554328Map
NCCone Health MedCenter AsheboroAsheboro27205NCT05564377Map
NCHope Women's Cancer Centers-AshevilleAsheville28816NCT05554328Map
NCMission HospitalAsheville28801NCT05554328Map
NCCone Health Cancer Center at Alamance RegionalBurlington27215NCT05554328Map
NCCone Health Cancer Center at Alamance RegionalBurlington27215NCT05564377Map
NCWakeMed Cancer Care - Waverly Hematology & Medical Oncology ( Site 0074)Cary27518NCT03486873Map
NCLineberger Comprehensive Cancer CenterChapel Hill27599NCT02693535Map
NCUNC Lineberger Comprehensive Cancer CenterChapel Hill27599NCT06580314Map
NCUniversity of North Carolina at Chapel HillChapel Hill27899NCT04711824Map
NCUniversity of North Carolina at Chapel Hill ( Site 0040)Chapel Hill27514NCT03486873Map
NCAtrium Health's Levine Cancer InstituteCharlotte28277NCT02693535Map
NCSoutheastern Medical Oncology Center-ClintonClinton28328NCT05564377Map
NCSoutheastern Medical Oncology Center-ClintonClinton28328NCT04858334Map
NCDuke Cancer Center ( Site 0028)Durham27710NCT03486873Map
NCDuke Cancer InstituteDurham27710NCT04711824Map
NCDuke University medical centerDurham27710NCT06785636Map
NCDuke University Medical CenterDurham27710NCT05554328Map
NCDuke University Medical CenterDurham27710NCT05564377Map
NCDuke University Medical CenterDurham27710NCT06580314Map
NCDurham VA Medical Center, Durham, NCDurham27705-3875NCT04038502Map
NCSoutheastern Medical Oncology Center-GoldsboroGoldsboro27534NCT05564377Map
NCSoutheastern Medical Oncology Center-GoldsboroGoldsboro27534NCT04858334Map
NCCone Health Cancer CenterGreensboro27403NCT05554328Map
NCCone Health Cancer CenterGreensboro27403NCT05564377Map
NCCone Health Cancer Center at Drawbridge ParkwayGreensboro27410NCT05554328Map
NCCone Health Cancer Center at Drawbridge ParkwayGreensboro27410NCT05564377Map
NCHayworth Cancer CenterHigh Point27262NCT05564377Map
NCSoutheastern Medical Oncology Center-JacksonvilleJacksonville28546NCT05564377Map
NCSoutheastern Medical Oncology Center-JacksonvilleJacksonville28546NCT04858334Map
NCDuke Women's Cancer Care RaleighRaleigh27607NCT05554328Map
NCDuke Women's Cancer Care RaleighRaleigh27607NCT05564377Map
NCDuke Women's Cancer Care RaleighRaleigh27607NCT06580314Map
NCAnnie Penn Memorial HospitalReidsville27320NCT05554328Map
NCAnnie Penn Memorial HospitalReidsville27320NCT05564377Map
NCWake Forest Baptist Comprehensive Cancer CenterWinston-Salem27157NCT01042379Map
NCWake Forest University Health SciencesWinston-Salem27157NCT05564377Map
NCWake Forest University Health SciencesWinston-Salem27157NCT04633239Map
NDSanford Bismarck Medical CenterBismarck58501NCT05554328Map
NDSanford Bismarck Medical CenterBismarck58501NCT05564377Map
NDSanford Bismarck Medical CenterBismarck58501NCT04858334Map
NDSanford Bismarck Medical CenterBismarck58501NCT06580314Map
NDSanford Health- BismarckBismarck58501NCT02693535Map
NDEssentia Health Cancer Center-South University ClinicFargo58103NCT06580314Map
NDSanford Broadway Medical CenterFargo58122NCT05554328Map
NDSanford Broadway Medical CenterFargo58122NCT05564377Map
NDSanford Broadway Medical CenterFargo58122NCT04858334Map
NDSanford Broadway Medical CenterFargo58122NCT06580314Map
NDSanford Health- FargoFargo58122NCT02693535Map
NDSanford Roger Maris Cancer CenterFargo58122NCT05554328Map
NDSanford Roger Maris Cancer CenterFargo58122NCT05564377Map
NDSanford Roger Maris Cancer CenterFargo58122NCT04858334Map
NDSanford Roger Maris Cancer CenterFargo58122NCT06580314Map
NDAltru Health System ( Site 0057)Grand Forks58201NCT06966700Map
NDEssentia Health - Jamestown ClinicJamestown58401NCT06580314Map
OHOhioHealth O'Bleness HospitalAthens45701NCT05564377Map
OHOhioHealth O'Bleness HospitalAthens45701NCT06580314Map
OHUH Seidman Cancer Center at UH Avon Health CenterAvon44011NCT05554328Map
OHUH Seidman Cancer Center at UH Avon Health CenterAvon44011NCT05564377Map
OHUHHS-Chagrin Highlands Medical CenterBeachwood44122NCT05554328Map
OHUHHS-Chagrin Highlands Medical CenterBeachwood44122NCT05564377Map
OHUHHS-Chagrin Highlands Medical CenterBeachwood44122NCT06580314Map
OHStrecker Cancer Center-BelpreBelpre45714NCT05554328Map
OHStrecker Cancer Center-BelpreBelpre45714NCT05564377Map
OHAultman Health FoundationCanton44710NCT05554328Map
OHAultman Health FoundationCanton44710NCT05564377Map
OHMiami Valley Hospital SouthCenterville45459NCT05554328Map
OHMiami Valley Hospital SouthCenterville45459NCT05564377Map
OHMiami Valley Hospital SouthCenterville45459NCT04858334Map
OHGeauga HospitalChardon44024NCT06580314Map
OHAdena Regional Medical CenterChillicothe45601NCT05554328Map
OHAdena Regional Medical CenterChillicothe45601NCT05564377Map
OHBethesda North HospitalCincinnati45242NCT06580314Map
OHGood Samaritan Hospital - CincinnatiCincinnati45220NCT05564377Map
OHGood Samaritan Hospital - CincinnatiCincinnati45220NCT06580314Map
OHGood Samaritan Hospital-TriHealth Cancer institute ( Site 0027)Cincinnati45220NCT06966700Map
OHTriHealth Cancer Institute-AndersonCincinnati45255NCT06580314Map
OHTriHealth Cancer Institute-WestsideCincinnati45247NCT06580314Map
OHUniversity of CincinnatiCincinnati45229NCT05498272Map
OHUniversity of Cincinnati Medical CenterCincinnati45219NCT02693535Map
OHUniversity of Cincinnati Medical Center. /ID# 278925Cincinnati45219NCT07024784Map
OHCall for Information (Investigational Site 2091)Cleveland44195NCT02861573Map
OHCase Western Reserve UniversityCleveland44106NCT05554328Map
OHCase Western Reserve UniversityCleveland44106NCT05564377Map
OHCase Western Reserve UniversityCleveland44106NCT06580314Map
OHCleveland ClinicCleveland44195NCT04711824Map
OHCleveland ClinicCleveland44106NCT01042379Map
OHCleveland Clinic Cancer Center/Fairview HospitalCleveland44111NCT06580314Map
OHCleveland Clinic FoundationCleveland44195NCT05564377Map
OHCleveland Clinic FoundationCleveland44195NCT06580314Map
OHExelixis Clinical Site #7Cleveland44106NCT05932862Map
OHUniversity Hospitals Cleveland Medical Center ( Site 0043)Cleveland44106NCT06353386Map
OHColumbus Oncology and Hematology Associates IncColumbus43214NCT05564377Map
OHColumbus Oncology and Hematology Associates IncColumbus43214NCT06580314Map
OHDoctors HospitalColumbus43228NCT05564377Map
OHDoctors HospitalColumbus43228NCT06580314Map
OHGrant Medical CenterColumbus43215NCT05564377Map
OHGrant Medical CenterColumbus43215NCT06580314Map
OHMount Carmel East HospitalColumbus43213NCT05554328Map
OHMount Carmel East HospitalColumbus43213NCT05564377Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT05554328Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT05564377Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT04633239Map
OHOhio State University Comprehensive Cancer CenterColumbus43210NCT06580314Map
OHRiverside Methodist HospitalColumbus43214NCT05554328Map
OHRiverside Methodist HospitalColumbus43214NCT05564377Map
OHRiverside Methodist HospitalColumbus43214NCT06580314Map
OHThe Mark H Zangmeister CenterColumbus43219NCT05554328Map
OHThe Mark H Zangmeister CenterColumbus43219NCT05564377Map
OHThe Ohio State UniversityColumbus43210NCT06785636Map
OHThe Ohio State University, Stefanie Spielman Comprehensive Breast CenterColumbus43212NCT01042379Map
OHMiami Valley HospitalDayton45409NCT05554328Map
OHMiami Valley HospitalDayton45409NCT05564377Map
OHMiami Valley HospitalDayton45409NCT04858334Map
OHMiami Valley Hospital NorthDayton45415NCT05554328Map
OHMiami Valley Hospital NorthDayton45415NCT05564377Map
OHMiami Valley Hospital NorthDayton45415NCT04858334Map
OHPremier Blood and Cancer CenterDayton45409NCT05564377Map
OHPremier Blood and Cancer CenterDayton45409NCT04858334Map
OHDelaware Health Center-Grady Cancer CenterDelaware43015NCT05564377Map
OHDelaware Health Center-Grady Cancer CenterDelaware43015NCT06580314Map
OHGrady Memorial HospitalDelaware43015NCT05564377Map
OHGrady Memorial HospitalDelaware43015NCT06580314Map
OHColumbus Oncology and Hematology AssociatesDublin43016NCT05564377Map
OHColumbus Oncology and Hematology AssociatesDublin43016NCT06580314Map
OHDublin Methodist HospitalDublin43016NCT05554328Map
OHDublin Methodist HospitalDublin43016NCT05564377Map
OHDublin Methodist HospitalDublin43016NCT06580314Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT05554328Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT05564377Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT04858334Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT05554328Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT05564377Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT04858334Map
OHKettering HealthKettering45429NCT02693535Map
OHKettering Medical CenterKettering45429NCT05564377Map
OHFairfield Medical CenterLancaster43130NCT05554328Map
OHFairfield Medical CenterLancaster43130NCT05564377Map
OHOhioHealth Mansfield HospitalMansfield44903NCT05554328Map
OHOhioHealth Mansfield HospitalMansfield44903NCT05564377Map
OHOhioHealth Mansfield HospitalMansfield44903NCT06580314Map
OHMarietta Memorial HospitalMarietta45750NCT05554328Map
OHOhioHealth Marion General HospitalMarion43302NCT05564377Map
OHOhioHealth Marion General HospitalMarion43302NCT06580314Map
OHMemorial HospitalMarysville43040NCT05554328Map
OHMemorial HospitalMarysville43040NCT05564377Map
OHTaylor Cancer Research CenterMaumee43537NCT06785636Map
OHHillcrest Hospital Cancer CenterMayfield Heights44124NCT06580314Map
OHUH Seidman Cancer Center at Lake Health Mentor CampusMentor44060NCT05554328Map
OHUH Seidman Cancer Center at Lake Health Mentor CampusMentor44060NCT05564377Map
OHUH Seidman Cancer Center at Lake Health Mentor CampusMentor44060NCT06580314Map
OHKnox Community HospitalMount Vernon43050NCT05554328Map
OHKnox Community HospitalMount Vernon43050NCT05564377Map
OHLicking Memorial HospitalNewark43055NCT05554328Map
OHLicking Memorial HospitalNewark43055NCT05564377Map
OHMercy Health - Perrysburg HospitalPerrysburg43551NCT05554328Map
OHMercy Health - Perrysburg HospitalPerrysburg43551NCT05564377Map
OHOhioHealth Pickerington Methodist HospitalPickerington43147NCT05554328Map
OHOhioHealth Pickerington Methodist HospitalPickerington43147NCT05564377Map
OHOhioHealth Pickerington Methodist HospitalPickerington43147NCT06580314Map
OHSouthern Ohio Medical CenterPortsmouth45662NCT05554328Map
OHSouthern Ohio Medical CenterPortsmouth45662NCT05564377Map
OHSpringfield Regional Cancer CenterSpringfield45504NCT05554328Map
OHSpringfield Regional Cancer CenterSpringfield45504NCT05564377Map
OHSpringfield Regional Medical CenterSpringfield45504NCT05554328Map
OHSpringfield Regional Medical CenterSpringfield45504NCT05564377Map
OHProMedica Flower HospitalSylvania43560NCT06580314Map
OHMercy Health - Saint Anne HospitalToledo43623NCT05554328Map
OHMercy Health - Saint Anne HospitalToledo43623NCT05564377Map
OHProMedica Toledo Hospital/Russell J Ebeid Children's HospitalToledo43606NCT06580314Map
OHUpper Valley Medical CenterTroy45373NCT05554328Map
OHUpper Valley Medical CenterTroy45373NCT05564377Map
OHUpper Valley Medical CenterTroy45373NCT04858334Map
OHWest Chester HospitalWest Chester45069NCT02693535Map
OHOhioHealth Westerville Medical Campus/Westerville Cancer CenterWesterville43082NCT05554328Map
OHOhioHealth Westerville Medical Campus/Westerville Cancer CenterWesterville43082NCT05564377Map
OHOhioHealth Westerville Medical Campus/Westerville Cancer CenterWesterville43082NCT06580314Map
OHSaint Ann's HospitalWesterville43081NCT05554328Map
OHSaint Ann's HospitalWesterville43081NCT05564377Map
OHUH Seidman Cancer Center at Saint John Medical CenterWestlake44145NCT05554328Map
OHUH Seidman Cancer Center at Saint John Medical CenterWestlake44145NCT06580314Map
OHGenesis Healthcare System Cancer Care CenterZanesville43701NCT05554328Map
OHGenesis Healthcare System Cancer Care CenterZanesville43701NCT05564377Map
OKExelixis Clinical Site #13Oklahoma City73104NCT05932862Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT04858334Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT06580314Map
OKOU Health - Stephenson Cancer Center /ID# 277656Oklahoma City73104NCT07024784Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT05554328Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT05564377Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT04633239Map
OKUniversity of Oklahoma Health Sciences CenterOklahoma City73104NCT06580314Map
OKOklahoma Cancer Specialists and Research Institute, LLC ( Site 0082)Tulsa74146NCT03486873Map
ORSaint Charles Health SystemBend97701NCT06580314Map
ORClackamas Radiation Oncology CenterClackamas97015NCT06580314Map
ORBay Area HospitalCoos Bay97420NCT06580314Map
ORProvidence Hood River Memorial HospitalHood River97031NCT06580314Map
ORProvidence Newberg Medical CenterNewberg97132NCT05554328Map
ORProvidence Newberg Medical CenterNewberg97132NCT05564377Map
ORProvidence Newberg Medical CenterNewberg97132NCT04858334Map
ORProvidence Newberg Medical CenterNewberg97132NCT06580314Map
ORSaint Alphonsus Cancer Care Center-OntarioOntario97914NCT05554328Map
ORSaint Alphonsus Cancer Care Center-OntarioOntario97914NCT05564377Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT05554328Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT05564377Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT04858334Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT06580314Map
ORCall for Information (Investigational Site 2094)Portland97239NCT02861573Map
ORLegacy Good Samaritan Hospital and Medical CenterPortland97210NCT06580314Map
OROHSU Knight Cancer InstitutePortland97239NCT04005690Map
OROregon Health & Science Institute (OHSU)Portland97239NCT01042379Map
OROregon Health and Science UniversityPortland97239NCT05554328Map
OROregon Health and Science UniversityPortland97239NCT05564377Map
OROregon Health and Science UniversityPortland97239NCT04858334Map
OROregon Health and Science UniversityPortland97239NCT06580314Map
ORProvidence Cancer InstitutePortland97213NCT06915025Map
ORProvidence Health & ServicesPortland97213NCT02693535Map
ORProvidence Portland Medical CenterPortland97213NCT05554328Map
ORProvidence Portland Medical CenterPortland97213NCT05564377Map
ORProvidence Portland Medical CenterPortland97213NCT04858334Map
ORProvidence Portland Medical CenterPortland97213NCT06580314Map
ORProvidence Portland Medical Center /ID# 277727Portland97213NCT07024784Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT05554328Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT05564377Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT04858334Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT06580314Map
ORVA Portland Health Care System, Portland, ORPortland97239NCT04038502Map
ORSaint Charles Health System-RedmondRedmond97756NCT06580314Map
ORNorthwest Cancer Specialists (Compass Oncology) ( Site 8003)Tigard97223NCT06797635Map
ORLegacy Meridian Park HospitalTualatin97062NCT06580314Map
PALehigh Valley Health Network (Data Collection Only)Allentown18103NCT05188508Map
PALehigh Valley Hospital - Cedar CrestAllentown18103NCT02693535Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT05554328Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT05564377Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT06580314Map
PASaint Luke's Cancer Center - AllentownAllentown18104NCT06580314Map
PAUPMC AltoonaAltoona16601NCT05554328Map
PAUPMC AltoonaAltoona16601NCT05564377Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT05554328Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT05564377Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT06580314Map
PALehigh Valley Hospital- MuhlenbergBethlehem18017NCT02693535Map
PASaint Luke's University Hospital-Bethlehem CampusBethlehem18015NCT06580314Map
PASt. Luke's University Health Network ( Site 0017)Bethlehem18015NCT03486873Map
PABryn Mawr HospitalBryn Mawr19010NCT05554328Map
PABryn Mawr HospitalBryn Mawr19010NCT05564377Map
PAChristiana Care Health System-Concord Health CenterChadds Ford19317NCT06580314Map
PAChambersburg HospitalChambersburg17201NCT06580314Map
PAPocono Medical CenterEast Stroudsburg18301NCT02693535Map
PAPocono Medical CenterEast Stroudsburg18301NCT05554328Map
PAPocono Medical CenterEast Stroudsburg18301NCT05564377Map
PAPocono Medical CenterEast Stroudsburg18301NCT06580314Map
PASaint Luke's Hospital-Anderson CampusEaston18045NCT06580314Map
PAEphrata Cancer CenterEphrata17522NCT06580314Map
PAUPMC Hillman Cancer Center ErieErie16505NCT05554328Map
PAUPMC Hillman Cancer Center ErieErie16505NCT05564377Map
PAAdams Cancer CenterGettysburg17325NCT06580314Map
PAUPMC Cancer Centers - Arnold Palmer PavilionGreensburg15601NCT05554328Map
PAUPMC Cancer Centers - Arnold Palmer PavilionGreensburg15601NCT05564377Map
PAWellSpan Medical Oncology and HematologyHanover17331NCT06580314Map
PALehigh Valley Hospital-HazletonHazleton18201NCT02693535Map
PALehigh Valley Hospital-HazletonHazleton18201NCT05564377Map
PALehigh Valley Hospital-HazletonHazleton18201NCT06580314Map
PAPenn State Milton S Hershey Medical CenterHershey17033-0850NCT06580314Map
PASechler Family Cancer CenterLebanon17042NCT06580314Map
PAUPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer PavilionMechanicsburg17050NCT05554328Map
PAUPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer PavilionMechanicsburg17050NCT05564377Map
PARiddle Memorial HospitalMedia19063NCT05554328Map
PARiddle Memorial HospitalMedia19063NCT05564377Map
PARiddle Memorial HospitalMedia19063NCT04858334Map
PAUPMC Hillman Cancer Center - MonroevilleMonroeville15146NCT05554328Map
PAUPMC Hillman Cancer Center - MonroevilleMonroeville15146NCT05564377Map
PAPaoli Memorial HospitalPaoli19301NCT05554328Map
PAPaoli Memorial HospitalPaoli19301NCT05564377Map
PAPaoli Memorial HospitalPaoli19301NCT04858334Map
PAFox Chase Cancer CenterPhiladelphia19111NCT02693535Map
PAFox Chase Cancer CenterPhiladelphia19111NCT05554328Map
PAFox Chase Cancer CenterPhiladelphia19111NCT05564377Map
PAFox Chase Cancer Center ( Site 0042)Philadelphia19111NCT03486873Map
PAJefferson Torresdale HospitalPhiladelphia19114NCT06580314Map
PAPenn Medicine Abramson Cancer CenterPhiladelphia19104NCT05498272Map
PAPennsylvania HospitalPhiladelphia19107NCT05554328Map
PAPennsylvania HospitalPhiladelphia19107NCT06580314Map
PAPhiladelphia MultiService Center, Philadelphia, PAPhiladelphia19106NCT04038502Map
PAThomas Jefferson University HospitalPhiladelphia19107NCT05554328Map
PAThomas Jefferson University HospitalPhiladelphia19107NCT05564377Map
PAThomas Jefferson University HospitalPhiladelphia19107NCT04633239Map
PAThomas Jefferson University HospitalPhiladelphia19107NCT06580314Map
PAUniversity of Pennsylvania ( Site 0010)Philadelphia19104NCT03486873Map
PAUniversity of Pennsylvania (U Penn)Philadelphia19104NCT01042379Map
PAUniversity of Pennsylvania Abramson Cancer CenterPhiladelphia19104NCT05238922Map
PAUniversity of Pennsylvania Health System, Perelman Center for Advanced MedicinePhiladelphia19104NCT05887609Map
PAUniversity of Pennsylvania/Abramson Cancer CenterPhiladelphia19104NCT04858334Map
PAUniversity of Pennsylvania/Abramson Cancer CenterPhiladelphia19104NCT06580314Map
PACall for Information (Investigational Site 0008)Pittsburgh15232NCT02861573Map
PAUniversity of Pittsburgh Cancer Institute (UPCI)Pittsburgh15232NCT05554328Map
PAUniversity of Pittsburgh Cancer Institute (UPCI)Pittsburgh15232NCT05564377Map
PAUniversity of Pittsburgh Cancer Institute (UPCI)Pittsburgh15232NCT04585958Map
PAUPMC Hillman Cancer Center ( Site 0008)Pittsburgh15232NCT03486873Map
PAUPMC Magee-Women's HospitalPittsburgh15213NCT05887609Map
PAUPMC-Magee Womens HospitalPittsburgh15213NCT05554328Map
PAUPMC-Magee Womens HospitalPittsburgh15213NCT05564377Map
PAUPMC-Passavant HospitalPittsburgh15237NCT05554328Map
PAUPMC-Passavant HospitalPittsburgh15237NCT05564377Map
PASaint Luke's Hospital - Upper Bucks CampusQuakertown18951NCT06580314Map
PAGuthrie Medical Group PC-Robert Packer HospitalSayre18840NCT05564377Map
PASaint Luke's Hospital - Monroe CampusStroudsburg18360NCT06580314Map
PAChester County HospitalWest Chester19380NCT06580314Map
PAAsplundh Cancer PavilionWillow Grove19090NCT05554328Map
PAAsplundh Cancer PavilionWillow Grove19090NCT05564377Map
PAAsplundh Cancer PavilionWillow Grove19090NCT06580314Map
PALankenau Medical CenterWynnewood19096NCT05554328Map
PALankenau Medical CenterWynnewood19096NCT05564377Map
PALankenau Medical CenterWynnewood19096NCT04858334Map
PAWellSpan Health-York Cancer CenterYork17403NCT06580314Map
PAWellSpan Health-York HospitalYork17403NCT06580314Map
RIRoger Williams Medical CenterProvidence02908NCT05564377Map
RIWomen & Infants Hospital /ID# 277930Providence02905NCT07024784Map
RIWomen and Infants HospitalProvidence02905NCT05554328Map
RIWomen and Infants HospitalProvidence02905NCT05564377Map
RIWomen and Infants HospitalProvidence02905NCT06580314Map
SCSC Cancer Specialists at St. Joseph's/Candler BlufftonBluffton29910NCT02693535Map
SCSt. Joseph's/Candler SmithBluffton29910NCT02693535Map
SCSummit Cancer Care at St. Josph's/Candler BlufftonBluffton29910NCT02693535Map
SCPrisma Health Cancer Institute - SpartanburgBoiling Springs29316NCT05564377Map
SCMedical University of South Carolina-Hollings Cancer Center ( Site 0016)Charleston29425NCT06966700Map
SCPrisma Health Richland HospitalColumbia29203NCT05564377Map
SCPrisma Health Cancer Institute - EasleyEasley29640NCT05564377Map
SCGibbs Cancer Center-GaffneyGaffney29341NCT06580314Map
SCBI-LO Charities Children's Cancer CenterGreenville29605NCT05564377Map
SCPrisma Health Cancer Institute - ButternutGreenville29605NCT05564377Map
SCPrisma Health Cancer Institute - EastsideGreenville29615NCT05564377Map
SCPrisma Health Cancer Institute - FarisGreenville29605NCT05564377Map
SCSaint Francis Cancer CenterGreenville29607NCT05564377Map
SCSaint Francis Health System ( Site 0089)Greenville29607NCT03486873Map
SCSaint Francis HospitalGreenville29601NCT05564377Map
SCSt Francis Cancer Center ( Site 0093)Greenville29607NCT06966700Map
SCGibbs Cancer Center-PelhamGreer29651NCT06580314Map
SCPrisma Health Cancer Institute - GreerGreer29650NCT05564377Map
SCSouth Carolina Cancer SpecialistsHilton Head Island29926NCT02693535Map
SCCall for Information (Investigational Site 0019)Myrtle Beach29572NCT02861573Map
SCPrisma Health Cancer Institute - SenecaSeneca29672NCT05564377Map
SCSpartanburg Medical CenterSpartanburg29303NCT06580314Map
SCSMC Center for Hematology Oncology UnionUnion29379NCT06580314Map
SDAvera Cancer Institute-AberdeenAberdeen57401NCT04858334Map
SDAvera Cancer Institute-AberdeenAberdeen57401NCT06580314Map
SDAvera Cancer Institute - MitchellMitchell57301NCT06580314Map
SDAvera Cancer Institute at PierrePierre57501NCT04858334Map
SDAvera Cancer Institute at PierrePierre57501NCT06580314Map
SDRapid City Regional HospitalRapid City57701NCT05564377Map
SDAvera Cancer InstituteSioux Falls57105NCT04858334Map
SDAvera Cancer InstituteSioux Falls57105NCT06580314Map
SDAvera McKennan Hospital ( Site 0002)Sioux Falls57105NCT06966700Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT05554328Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT05564377Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT04858334Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT06580314Map
SDSanford Cancer Center Oncology Clinic and PharmacySioux Falls57104NCT02693535Map
SDSanford Clinical ResearchSioux Falls57104NCT01042379Map
SDSanford HealthSioux Falls57104NCT06915025Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT05554328Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT05564377Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT04858334Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT06580314Map
SDAvera Cancer Institute - Yankton ( Site 0089)Yankton57078NCT06966700Map
SDAvera Cancer Institute at YanktonYankton57078NCT06580314Map
TNErlanger HealthChattanooga37403NCT06915025Map
TNBaptist Memorial Hospital and Cancer Center-ColliervilleCollierville38017NCT05564377Map
TNBaptist Memorial Hospital and Cancer Center-ColliervilleCollierville38017NCT04858334Map
TNVanderbilt-Ingram Cancer Center at FranklinFranklin37067NCT06580314Map
TNVanderbilt-Ingram Cancer Center Cool SpringsFranklin37067NCT06580314Map
TNCall for Information (Investigational Site 2090)Germantown38138NCT02861573Map
TNExelixis Clinical Site #11Germantown38138NCT05932862Map
TNRegional Cancer Center at Johnson City Medical CenterJohnson City37604NCT05564377Map
TNBallad Health Cancer Care - KingsportKingsport37660NCT05564377Map
TNTennessee Cancer Specialists ( Site 7001)Knoxville37909NCT06966700Map
TNBaptist Memorial Hospital and Cancer Center-MemphisMemphis38120NCT05564377Map
TNBaptist Memorial Hospital and Cancer Center-MemphisMemphis38120NCT04858334Map
TNExelixis Clinical Site #6Nashville37203NCT05932862Map
TNNashville General Hospital ( Site 0017)Nashville37208NCT06966700Map
TNSCRI Oncology Partners ( Site 7000)Nashville37203NCT06797635Map
TNSCRI Oncology Partners /ID# 279733Nashville37203NCT07024784Map
TNTennessee Oncology - Nashville / Sarah Cannon Research InstituteNashville37203NCT02693535Map
TNVanderbilt Breast Center at One Hundred OaksNashville37204NCT05564377Map
TNVanderbilt Breast Center at One Hundred OaksNashville37204NCT06580314Map
TNVanderbilt Health One Hundred Oaks Diagnostic ( Site 0060)Nashville37204NCT03486873Map
TNVanderbilt Ingram Cancer Center ( Site 0015)Nashville37232NCT03486873Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT05564377Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT04633239Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT06580314Map
TNVanderbilt-Ingram Cancer Center ( Site 0038)Nashville37232NCT06966700Map
TXHendrick Medical CenterAbilene79601NCT05564377Map
TXHendrick Medical Center ( Site 0009)Abilene79601NCT06966700Map
TXExelixis Clinical Site #4Austin78758NCT05932862Map
TXTexas Oncology - Central/South Texas ( Site 8001)Austin78745NCT03486873Map
TXTexas Oncology-Austin North /ID# 279958Austin78758NCT07024784Map
TXMD Anderson in The WoodlandsConroe77384NCT05554328Map
TXParkland Memorial HospitalDallas75235NCT04858334Map
TXParkland Memorial HospitalDallas75235NCT06580314Map
TXTexas Oncology - DFW ( Site 8000)Dallas75246NCT06797635Map
TXTexas Oncology-Baylor Sammons Cancer Center ( Site 0062)Dallas75246NCT03486873Map
TXUniversity of Texas Southwestern Medical CenterDallas75390NCT06785636Map
TXUT Southwestern Simmons Cancer Center - RedBirdDallas75237NCT04858334Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT05554328Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT05564377Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT04858334Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT06580314Map
TXTexas Oncology - Northeast Texas ( Site 8002)Flower Mound75028NCT06966700Map
TXJPS Oncology and Infusion Center ( Site 0083)Fort Worth76104NCT06966700Map
TXUT Southwestern/Simmons Cancer Center-Fort WorthFort Worth76104NCT04858334Map
TXUT Southwestern/Simmons Cancer Center-Fort WorthFort Worth76104NCT06580314Map
TXExelixis Clinical Site #1Houston77030NCT05932862Map
TXHouston Methodist HospitalHouston77030NCT06580314Map
TXHouston Methodist Hospital ( Site 0022)Houston77030NCT06797635Map
TXHouston Methodist West HospitalHouston77094NCT06580314Map
TXKelsey-Seybold Clinic ( Site 0042)Houston77025NCT06966700Map
TXKelsey-Seybold Clinic ( Site 0088)Houston77025NCT06966700Map
TXLyndon Baines Johnson General HospitalHouston77026-1967NCT05554328Map
TXLyndon Baines Johnson General HospitalHouston77026-1967NCT05564377Map
TXM D Anderson Cancer CenterHouston77030NCT05554328Map
TXM D Anderson Cancer CenterHouston77030NCT05564377Map
TXM D Anderson Cancer CenterHouston77030NCT04090567Map
TXMD Anderson Cancer CenterHouston77030NCT06525298Map
TXMD Anderson West HoustonHouston77079NCT05554328Map
TXMemorial Hermann Texas Medical CenterHouston77030NCT06580314Map
TXMethodist Willowbrook HospitalHouston77070NCT06580314Map
TXOncology Consultants P.A. ( Site 0073)Houston77030NCT06966700Map
TXOncology Consultants, P.AHouston77030NCT06785636Map
TXThe University of Texas M. D. Anderson Cancer CenterHouston77030NCT07382544Map
TXThe University of Texas MD Anderson Cancer CenterHouston77030NCT02693535Map
TXUniversity of Texas MD Anderson Cancer Center ( Site 0007)Houston77030NCT03486873Map
TXMD Anderson League CityLeague City77573NCT05554328Map
TXTexas Tech University Health Sciences Center ( Site 0087)Lubbock79430NCT06966700Map
TXHouston Methodist Saint John HospitalNassau Bay77058NCT06580314Map
TXUT Southwestern Clinical Center at Richardson/PlanoRichardson75080NCT04858334Map
TXUT Southwestern Clinical Center at Richardson/PlanoRichardson75080NCT06580314Map
TXExelixis Clinical Site #3San Antonio78229NCT05932862Map
TXSouth Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001)San Antonio78229NCT03486873Map
TXTexas Oncology - San Antonio ( Site 8004)San Antonio78240NCT06966700Map
TXMD Anderson in Sugar LandSugar Land77478NCT05554328Map
TXScott and White Memorial HospitalTemple76508NCT05564377Map
TXHouston Methodist The Woodlands HospitalThe Woodlands77385NCT06580314Map
UTCedar City Hospital, SW Cancer Clinic, Sandra Maxwell Cancer CenterCedar City84720NCT02693535Map
UTFarmington Health CenterFarmington84025NCT04858334Map
UTIntermountain Medical Center ( Site 0074)Murray84107NCT06966700Map
UTHuntsman Cancer InstituteSalt Lake City84112NCT05568550Map
UTHuntsman Cancer Institute, University of UtahSalt Lake City84112NCT01042379Map
UTHuntsman Cancer Institute/University of UtahSalt Lake City84112NCT04858334Map
UTHuntsman Cancer Institute/University of UtahSalt Lake City84112NCT06580314Map
UTIntermountain HealthcareSalt Lake City84107NCT02693535Map
UTUniversity of Utah Sugarhouse Health CenterSalt Lake City84106NCT04858334Map
UTUniversity of Utah Sugarhouse Health CenterSalt Lake City84106NCT06580314Map
UTSouth Jordan Health CenterSouth Jordan84009NCT06580314Map
UTDixie Regional Medical Center-River Road CampusSt. George84770NCT02693535Map
VTDartmouth Cancer Center - NorthSaint Johnsbury05819NCT04858334Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT05554328Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT05564377Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT04633239Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT06580314Map
VAUniversity of Virginia Health System ( Site 0035)Charlottesville22908NCT03486873Map
VAInova Schar Cancer InstituteFairfax22042NCT02693535Map
VAInova Schar Cancer InstituteFairfax22031NCT05564377Map
VANEXT Oncology - VirginiaFairfax22031NCT06785636Map
VANext Virginia /ID# 279684Fairfax22031NCT07024784Map
VAVirginia Cancer InstituteFairfax22031NCT05238922Map
VAInova Fairfax HospitalFalls Church22042NCT05564377Map
VABon Secours Cancer Institute at St. Francis ( Site 0048)Midlothian23114NCT06966700Map
VAVirginia Oncology Associates (VOA) ( Site 8001)Norfolk23502NCT06797635Map
VAHenrico Doctor's HospitalRichmond23229NCT05554328Map
VAHenrico Doctor's HospitalRichmond23229NCT05564377Map
VAVCU Health Adult Outpatient Pavillion ( Site 0080)Richmond23219NCT03486873Map
VAVCU Massey Cancer Center at Stony PointRichmond23235NCT05554328Map
VAVCU Massey Cancer Center at Stony PointRichmond23235NCT05564377Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT05554328Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT05564377Map
VAVCU Massey Comprehensive Cancer CenterRichmond23298NCT06580314Map
VAVirginia Cancer InstituteRichmond23229NCT05554328Map
VABlue Ridge Cancer Care ( Site 0067)Roanoke24014NCT03486873Map
VACarilion Roanoke Memorial HospitalRoanoke24033NCT05554328Map
VACarilion Roanoke Memorial HospitalRoanoke24033NCT05564377Map
VAOncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8005)Roanoke24014NCT06966700Map
VAVCU Community Memorial Health CenterSouth Hill23970NCT05554328Map
VAVCU Community Memorial Health CenterSouth Hill23970NCT05564377Map
WAProvidence Regional Cancer System-AberdeenAberdeen98520NCT06580314Map
WAPeaceHealth Saint Joseph Medical CenterBellingham98225NCT06580314Map
WANorthwest Medical SpecialtiesBonney Lake98391NCT02693535Map
WAProvidence Regional Cancer System-CentraliaCentralia98531NCT06580314Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT05554328Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT05564377Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT04858334Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT06580314Map
WAProvidence Regional Cancer PartnershipEverett98201NCT06580314Map
WANorthwest Medical SpecialtiesFederal Way98003NCT02693535Map
WANorthwest Medical SpecialtiesGig Harbor98332NCT02693535Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT05554328Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT05564377Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT04858334Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT06580314Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT04858334Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT06580314Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT05554328Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT05564377Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT04858334Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT06580314Map
WAPeaceHealth Saint John Medical CenterLongview98632NCT06580314Map
WASkagit Regional Health Cancer Care CenterMount Vernon98274NCT06580314Map
WANorthwest Medical SpecialtiesOlympia98502NCT02693535Map
WANorthwest Medical SpecialtiesPuyallup98373NCT02693535Map
WAValley Medical CenterRenton98055NCT05554328Map
WAValley Medical CenterRenton98055NCT05564377Map
WAValley Medical CenterRenton98055NCT04858334Map
WACall for Information (Investigational Site 0016)Seattle98109NCT02861573Map
WAFred Hutchinson Cancer CenterSeattle98109NCT06580314Map
WAFred Hutchinson Cancer Center ( Site 0024)Seattle98109NCT03486873Map
WAFred Hutchinson Cancer Center ( Site 0069)Seattle98109NCT06966700Map
WASwedish Cancer InstituteSeattle98104NCT02693535Map
WASwedish Medical Center-Ballard CampusSeattle98107NCT06580314Map
WASwedish Medical Center-Cherry HillSeattle98122-5711NCT06580314Map
WASwedish Medical Center-First HillSeattle98122NCT05554328Map
WASwedish Medical Center-First HillSeattle98122NCT05564377Map
WASwedish Medical Center-First HillSeattle98122NCT04858334Map
WASwedish Medical Center-First HillSeattle98122NCT06580314Map
WAUniversity of Washington Medical Center - MontlakeSeattle98195NCT06580314Map
WAUniversity of Washington Medical Center - NorthwestSeattle98133NCT06580314Map
WAVA Puget Sound Health Care System Seattle Division, Seattle, WASeattle98108-1532NCT04038502Map
WAPeaceHealth United General Medical CenterSedro-Woolley98284NCT06580314Map
WASaint Michael Cancer CenterSilverdale98383NCT06580314Map
WACancer Care Northwest - Spokane SouthSpokane99202NCT06580314Map
WACancer Care Northwest ( Site 0003)Spokane99202NCT06966700Map
WACancer Care Northwest-North SpokaneSpokane99218NCT06580314Map
WACancer Care Northwest-ValleySpokane99216NCT06580314Map
WAProvidence Sacred Heart Medical Center & Children's HospitalSpokane99204NCT06915025Map
WANorthwest Medical SpecialtiesTacoma98405NCT02693535Map
WANorthwest Medical Specialties, PLLC ( Site 0067)Tacoma98405NCT06966700Map
WALegacy Salmon Creek HospitalVancouver98686NCT06580314Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT05554328Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT06580314Map
WANorth Star Lodge Cancer Center at Yakima Valley Memorial HospitalYakima98902NCT05554328Map
WVUnited Hospital CenterBridgeport26330NCT04858334Map
WVUnited Hospital CenterBridgeport26330NCT06580314Map
WVWest Virginia University Charleston DivisionCharleston25304NCT05564377Map
WVEdwards Comprehensive Cancer CenterHuntington25701NCT05554328Map
WVEdwards Comprehensive Cancer CenterHuntington25701NCT05564377Map
WVWVUH-Berkely Medical CenterMartinsburg25401NCT06580314Map
WVWest Virginia University HealthcareMorgantown26506NCT05554328Map
WVWest Virginia University HealthcareMorgantown26506NCT05564377Map
WVWest Virginia University HealthcareMorgantown26506NCT04858334Map
WVWest Virginia University HealthcareMorgantown26506NCT06580314Map
WVCamden Clark Medical CenterParkersburg26101NCT04858334Map
WVCamden Clark Medical CenterParkersburg26101NCT06580314Map
WVPrinceton Community HospitalPrinceton24740NCT06580314Map
WVWheeling Hospital/Schiffler Cancer CenterWheeling26003NCT06580314Map
WIThedaCare Regional Cancer CenterAppleton54911NCT05564377Map
WIThedaCare Regional Cancer CenterAppleton54911NCT04858334Map
WIThedaCare Regional Medical Center - AppletonAppleton54911NCT05564377Map
WIDuluth Clinic AshlandAshland54806NCT05554328Map
WIDuluth Clinic AshlandAshland54806NCT05564377Map
WIDuluth Clinic AshlandAshland54806NCT06580314Map
WINorthwest Wisconsin Cancer CenterAshland54806NCT06580314Map
WIThedaCare Cancer Care - BerlinBerlin54923NCT05564377Map
WIAurora Cancer Care - BurlingtonBurlington53105NCT02693535Map
WIAurora Cancer Care-Southern Lakes VLCCBurlington53105NCT05554328Map
WIAurora Cancer Care-Southern Lakes VLCCBurlington53105NCT05564377Map
WIAurora Cancer Care-Southern Lakes VLCCBurlington53105NCT06580314Map
WIAurora Saint Luke's South ShoreCudahy53110NCT05554328Map
WIAurora Saint Luke's South ShoreCudahy53110NCT06580314Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT05564377Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT04858334Map
WIAurora Health Care - Germantown Health CenterGermantown53022NCT02693535Map
WIAurora Health Care Germantown Health CenterGermantown53022NCT05554328Map
WIAurora Health Care Germantown Health CenterGermantown53022NCT05564377Map
WIAurora Health Care Germantown Health CenterGermantown53022NCT06580314Map
WIAurora Cancer Care - GraftonGrafton53024NCT02693535Map
WIAurora Cancer Care-GraftonGrafton53024NCT05554328Map
WIAurora Cancer Care-GraftonGrafton53024NCT05564377Map
WIAurora Cancer Care-GraftonGrafton53024NCT06580314Map
WIAurora BayCare Medical CenterGreen Bay54311NCT02693535Map
WIAurora BayCare Medical CenterGreen Bay54311NCT05554328Map
WIAurora BayCare Medical CenterGreen Bay54311NCT05564377Map
WIAurora BayCare Medical CenterGreen Bay54311NCT06580314Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT05554328Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT05564377Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT04858334Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT06580314Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT05554328Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT05564377Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT04858334Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT06580314Map
WIEssentia Health-Hayward ClinicHayward54843NCT06580314Map
WITamarack Health Hayward Medical CenterHayward54843NCT06580314Map
WIMercyhealth Hospital and Cancer Center - JanesvilleJanesville53548NCT05564377Map
WIMercyhealth Hospital and Cancer Center - JanesvilleJanesville53548NCT04858334Map
WIUniversity of Wisconsin Carbone Cancer Center - Johnson CreekJohnson Creek53038NCT04858334Map
WIAurora Cancer Care - Kenosha SouthKenosha53142NCT02693535Map
WIAurora Cancer Care-Kenosha SouthKenosha53142NCT05554328Map
WIAurora Cancer Care-Kenosha SouthKenosha53142NCT05564377Map
WIAurora Cancer Care-Kenosha SouthKenosha53142NCT06580314Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT05554328Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT05564377Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT04858334Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT06580314Map
WIUniversity of Wisconsin - Carbone Cancer Center - University HospitalMadison53792NCT05887609Map
WIUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical CenterMadison53718NCT05554328Map
WIUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical CenterMadison53718NCT05564377Map
WIUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical CenterMadison53718NCT04858334Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT05554328Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT05564377Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT04858334Map
WIUniversity of Wisconsin-Madison ( Site 0024)Madison53792NCT06966700Map
WIWilliam S. Middleton Memorial Veterans Hospital, Madison, WIMadison53705-2254NCT04038502Map
WIAurora Bay Area Medical CenterMarinette54143NCT02693535Map
WIAurora Bay Area Medical Group-MarinetteMarinette54143NCT05554328Map
WIAurora Bay Area Medical Group-MarinetteMarinette54143NCT05564377Map
WIAurora Bay Area Medical Group-MarinetteMarinette54143NCT06580314Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT05564377Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT04858334Map
WIAurora Cancer Care MilwaukeeMilwaukee53209NCT02693535Map
WIAurora Cancer Care-MilwaukeeMilwaukee53209NCT05554328Map
WIAurora Cancer Care-MilwaukeeMilwaukee53209NCT05564377Map
WIAurora Cancer Care-MilwaukeeMilwaukee53209NCT06580314Map
WIAurora Saint Luke's Medical CenterMilwaukee53215NCT05554328Map
WIAurora Saint Luke's Medical CenterMilwaukee53215NCT05564377Map
WIAurora Saint Luke's Medical CenterMilwaukee53215NCT06580314Map
WIAurora Sinai Medical CenterMilwaukee53223NCT02693535Map
WIAurora Sinai Medical CenterMilwaukee53233NCT05554328Map
WIAurora Sinai Medical CenterMilwaukee53233NCT05564377Map
WIAurora Sinai Medical CenterMilwaukee53233NCT06580314Map
WIAurora St. Luke's Medical CenterMilwaukee53215NCT02693535Map
WIAurora West Allis Medical CenterMilwaukee53227NCT02693535Map
WIFroedtert and The Medical College of WisconsinMilwaukee53226NCT06915025Map
WIMedical College of WisconsinMilwaukee53226NCT06580314Map
WIMEDICAL COLLEGE OF WISCONSIN-Cancer Center Clinical Trials Office ( Site 0020)Milwaukee53226NCT06353386Map
WIMarshfield Medical Center - MinocquaMinocqua54548NCT05564377Map
WIMarshfield Medical Center - MinocquaMinocqua54548NCT04858334Map
WIProHealth D N Greenwald CenterMukwonago53149NCT05564377Map
WIProHealth D N Greenwald CenterMukwonago53149NCT04858334Map
WIProHealth D N Greenwald CenterMukwonago53149NCT06580314Map
WIThedaCare Regional Medical Center - NeenahNeenah54956NCT05564377Map
WIThedaCare Cancer Care - New LondonNew London54961NCT05564377Map
WICancer Center of Western WisconsinNew Richmond54017NCT05554328Map
WICancer Center of Western WisconsinNew Richmond54017NCT05564377Map
WICancer Center of Western WisconsinNew Richmond54017NCT06580314Map
WIProHealth Oconomowoc Memorial HospitalOconomowoc53066NCT05564377Map
WIProHealth Oconomowoc Memorial HospitalOconomowoc53066NCT04858334Map
WIProHealth Oconomowoc Memorial HospitalOconomowoc53066NCT06580314Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT05554328Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT05564377Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT04858334Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT06580314Map
WIThedaCare Cancer Care - OshkoshOshkosh54904NCT05564377Map
WIVince Lombardi Cancer Clinic - OshkoshOshkosh54904NCT02693535Map
WIVince Lombardi Cancer Clinic - OshkoshOshkosh54904NCT05554328Map
WIVince Lombardi Cancer Clinic - OshkoshOshkosh54904NCT05564377Map
WIVince Lombardi Cancer Clinic - OshkoshOshkosh54904NCT06580314Map
WIAurora Cancer Care - RacineRacine53406NCT02693535Map
WIAurora Cancer Care-RacineRacine53406NCT05554328Map
WIAurora Cancer Care-RacineRacine53406NCT05564377Map
WIAurora Cancer Care-RacineRacine53406NCT06580314Map
WIMarshfield Medical Center-Rice LakeRice Lake54868NCT05564377Map
WIThedaCare Cancer Care - ShawanoShawano54166NCT05564377Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT05554328Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT05564377Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT04858334Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT06580314Map
WISheboygan Physicians GroupSheboygan53081NCT05564377Map
WISheboygan Physicians GroupSheboygan53081NCT06580314Map
WIVince Lombardi Cancer CenterSheboygan53081NCT02693535Map
WIVince Lombardi Cancer Clinic-SheboyganSheboygan53081NCT05554328Map
WIVince Lombardi Cancer Clinic-SheboyganSheboygan53081NCT05564377Map
WIVince Lombardi Cancer Clinic-SheboyganSheboygan53081NCT06580314Map
WIEssentia Health-Spooner ClinicSpooner54801NCT06580314Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT05564377Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT04858334Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT05554328Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT05564377Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT04858334Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT06580314Map
WIAurora Medical Center in SummitSummit53066NCT02693535
WIAurora Medical Center in SummitSummit53066NCT05554328
WIAurora Medical Center in SummitSummit53066NCT05564377
WIAurora Medical Center in SummitSummit53066NCT06580314
WIEssentia Health Saint Mary's Hospital - SuperiorSuperior54880NCT06580314Map
WIVince Lombardi Cancer Clinic - Two RiversTwo Rivers54241NCT02693535Map
WIVince Lombardi Cancer Clinic-Two RiversTwo Rivers54241NCT05554328Map
WIVince Lombardi Cancer Clinic-Two RiversTwo Rivers54241NCT05564377Map
WIVince Lombardi Cancer Clinic-Two RiversTwo Rivers54241NCT06580314Map
WIProHealth Waukesha Memorial HospitalWaukesha53188NCT04858334Map
WIProHealth Waukesha Memorial HospitalWaukesha53188NCT06580314Map
WIUW Cancer Center at ProHealth CareWaukesha53188NCT05564377Map
WIUW Cancer Center at ProHealth CareWaukesha53188NCT04858334Map
WIUW Cancer Center at ProHealth CareWaukesha53188NCT06580314Map
WIThedaCare Cancer Care - WaupacaWaupaca54981NCT05564377Map
WIAurora Cancer Care - Milwaukee WestWauwatosa53226NCT02693535Map
WIAurora Cancer Care-Milwaukee WestWauwatosa53226NCT05554328Map
WIAurora Cancer Care-Milwaukee WestWauwatosa53226NCT05564377Map
WIAurora Cancer Care-Milwaukee WestWauwatosa53226NCT06580314Map
WIAurora West Allis Medical CenterWest Allis53227NCT05554328Map
WIAurora West Allis Medical CenterWest Allis53227NCT05564377Map
WIAurora West Allis Medical CenterWest Allis53227NCT06580314Map
WIMarshfield Medical Center - WestonWeston54476NCT05564377Map
WIMarshfield Medical Center - WestonWeston54476NCT04858334Map
WYMemorial Hospital of Laramie CountyCheyenne82001NCT06580314Map
WYBillings Clinic-CodyCody82414NCT06580314Map

Olaparib clinical trials at a glance: phase × recruitment status

Phaserecruitingactive not recruitingenrolling by invitationcompletedterminatedwithdrawnsuspendednot yet recruitingunknownno longer availableapproved for marketingTotal
Early P1214119
P116124210411288
P1/P21310651540
P239552491710628206
P2/P3224
P361516111141
P412216
N/A261131115

Recruiting Olaparib clinical trials (93)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT03486873MK-3475Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)P3Solid Tumors3,500Aug 2018
NCT07486687PLANETPembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus ChemotherapyP3Triple Negative Breast Cancer (TNBC), Early Setting1,000Apr 2026
NCT06797635Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)P2Breast Neoplasms372Mar 2025
NCT06580314Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerP3Fallopian Tube Endometrioid Adenocarcinoma880Mar 2025
NCT06966700MK-2870-032A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)P3Breast Neoplasms2,400Jun 2025
NCT03150576PARTNERPlatinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast CancerP2/P3Breast Cancer780May 2016
NCT06915025OVATION-3Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerP3Epithelial Ovarian Cancer500Jul 2025
NCT07460180PROOVThe PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian CancerP1/P2Ovarian Cancer55May 2025
NCT07382544Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP LossP1Advanced Cancer36Feb 2026
NCT06712472RAINBO-REDRandomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial CancerP3Endometrial Cancer554Jun 2024
NCT01042379I-SPYI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerP2Breast Neoplasms5,000Mar 2010
NCT07151911ROYALReal wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer PatientsBreast Cancer100Aug 2024
NCT05522491Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast CancerP2Solid Tumor30Sep 2026
NCT02813135ESMARTEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsP1/P2Pediatric Cancer472Aug 2016
NCT05887609An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and OlaparibP2Ovary Cancer53Oct 2023
NCT05255653RAINBORefining Adjuvant Treatment IN Endometrial Cancer Based On Molecular FeaturesP2/P3Endometrial Cancer1,615Nov 2021
NCT05332561COGNITION-GUIDEGenomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)P2Early-stage Breast Cancer240Jun 2023
NCT05952453Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/PembroP2Ovarian Cancer20Feb 2025
NCT05564377Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialP2Advanced Malignant Solid Neoplasm2,900Apr 2023
NCT06245889NeoADAPTPET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBCP2Triple Negative Breast Cancer30May 2024
NCT07005583Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast CancerP2Triple-Negative Breast Cancer (TNBC)46Jun 2025
NCT06607692LUPARPEDStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).P1/P2Solid Tumor Cancer25Sep 2024
NCT05932862ISM3091A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsP1Advanced Solid Tumor429Apr 2024
NCT06856499Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian CancerP1Endometrioid Ovarian Cancer50Dec 2025
NCT05568550Pembro With Radiation With or Without OlaparibP2Prostate Cancer64Jul 2023
NCT06298084ICARUSBREAST02Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXdP1/P2Breast Cancer Metastatic152Mar 2024
NCT03740893PHOENIXPHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast CancerP2Breast Neoplasm119Oct 2019
NCT06785636P300A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPCP1/P2mCRPC (Metastatic Castration-resistant Prostate Cancer)120Feb 2025
NCT07113964HRDQL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)P2Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency79Aug 2025
NCT06488378Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast CancerP1Breast Cancer20Aug 2024
NCT07453394QLS5132 Combination Therapy in Advanced Solid TumorsP1/P2Gastric Cancer (GC)626Apr 2026
NCT07156253Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid TumorsP1Metastatic Solid Tumor110Aug 2025
NCT06353386MK-5684Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)P1/P2Prostatic Neoplasms, Castration-Resistant220May 2024
NCT07407452QL1706Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian CancerP2Ovarian Cancers50Feb 2026
NCT07187674The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and PaclitaxelN/ATriple Negative Breast Cancer (TNBC)20Dec 2025
NCT06201234ELEMENTEvaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast CancerP2Hormone Receptor Positive HER-2 Negative Breast Cancer176Dec 2024
NCT05900895PHOEBEEstradiol Plus Olaparib for Breast Cancer (PHOEBE)P1Metastatic Breast Cancer6Jul 2024
NCT02693535TAPURTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerP2Lymphoma, Non-Hodgkin4,200Mar 2016
NCT06686745Study of SIM0508 Alone and in Combination in Patients With Advanced Solid TumorsP1Advanced Solid Tumors130Dec 2024
NCT07090369LumOnatePhase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate CancerP1Metastatic Castrate Resistant Prostate Cancer (mCRPC)20Nov 2025
NCT06650709NEOCATSNEoadjuvant Olaparib Combination OvArian Cancer Targeted StudyP2Ovarian Cancer Stage IV40Nov 2024
NCT06217757Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLCP1/P2Lung Cancer45Apr 2024
NCT05554328Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialP2Recurrent Endometrial Carcinoma165Apr 2023
NCT05485766Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerP2Triple Negative Breast Neoplasms23Jul 2024
NCT05898399POLKAStudy of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)P1/P2Advanced Solid Tumor181Jun 2023
NCT06441747MEDI4736Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)P2Cholangiocarcinoma40Sep 2024
NCT06686030Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian CancerP2Platinum-sensitive Ovarian Cancer150Feb 2025
NCT02861573MK-3475Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)P1/P2Metastatic Castration-Resistant Prostate Cancer1,200Nov 2016
NCT05128734TNBCTemozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)P2Breast Cancer Triple Negative40Apr 2026
NCT04644289WoOWoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOCP2Epithelial Ovarian Cancer60May 2022
NCT04515836Olaparib in Patients With HRD Malignant MesotheliomaP2Mesothelioma56Feb 2021
NCT04550104CONCORDEA Platform Study of Novel Agents in Combination With Radiotherapy in NSCLCP1Non Small Cell Lung Cancer200Mar 2021
NCT03786796ORCHIDStudy of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene MutationsP2Renal Cell Carcinoma20Jun 2019
NCT07024784A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesP2Gynecologic Cancers377Jul 2025
NCT04005690Targeted Pathway Inhibition in Patients With Pancreatic CancerEarly P1Locally Advanced Pancreatic Ductal Adenocarcinoma90Aug 2019
NCT06160843POLARPembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell LymphomaP2Relapsed Peripheral T-Cell Lymphoma24Jul 2024
NCT06177171HRDOlaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated TumorsP1BRCA1 Mutation18Feb 2024
NCT05255471MITO 35BMITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.P3Ovarian Cancer200Jan 2022
NCT05093231Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic CancerP2Pancreatic Cancer20Feb 2025
NCT04086485GEP-NETLu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)P1/P2Gastroenteropancreatico Tumors56Oct 2022
NCT06525298EIS-12656 as Single Agent and in Combination in Patients With Specified Solid TumorsP1/P2Advanced Solid Tumor144Sep 2024
NCT05524935Olaparib in Combination With Pembrolizumab for Advanced Uveal MelanomaP2Uveal Melanoma37Oct 2022
NCT04090567Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerP2Advanced Breast Carcinoma60Jul 2020
NCT02925234DRUPThe Drug Rediscovery Protocol (DRUP Trial)P2Cancer1,550Aug 2016
NCT05432518Pilot Trial for Treatment of Recurrent GlioblastomaEarly P1Glioblastoma10Jun 2023
NCT04858334APOLLOAPOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationP2Pancreatic Acinar Cell Carcinoma152Jun 2021
NCT02029001MOST plusAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentP2Malignant Solid Neoplasms900Mar 2014
NCT05238922Study of INCB123667 in Subjects With Advanced Solid TumorsP1Solid Tumors604Jul 2022
NCT04038502COBRACarboplatin or Olaparib for BRcA Deficient Prostate CancerP2Metastatic Castrate Resistant Prostate Cancer100Oct 2019
NCT05623319THORPembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)P2SCLC,Extensive Stage60Mar 2023
NCT05568212NSCLCRandomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and DurvalumabP2Non-small-cell Lung Cancer Patients176May 2022
NCT06739395Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment ExhaustionP2Solid Tumor300Nov 2024
NCT07371104Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian CancerP1Cancer40Apr 2026
NCT05463848Surgical Pembro +/- Olaparib w TMZ for rGBMP2Glioblastoma78Oct 2022
NCT05188508Pembrolizumab, Olaparib, and Temozolomide for People With GliomaP2Glioma57Jan 2022
NCT04683679A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerP2Triple Negative Breast Cancer34Apr 2021
NCT03297606CAPTURCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)P2Lymphoma, Non-Hodgkin720Mar 2018
NCT05870423PRRT-PARPiImproving Peptide Receptor Radionuclide Therapy With PARP InhibitorsP1Neuroendocrine Tumors24Jun 2022
NCT06419179GUIDANCEMaintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)P2Small Cell Lung Carcinoma29Oct 2024
NCT05498272NePtuneStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsP2Prostate Cancer32Feb 2023
NCT06783127COROSClinical Outcomes of Use of Olaparib in Castration Resistant Prostate CancerProstate Cancer3,000Jan 2023
NCT04585958Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian CancerP1Metastatic Malignant Solid Neoplasm55May 2021
NCT03772561MEDIPACPhase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor MalignanciesP1Solid Tumor, Adult40Dec 2018
NCT05222971OPTIMUMOlaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based ChemotherapyP2Biliary Tract Cancer62Apr 2022
NCT04711824SOLARAStudy of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesP1/P2Breast Cancer41Mar 2022
NCT04633239Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian CancerP1Recurrent Ovarian High Grade Serous Adenocarcinoma42Jul 2021
NCT04361370OPEB-01Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian CancerP2Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer44Oct 2020
NCT06078787PALBOLAOlaparib in PALB2 Advanced Pancreatic CancerP2Advanced Pancreatic Cancer16Aug 2023
NCT04592211GEJPembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) CancerP1/P2Gastric Cancer Stage IV71Oct 2021
NCT07069335A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian CancerP1Ovarian Cancer24Jun 2025
NCT05536128Post-CDKEvaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 InhibitorP2Advanced Breast Cancer64Dec 2022
NCT05078671PROACTIVEPharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectivenessP4Cancer160Dec 2021
NCT03991832SOLIDStudy of Olaparib and Durvalumab in IDH-Mutated Solid TumorsP2Glioma58Dec 2019

Olaparib clinical trials by indication

Ovarian Cancer (37)

NCTAcronymPhaseStatusTitle
NCT07460180PROOVP1/P2recruitingThe PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer
NCT04742075DOVACCP2active not recruitingOlaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer
NCT05952453P2recruitingNewly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
NCT06120972P2withdrawnUpfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency
NCT04931342BOUQUETP2active not recruitingA Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
NCT05255471MITO 35BP3recruitingMITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
NCT04884360MONO-OLA1P3active not recruitingD9319C00001- 1L OC Mono Global RCT
NCT02571725P1/P2active not recruitingPARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
+ 29 more, see All trials below.

Breast Cancer (17)

NCTAcronymPhaseStatusTitle
NCT03150576PARTNERP2/P3recruitingPlatinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
NCT02810743SubitoP3active not recruitingSubstantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer
NCT06112379P3active not recruitingA Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
NCT07151911ROYALN/ArecruitingReal wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients
NCT02624973PETREMACP2active not recruitingPErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
NCT02032823OlympiAP3active not recruitingOlaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
NCT06488378P1recruitingPhase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
NCT05203445TNBCP2active not recruitingA Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
+ 9 more, see All trials below.

Prostate Cancer (11)

NCTAcronymPhaseStatusTitle
NCT05568550P2recruitingPembro With Radiation With or Without Olaparib
NCT03787680P2active not recruitingTargeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
NCT05498272NePtuneP2recruitingStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
NCT06783127COROSN/ArecruitingClinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
NCT04748042ADTP2active not recruitingFocal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
NCT05167175P2unknownThe Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation
NCT05501548P2terminatedPhase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
NCT05262608PROspectP2unknownThe Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation
+ 3 more, see All trials below.

Metastatic Castration-resistant Prostate Cancer (8)

NCTAcronymPhaseStatusTitle
NCT06909825P2active not recruitingFPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT03732820P3active not recruitingStudy on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
NCT05457257P4active not recruitingClinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
NCT05171816P3active not recruitingStudy on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)
NCT05700669P1/P2completedStudy to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors
NCT01972217P2completedPh II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
NCT02987543P3completedStudy of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
NCT04556617P1/P2terminatedPLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Advanced Solid Tumor (8)

NCTAcronymPhaseStatusTitle
NCT05932862ISM3091P1recruitingA Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
NCT05898399POLKAP1/P2recruitingStudy of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
NCT06525298P1/P2recruitingEIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
NCT06545942P1active not recruitingStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
NCT05933265P1/P2active not recruitingStudy of LP-184 in Patients With Advanced Solid Tumors
NCT06130254MRTX849P1terminatedPhase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
NCT06560632POLARP1terminatedPhase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors
NCT05252390P1terminatedNUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Advanced Malignant Solid Neoplasm (8)

NCTAcronymPhaseStatusTitle
NCT05564377P2recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
NCT02498613P2active not recruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
NCT03155620P2active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
NCT04197713AZD1775P1active not recruitingTesting the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study
NCT03842228CODP1active not recruitingTesting the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations
NCT03212274P2active not recruitingOlaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
NCT02419495KPT-330P1terminatedPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
NCT03233204P2completedOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Solid Tumours (8)

NCTAcronymPhaseStatusTitle
NCT04236414P1completedInvestigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours
NCT01921140P1completedTo Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours
NCT02093351P1completedTo Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer
NCT01851265P1completedD081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours
NCT01894243P1completedStudy to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
NCT01929603P1completedStudy to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours
NCT01900028P1completedTo Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours
NCT01894256P1completedStudy to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Cancer (7)

NCTAcronymPhaseStatusTitle
NCT06116578NeoSarcP2withdrawnStudy Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab
NCT02925234DRUPP2recruitingThe Drug Rediscovery Protocol (DRUP Trial)
NCT07371104P1recruitingBioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
NCT05078671PROACTIVEP4recruitingPharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness
NCT04801966TAILORN/AterminatedSafety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
NCT04774406N/AcompletedArterial Hypertension Related to PARP Inhibitors (ArteRIB)
NCT01813474P1completedInvestigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies

Breast Neoplasms (5)

NCTAcronymPhaseStatusTitle
NCT06797635P2recruitingStudy of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
NCT06966700MK-2870-032P3recruitingA Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT01042379I-SPYP2recruitingI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
NCT03594396P1/P2active not recruitingWindow of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer
NCT00494234ICEBERG 1P2completedStudy to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer

Metastatic Breast Cancer (5)

NCTAcronymPhaseStatusTitle
NCT05900895PHOEBEP1recruitingEstradiol Plus Olaparib for Breast Cancer (PHOEBE)
NCT03344965P2active not recruitingOlaparib In Metastatic Breast Cancer
NCT05629429P2unknownOlaparib Maintenance Therapy in Metastatic Breast Cancer
NCT02299999SAFIR02_BreastP2active not recruitingSAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
NCT03685331HOPEP1completedHOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

Epithelial Ovarian Cancer (4)

NCTAcronymPhaseStatusTitle
NCT06915025OVATION-3P3recruitingPhase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
NCT04644289WoOP2recruitingWoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
NCT04015739BOLDP2unknownTri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse
NCT03106987OReOP3completedA Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.

Triple Negative Breast Cancer (4)

NCTAcronymPhaseStatusTitle
NCT06245889NeoADAPTP2recruitingPET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
NCT04683679P2recruitingA Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
NCT05174832P2unknownInduction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients
NCT03167619DORAP2completedPhase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)

Gastric Cancer (4)

NCTAcronymPhaseStatusTitle
NCT05379972P2completedStudy of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
NCT05411679P2withdrawnEP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer
NCT01063517P2completedEfficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients
NCT01924533P3completedEfficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.

Advanced Breast Cancer (4)

NCTAcronymPhaseStatusTitle
NCT05536128Post-CDKP2recruitingEvaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor
NCT03182634plasmaMATCHP2unknownThe UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
NCT03205761COMETABreastP2completedAnalysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
NCT03931551OPHELIAP2terminatedOlaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer

Solid Tumor (3)

NCTAcronymPhaseStatusTitle
NCT05522491P2not yet recruitingOlaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
NCT06739395P2recruitingPrecision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
NCT03057145P1completedCombination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Advanced Cancer (3)

NCTAcronymPhaseStatusTitle
NCT07382544P1recruitingPhase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
NCT02684318P1/P2unknownStudy to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
NCT02338622ComPAKTP1completedTrial of Olaparib in Combination With AZD5363 (ComPAKT)

Pancreatic Cancer (3)

NCTAcronymPhaseStatusTitle
NCT05093231P2recruitingPembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
NCT0251122310P2completedEfficacy and Safety of PARPi to Treat Pancreatic Cancer
NCT01296763P1completedTrial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer

Advanced Solid Tumors (3)

NCTAcronymPhaseStatusTitle
NCT06686745P1recruitingStudy of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
NCT05240898P1completedA Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors
NCT06331559P1terminatedStudy of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors

Endometrial Cancer (3)

NCTAcronymPhaseStatusTitle
NCT06712472RAINBO-REDP3recruitingRandomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer
NCT05255653RAINBOP2/P3recruitingRefining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
NCT05320757Early P1completedEffects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients

Lung Cancer (3)

NCTAcronymPhaseStatusTitle
NCT06217757P1/P2recruitingSafety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
NCT05245994MEDI4736P2unknownAn Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese
NCT04939662SUKSES-B2P2completedOlaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects

Breast Cancer Metastatic (3)

NCTAcronymPhaseStatusTitle
NCT06298084ICARUSBREAST02P1/P2recruitingDose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
NCT03742245P1active not recruitingOlaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
NCT02000622OlympiADP3completedAssessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

Anatomic Stage IV Breast Cancer AJCC v8 (3)

NCTAcronymPhaseStatusTitle
NCT05807126P1withdrawnTesting the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations
NCT03801369AMTEC IITP2terminatedAMTEC IIT: Phase 2 Multiarm Study in TNBC
NCT03544125P1completedOlaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Glioblastoma (3)

NCTAcronymPhaseStatusTitle
NCT05432518Early P1recruitingPilot Trial for Treatment of Recurrent Glioblastoma
NCT05463848P2recruitingSurgical Pembro +/- Olaparib w TMZ for rGBM
NCT04614909Early P1completedStudy of Pamiparib in Newly Diagnosed and rGBM

Castration-Resistant Prostate Carcinoma (3)

NCTAcronymPhaseStatusTitle
NCT03317392P1/P2active not recruitingTesting the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
NCT03516812P2completedTestosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
NCT04951492P2terminatedOlaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma

Solid Tumors (3)

NCTAcronymPhaseStatusTitle
NCT03486873MK-3475P3recruitingLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
NCT05238922P1recruitingStudy of INCB123667 in Subjects With Advanced Solid Tumors
NCT04123366MK-7339P2active not recruitingStudy of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

Ovarian Neoplasms (3)

NCTAcronymPhaseStatusTitle
NCT05440578N/AunknownFirst-line Olaparib Combined With Bevacizumab Maintenance Therapy
NCT05153603N/AunknownOutcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting
NCT03314740BAROCCOP2completedBest Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib

Metastatic Castration-Resistant Prostate Cancer (3)

NCTAcronymPhaseStatusTitle
NCT02861573MK-3475P1/P2recruitingStudy of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
NCT03568656P1/P2completedStudy to Evaluate CCS1477 in Advanced Tumours
NCT05005728P2completedXmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Non Small Cell Lung Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04550104CONCORDEP1recruitingA Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
NCT02679963PIPSeNP2terminatedTrial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
NCT01513174GOALP1/P2completedStudy With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone

Metastatic Pancreatic Adenocarcinoma (3)

NCTAcronymPhaseStatusTitle
NCT04548752P2active not recruitingTesting the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
NCT04348045MAZEPPAP2active not recruitingMaintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.
NCT02677038P2completedOlaparib in Treating Patients With Stage IV Pancreatic Cancer

Cervical Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04487587COMICEP2active not recruitingA Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer
NCT04483544P2terminatedPembrolizumab and Olaparib in Cervical Cancer Patients
NCT04641728P2unknownPembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Small Cell Lung Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04624204LS-SCLCP3active not recruitingPlacebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
NCT02446704P1/P2unknownStudy of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
NCT03009682SUKSES-BP2completedOlaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations

Colorectal Cancer (3)

NCTAcronymPhaseStatusTitle
NCT04166435P2completedTMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer
NCT00535353P1completedAZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
NCT00912743MSIP2completedEfficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status

Squamous Cell Carcinoma of the Head and Neck (3)

NCTAcronymPhaseStatusTitle
NCT02882308OPHELIAP2completedPreoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.
NCT02686008P1withdrawnPharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC
NCT01758731P1completedStudy of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History

Cholangiocarcinoma (2)

NCTAcronymPhaseStatusTitle
NCT06441747MEDI4736P2recruitingPhase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)
NCT04306367P2completedStudy of Pembrolizumab and Olaparib in Bile Duct Cancer

Triple Negative Breast Neoplasms (2)

NCTAcronymPhaseStatusTitle
NCT05485766P2recruitingNovel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
NCT04191135TNBCP2completedStudy of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

Renal Cell Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT03786796ORCHIDP2recruitingStudy of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
NCT05949424OPTI-DOSEP4unknownOPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults

Pancreatic Acinar Cell Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT04858334APOLLOP2recruitingAPOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
NCT05286827P2terminatedOlaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Anatomic Stage III Breast Cancer AJCC v8 (2)

NCTAcronymPhaseStatusTitle
NCT02849496P2active not recruitingTesting Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer
NCT05967286P2withdrawnOlaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment Trial

Ovary Cancer (2)

NCTAcronymPhaseStatusTitle
NCT05887609P2recruitingAn Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
NCT04532645OVAL-1N/AcompletedOlaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

Carcinoma, Ovarian Epithelial (2)

NCTAcronymPhaseStatusTitle
NCT06121401IOLANTHEP4active not recruitingFirst Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
NCT05158062P2unknownPembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Advanced Breast Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT04090567P2recruitingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
NCT05238831ACTEarly P1withdrawnSMMART Adaptive Clinical Treatment (ACT) Trial

Metastatic Pancreatic Cancer (2)

NCTAcronymPhaseStatusTitle
NCT04753879P2active not recruitingMulti-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
NCT05659914MEDI4736P2active not recruitingOlaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations

High Grade Serous Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT03462342CAPRIP2completedCombination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer
NCT05358639P1active not recruitingCombination of Olaparib and Navitoclax in Women with HGSC and TNBC

Malignant Neoplasm of Breast (2)

NCTAcronymPhaseStatusTitle
NCT03162627P1active not recruitingSelumetinib and Olaparib in Solid Tumors
NCT05033756COMPRENDOP2active not recruitingComprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO

Metastatic Colorectal Cancer (2)

NCTAcronymPhaseStatusTitle
NCT05201612PEMBROLAP2unknownPembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).
NCT04456699MK-7339P3completedEfficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)

Glioma (2)

NCTAcronymPhaseStatusTitle
NCT05188508P2recruitingPembrolizumab, Olaparib, and Temozolomide for People With Glioma
NCT03991832SOLIDP2recruitingStudy of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

Bladder Cancer (2)

NCTAcronymPhaseStatusTitle
NCT04579133P2terminatedNeoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy
NCT03534492NEODURVARIBP2completedDurvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)

Mesothelioma (2)

NCTAcronymPhaseStatusTitle
NCT04515836P2recruitingOlaparib in Patients With HRD Malignant Mesothelioma
NCT03531840P2completedOlaparib in People With Malignant Mesothelioma

Extensive Stage Lung Small Cell Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT04728230P1/P2active not recruitingOlaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
NCT02899728P2terminatedOlaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Pulmonary Arterial Hypertension (2)

NCTAcronymPhaseStatusTitle
NCT03782818OPTIONP1/P2terminatedOlaparib for PAH: a Multicenter Clinical Trial
NCT03251872OPTION-pEarly P1terminatedOlaparib for PAH: a Pilot Study

Soft Tissue Sarcoma (2)

NCTAcronymPhaseStatusTitle
NCT03784014MULTISARCP3completedMolecular Profiling of Advanced Soft-tissue Sarcomas
NCT02398058TOMASP1completedTrabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)

Endometrial Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT03745950UTOLAP2completedUTOLA: UTerin OLAparib
NCT02506816PolenN/AcompletedPreoperative Olaparib Endometrial Carcinoma Study (POLEN)

Advanced Ovarian Cancer (2)

NCTAcronymPhaseStatusTitle
NCT03737643DUO-OP3active not recruitingDurvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
NCT03161132ROLANDOP2completedResistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin

Lymphoma, Non-Hodgkin (2)

NCTAcronymPhaseStatusTitle
NCT02693535TAPURP2recruitingTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
NCT03297606CAPTURP2recruitingCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity (2)

NCTAcronymPhaseStatusTitle
NCT02282020SOLO3P3completedOlaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
NCT02983799P2completedOlaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Fallopian Tube Carcinoma (2)

NCTAcronymPhaseStatusTitle
NCT02345265P2active not recruitingTesting the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
NCT01116648P1/P2active not recruitingCediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Fallopian Tube Clear Cell Adenocarcinoma (2)

NCTAcronymPhaseStatusTitle
NCT02502266P2/P3active not recruitingTesting the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
NCT02446600P3active not recruitingTesting the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian (2)

NCTAcronymPhaseStatusTitle
NCT02734004MEDIOLAP1/P2active not recruitingA Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
NCT01078662P2completedOpen Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Advanced Solid Tumours (2)

NCTAcronymPhaseStatusTitle
NCT02588105AToMP1completedStudy to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer
NCT02430311P1completedThe Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.

Triple Negative Breast Cancer (TNBC), Early Setting (1)

NCTAcronymPhaseStatusTitle
NCT07486687PLANETP3not yet recruitingPembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

Gastric Cancer (GC) (1)

NCTAcronymPhaseStatusTitle
NCT07453394P1/P2not yet recruitingQLS5132 Combination Therapy in Advanced Solid Tumors

Breast Cancer Triple Negative (1)

NCTAcronymPhaseStatusTitle
NCT05128734TNBCP2not yet recruitingTemozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

Ovarian Cancers (1)

NCTAcronymPhaseStatusTitle
NCT07407452QL1706P2not yet recruitingIparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer

Triple Negative Breast Cancer (TNBC) (1)

NCTAcronymPhaseStatusTitle
NCT07187674N/Anot yet recruitingThe Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

Endometrioid Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06856499P1recruitingCirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

Metastatic Castrate Resistant Prostate Cancer (mCRPC) (1)

NCTAcronymPhaseStatusTitle
NCT07090369LumOnateP1not yet recruitingPhase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer

Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (1)

NCTAcronymPhaseStatusTitle
NCT07113964HRDP2not yet recruitingQL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)

Metastatic Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT07156253P1recruitingStudy of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Gynecologic Cancers (1)

NCTAcronymPhaseStatusTitle
NCT07024784P2recruitingA Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Triple-Negative Breast Cancer (TNBC) (1)

NCTAcronymPhaseStatusTitle
NCT07005583P2not yet recruitingClinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Early Triple Negative Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06829199MK-5890P2withdrawnA Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)

Fallopian Tube Endometrioid Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06580314P3recruitingTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Platinum-sensitive Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06686030P2recruitingCombination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

mCRPC (Metastatic Castration-resistant Prostate Cancer) (1)

NCTAcronymPhaseStatusTitle
NCT06785636P300P1/P2recruitingA Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Advanced or Recurrent Endometrial Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06746116DUoENDEP3active not recruitingA Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

Hormone Receptor Positive HER-2 Negative Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06201234ELEMENTP2recruitingEvaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer

Ovarian Cancer Stage IV (1)

NCTAcronymPhaseStatusTitle
NCT06650709NEOCATSP2not yet recruitingNEoadjuvant Olaparib Combination OvArian Cancer Targeted Study

Small Cell Lung Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06419179GUIDANCEP2enrolling by invitationMaintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

Solid Tumor Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06607692LUPARPEDP1/P2recruitingStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Relapsed Peripheral T-Cell Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT06160843POLARP2recruitingPembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma

Prostatic Neoplasms, Castration-Resistant (1)

NCTAcronymPhaseStatusTitle
NCT06353386MK-5684P1/P2recruitingSubstudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

BRCA1 Mutation (1)

NCTAcronymPhaseStatusTitle
NCT06177171HRDP1recruitingOlaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

TNBC - Triple-Negative Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05209529P2withdrawnChemo-free BRCA-targeted Neoadjuvant Strategy

Extensive-stage Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05975944P1/P2unknownStudy of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Advanced Pancreatic Cancer (1)

NCTAcronymPhaseStatusTitle
NCT06078787PALBOLAP2recruitingOlaparib in PALB2 Advanced Pancreatic Cancer

Early-stage Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05332561COGNITION-GUIDEP2recruitingGenomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Locally Advanced Pancreatic Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05411094P1suspendedTesting the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Recurrent Endometrial Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05554328P2recruitingTesting the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Locally Advanced Uterine Corpus Leiomyosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT05432791P2/P3active not recruitingTesting Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

SCLC,Extensive Stage (1)

NCTAcronymPhaseStatusTitle
NCT05623319THORP2recruitingPembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)

Uveal Melanoma (1)

NCTAcronymPhaseStatusTitle
NCT05524935P2recruitingOlaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Recurrent Metastatic Melanoma (1)

NCTAcronymPhaseStatusTitle
NCT05482074P2withdrawnOlaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Gastroenteropancreatico Tumors (1)

NCTAcronymPhaseStatusTitle
NCT04086485GEP-NETP1/P2recruitingLu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Chronic Lymphocytic Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT05405309CORONADO CLLP1/P2terminatedRP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia

Esophagogastric Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05268510P2completedChemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck (1)

NCTAcronymPhaseStatusTitle
NCT05366166P2active not recruitingPembrolizumab Plus Olaparib in LA-HNSCC

Platinum-Refractory Fallopian Tube Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT05295589P2withdrawnComparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Neuroendocrine Tumors (1)

NCTAcronymPhaseStatusTitle
NCT05870423PRRT-PARPiP1recruitingImproving Peptide Receptor Radionuclide Therapy With PARP Inhibitors

Healthy Participants (1)

NCTAcronymPhaseStatusTitle
NCT06360445P1completedBioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects

Non-small-cell Lung Cancer Patients (1)

NCTAcronymPhaseStatusTitle
NCT05568212NSCLCP2recruitingRandomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab

Biliary Tract Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05222971OPTIMUMP2recruitingOlaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy

HER2-negative Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT05340413RADIOLAP2completedPredicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.

Endometrial Carcinosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT05156268P2completedA Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma

Gastric Cancer Stage IV (1)

NCTAcronymPhaseStatusTitle
NCT04592211GEJP1/P2recruitingPembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Recurrent Head and Neck Squamous Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04643379P2active not recruitingOlaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

EGFR-Mutated Non-Small-Cell Lung Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04538378LYNPARZAP2terminatedOlaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors

Recurrent Ovarian High Grade Serous Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04633239P1recruitingTesting the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Fallopian Tube Mucinous Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04739800P2active not recruitingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Metastatic Malignant Solid Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT04585958P1recruitingTesting the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT05860530N/AcompletedBioequivalence Study of Two Olaparib Tablets in Patients With Cancers

Biochemically Recurrent Prostate Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04336943P2terminatedDurvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Advanced Adrenal Gland Pheochromocytoma (1)

NCTAcronymPhaseStatusTitle
NCT04394858P2active not recruitingTesting the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

Metastatic Melanoma (1)

NCTAcronymPhaseStatusTitle
NCT04633902HRP2unknownPhase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

Stomach Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04410887LIGCP1/P2unknownNeoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Metastatic Pancreatic Ductal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04666740P2active not recruitingA Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy

Osteosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT04417062P2active not recruitingOlaparib With Ceralasertib in Recurrent Osteosarcoma

Advanced Bladder Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03375307P2active not recruitingTesting Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04361370OPEB-01P2enrolling by invitationOlaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer

Fallopian Tube Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03924245P1terminatedOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Acute Myeloid Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT03953898IDHP2active not recruitingUsing the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation

Advanced Gastric Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04209686P2active not recruitingPaclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma

Renal Cell Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03741426WIREP2unknownWIRE - Novel Treatments in Renal Cell Cancer

Lung Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT04380636NSCLCP3active not recruitingStudy of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Bile Duct Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04298021P2unknownDDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Bile Duct Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04042831P2active not recruitingOlaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Advanced Soft Tissue Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT03838744TOMAS2P2completedRandomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

Endometrial Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT04269200DUO-EP3active not recruitingDurvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Clinical Trial, Phase I (1)

NCTAcronymPhaseStatusTitle
NCT04375267LuPARPP1completed177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (1)

NCTAcronymPhaseStatusTitle
NCT03878524SMMARTP1terminatedSerial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT04076579P2completedTrabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

Immunotherapy (1)

NCTAcronymPhaseStatusTitle
NCT04169841GUIDE2REPAIRP2active not recruitingStudy Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment

Malignant Solid Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT03878095P2active not recruitingTesting Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors

Fallopian Tube Endometrioid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT04034927P2active not recruitingTesting the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

High Grade Serous Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04261465NUVOLAP2unknownNUVOLA TRIAL Open-label Multicentre Study

Gynaecological Cancers (1)

NCTAcronymPhaseStatusTitle
NCT04065269ATARIP2active not recruitingATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

Breast Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT03740893PHOENIXP2recruitingPHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer

Metastatic Castrate Resistant Prostate Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04038502COBRAP2recruitingCarboplatin or Olaparib for BRcA Deficient Prostate Cancer

Recurrent Diffuse Large B-Cell Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT03259503P1completedOlaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04053322DOLAFP2active not recruitingDurvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

Stage III Uterine Corpus Leiomyosarcoma AJCC v8 (1)

NCTAcronymPhaseStatusTitle
NCT03880019P2active not recruitingA Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma

Locally Advanced Pancreatic Ductal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT04005690Early P1recruitingTargeted Pathway Inhibition in Patients With Pancreatic Cancer

Metastatic Castration Resistant Prostate Cancer (mCRPC) (1)

NCTAcronymPhaseStatusTitle
NCT03874884LuPARPP1active not recruiting177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT04091204MITO 31P2unknownOlaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study

Oesophageal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03829345SOLARP2unknownA Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

Carcinoma, Squamous Cell, Non-small-cell Lung (1)

NCTAcronymPhaseStatusTitle
NCT03976362MK-3475P3completedA Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

Carcinoma, Nonsquamous Non-small-cell Lung (1)

NCTAcronymPhaseStatusTitle
NCT03976323NSCLCP3completedStudy of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

BRCA-Mutated Ovarian Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03943173Early P1active not recruitingOlaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

Small Cell Lung Cancer Extensive Stage (1)

NCTAcronymPhaseStatusTitle
NCT03923270P1active not recruitingRadiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

Metastatic Malignant Neoplasm in the Chest Wall (1)

NCTAcronymPhaseStatusTitle
NCT03955640P1terminatedHyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences

Prostatic Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT03834519KEYLYNK-010P3completedStudy of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Mismatch Repair Proficient Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03851614DAPPERP2active not recruitingStudy of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors

Recurrent IDH (1)

NCTAcronymPhaseStatusTitle
NCT03561870OLAGLIP2completedOlaparib in Recurrent IDH-mutant Glioma

Advanced Cancers Harbouring Mutations in HRG (1)

NCTAcronymPhaseStatusTitle
NCT039679381-2018 BSMOP2active not recruitingEfficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes

Ovarian Neoplasm Epithelial (1)

NCTAcronymPhaseStatusTitle
NCT04780945FABP2terminatedFunctional Analysis of BRCAness

Breast Inflammatory Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03598257P2active not recruitingRadiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

Clear Cell Renal Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03682289AZD6738P2active not recruitingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Breast Cancer Organoids (1)

NCTAcronymPhaseStatusTitle
NCT03925233N/AunknownBreast Cancer Treatment Based on Organ-like Culture

Non-small Cell Lung Cancer NSCLC (1)

NCTAcronymPhaseStatusTitle
NCT03775486ORIONP2active not recruitingStudy of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

Advanced Solid Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT03742895MK-7339P2active not recruitingEfficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

Recurrent Fallopian Tube Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03579316P2active not recruitingAdavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Solid Tumor, Adult (1)

NCTAcronymPhaseStatusTitle
NCT03772561MEDIPACP1recruitingPhase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies

Advanced Gastric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03579784MEDI4736P2unknownBiomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer

Platinum-resistant Recurrent Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03699449AMBITIONP2unknownAn uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)

Cancers With DNA Repair-Deficiency (1)

NCTAcronymPhaseStatusTitle
NCT03127215NCT-PMO-1603P2completedStudy of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors

SCLC (1)

NCTAcronymPhaseStatusTitle
NCT03428607P2completedStudy of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]

Relapsed Ovarian Cancers Patients (1)

NCTAcronymPhaseStatusTitle
NCT04152941RETROLAN/AcompletedReal-life Data of Olaparib in Relapsed Ovarian Cancers Patients

Endometrial Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03660826P2active not recruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Prostate Adenocarcinoma Without Neuroendocrine Differentiation (1)

NCTAcronymPhaseStatusTitle
NCT03570476P2terminatedOlaparib Before Surgery in Treating Participants With Localized Prostate Cancer

Small-cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03532880P1completedA Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

Cancer of Unknown Primary Site (1)

NCTAcronymPhaseStatusTitle
NCT03498521CUPISCOP2completedA Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT03575078P1withdrawnARQ761 + PARP Inhibitor in Refractory Solid Tumors

Relapsed Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03534453L-MOCAP3completedOlaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Carcinosarcoma (1)

NCTAcronymPhaseStatusTitle
NCT03570437COPELIAP2unknownDoes Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Malignant Solid Tumor (1)

NCTAcronymPhaseStatusTitle
NCT03553108IVIVCP1completedA Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

Metastatic Urothelial Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03448718P2completedTrial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations

Urinary Bladder Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT03459846BAYOUP2active not recruitingA Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Metastatic Triple Negative Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03330847P2active not recruitingTo Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.

Metastatic Esophageal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03008278P1/P2completedOlaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

Prostate Cancer Metastatic (1)

NCTAcronymPhaseStatusTitle
NCT03434158IMANOLP2completedOlaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)

Non-Germline BRCA Mutated Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03402841OPINIONP3completedMulticentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients

HER2-ve Metastatic Breast Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03286842P3completedTo Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.

Non-Small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03334617HUDSONP2active not recruitingPhase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy

Recurrent Glioblastoma (1)

NCTAcronymPhaseStatusTitle
NCT02974621P2active not recruitingCediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma

Prostate Cancer Aggressiveness (1)

NCTAcronymPhaseStatusTitle
NCT03263650P2active not recruitingStudy of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Head and Neck Squamous Cell Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03022409DDRP1completedA Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).

Malignant Gliomas (1)

NCTAcronymPhaseStatusTitle
NCT03212742OLA-TMZ-RTE-01P1/P2active not recruitingPhase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients

Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation (1)

NCTAcronymPhaseStatusTitle
NCT02893917P2active not recruitingTesting Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Breast Neoplasms, Triple-Negative (1)

NCTAcronymPhaseStatusTitle
NCT03109080RadioPARPP1completedOlaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

Malignant Solid Tumors (1)

NCTAcronymPhaseStatusTitle
NCT03205176P1completedAZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

BRCA1 Gene Mutation (1)

NCTAcronymPhaseStatusTitle
NCT02953457P2completedOlaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation

Metastatic High Grade Fallopian Tube Serous Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02898207P1completedOlaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

Oral Squamous Cell Carcinoma (OSCC) (1)

NCTAcronymPhaseStatusTitle
NCT03085147P1/P2active not recruitingA Dye for the Detection of Cancer of the Tongue and Mouth

Prostate (1)

NCTAcronymPhaseStatusTitle
NCT03047135P2active not recruitingOlaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Recurrent Platinum Resistant Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02889900CONCERTOP2completedEfficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

Prostate Cancer Metastatic Castration-Resistant (1)

NCTAcronymPhaseStatusTitle
NCT03012321P2active not recruitingAbiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Rare Tumor (1)

NCTAcronymPhaseStatusTitle
NCT03239015P2unknownEfficacy and Safety of Precision Therapy in Refractory Tumor

Muscle Invasive Bladder Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02546661BISCAYP1active not recruitingOpen-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer

Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02937818P2completedA Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Recurrent Endometrial Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02755844ENDOLAP1/P2completedSafety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients

Ovarian Epithelial Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02822157CLIOP2unknownCirculating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer

Pediatric Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02813135ESMARTP1/P2recruitingEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Platinum Sensitive Relapsed Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02392676P3withdrawnOlaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Urothelial Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02769962P1/P2completedTrial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Soft-tissue Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT02787642RADIOSARPP1completedA Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma

Primary Peritoneal Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT02485990P1terminatedStudy of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)

Head and Neck Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02308072ORCA-2P1completedPhase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer

BRCA or HRR+ Mutated Ovarian Cancer Patients (1)

NCTAcronymPhaseStatusTitle
NCT02476968ORZORAP4completedTo Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer

Neoplasms, Germ Cell and Embryonal (1)

NCTAcronymPhaseStatusTitle
NCT02533765P2completedOlaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor

Refractory Solid Tumours (1)

NCTAcronymPhaseStatusTitle
NCT02511795P1completedAZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors

Colorectal Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT02484404MEDI4736P1/P2active not recruitingPhase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...

Germline BRCA1/2 Mutations and (1)

NCTAcronymPhaseStatusTitle
NCT02184195POLOP3completedOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

BRCA1 Mutation Carrier (1)

NCTAcronymPhaseStatusTitle
NCT02208375P1active not recruitingmTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02264678P1active not recruitingAscending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

Laryngeal Cancer Stage II (1)

NCTAcronymPhaseStatusTitle
NCT02229656P1unknownOlaparib and Radiotherapy in Head and Neck Cancer

Non-small Cell Lung Cancer Metastatic (1)

NCTAcronymPhaseStatusTitle
NCT02117167SAFIR02_LungP2completedSAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients

Malignant Solid Neoplasms (1)

NCTAcronymPhaseStatusTitle
NCT02029001MOST plusP2recruitingAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Non-small Cell Lung Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01788332PINP2unknownParp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)

Locally Advanced Malignant Neoplasm (1)

NCTAcronymPhaseStatusTitle
NCT02227082P1completedOlaparib and Radiotherapy in Inoperable Breast Cancer

Platinum Sensitive (1)

NCTAcronymPhaseStatusTitle
NCT01874353P3active not recruitingOlaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Newly Diagnosed (1)

NCTAcronymPhaseStatusTitle
NCT01844986SOLO-1P3active not recruitingOlaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Carcinoma of the Oesophagus (1)

NCTAcronymPhaseStatusTitle
NCT01460888ROCOCOP1unknownRadiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus

Ewing Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT01858168P1completedPhase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma

Stage III Ovarian Cancer (1)

NCTAcronymPhaseStatusTitle
NCT01650376P1/P2unknownPhase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Adenocarcinoma of the Prostate (1)

NCTAcronymPhaseStatusTitle
NCT01682772TOPARPP2unknownTOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer

Ewing's Sarcoma (1)

NCTAcronymPhaseStatusTitle
NCT01583543P2completedOlaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma

NSCLC (1)

NCTAcronymPhaseStatusTitle
NCT01562210olaparibP1completedOlaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC

Brain and Central Nervous System Tumors (1)

NCTAcronymPhaseStatusTitle
NCT01390571P1completedOlaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

PSR Ovarian Cancer With a BRCA Mutation (1)

NCTAcronymPhaseStatusTitle
NCT03063710N/Ano longer availableOlaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

Carcinoma, Squamous Cell (1)

NCTAcronymPhaseStatusTitle
NCT01491139ORCAP1withdrawnPhase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Olaparib pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

AcronymNCTPhaseStatusIndicationEnrollmentPubMed
IOLANTHENCT06121401P4active not recruitingCarcinoma, Ovarian Epithelial190
PROACTIVENCT05078671P4recruitingCancer160PMID 37806255
OPTI-DOSENCT05949424P4unknownRenal Cell Carcinoma30
SOLINCT04330040P4completedOvarian Cancer202
ORZORANCT02476968P4completedBRCA or HRR+ Mutated Ovarian Cancer Patients181
MK-3475NCT03486873P3recruitingSolid Tumors3,500PMID 37348035
PLANETNCT07486687P3not yet recruitingTriple Negative Breast Cancer (TNBC), Early Setting1,000
MK-2870-032NCT06966700P3recruitingBreast Neoplasms2,400
SubitoNCT02810743P3active not recruitingBreast Cancer174
OVATION-3NCT06915025P3recruitingEpithelial Ovarian Cancer500
RAINBO-REDNCT06712472P3recruitingEndometrial Cancer554
NSCLCNCT04380636P3active not recruitingLung Neoplasms870PMID 35618629
OlympiANCT02032823P3active not recruitingBreast Cancer1,837PMID 34081848
DUoENDENCT06746116P3active not recruitingAdvanced or Recurrent Endometrial Cancer45
SOLO-1NCT01844986P3active not recruitingNewly Diagnosed450PMID 30345884
MITO 35BNCT05255471P3recruitingOvarian Cancer200PMID 35318277
LS-SCLCNCT04624204P3active not recruitingSmall Cell Lung Cancer672PMID 35613997
MONO-OLA1NCT04884360P3active not recruitingOvarian Cancer366
ROSY-ONCT04421963P3active not recruitingOvarian Cancer185
DUO-ENCT04269200P3active not recruitingEndometrial Neoplasms805PMID 41943281
DUO-ONCT03737643P3active not recruitingAdvanced Ovarian Cancer1,407PMID 37185961
MK-3475NCT03740165P3completedOvarian Cancer1,367
MK-3475NCT03976362P3completedCarcinoma, Squamous Cell, Non-small-cell Lung851PMID 39477187
NSCLCNCT03976323P3completedCarcinoma, Nonsquamous Non-small-cell Lung1,003PMID 39521434
MULTISARCNCT03784014P3completedSoft Tissue Sarcoma603PMID 34740331
OlympiADNCT02000622P3completedBreast Cancer Metastatic302PMID 28578601
L-MOCANCT03534453P3completedRelapsed Ovarian Cancer229PMID 38755585
KEYLYNK-010NCT03834519P3completedProstatic Neoplasms793PMID 37290035
ICON9NCT03278717P3unknownOvarian Cancer330PMID 33097567
MK-7339NCT04456699P3completedMetastatic Colorectal Cancer335PMID 38749110
POLONCT02184195P3completedGermline BRCA1/2 Mutations and154PMID 33364840
SOLO3NCT02282020P3completedRelapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity266PMID 39668137
PAOLA-1NCT02477644P3completedOvarian Cancer806PMID 31851799
OPINIONNCT03402841P3completedNon-Germline BRCA Mutated Ovarian Cancer279PMID 31553234
OReONCT03106987P3completedEpithelial Ovarian Cancer220PMID 37797734
I-SPYNCT01042379P2recruitingBreast Neoplasms5,000PMID 21796368
MK-5890NCT06829199P2withdrawnEarly Triple Negative Breast Cancer0
COGNITION-GUIDENCT05332561P2recruitingEarly-stage Breast Cancer240
DOVACCNCT04742075P2active not recruitingOvarian Cancer188
NeoADAPTNCT06245889P2recruitingTriple Negative Breast Cancer30PMID 32101663
PETREMACNCT02624973P2active not recruitingBreast Cancer200PMID 33242536
NeoSarcNCT06116578P2withdrawnCancer0
PHOENIXNCT03740893P2recruitingBreast Neoplasm119
HRDNCT07113964P2not yet recruitingPreviously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency79
QL1706NCT07407452P2not yet recruitingOvarian Cancers50
ELEMENTNCT06201234P2recruitingHormone Receptor Positive HER-2 Negative Breast Cancer176PMID 35584336
TAPURNCT02693535P2recruitingLymphoma, Non-Hodgkin4,200PMID 36753688
NEOCATSNCT06650709P2not yet recruitingOvarian Cancer Stage IV40
MEDI4736NCT06441747P2recruitingCholangiocarcinoma40
TNBCNCT05128734P2not yet recruitingBreast Cancer Triple Negative40
WoONCT04644289P2recruitingEpithelial Ovarian Cancer60
BOUQUETNCT04931342P2active not recruitingOvarian Cancer176
ORCHIDNCT03786796P2recruitingRenal Cell Carcinoma20
AZD6738NCT03682289P2active not recruitingClear Cell Renal Cell Carcinoma83PMID 41686845
POLARNCT06160843P2recruitingRelapsed Peripheral T-Cell Lymphoma24
DRUPNCT02925234P2recruitingCancer1,550PMID 37424386
APOLLONCT04858334P2recruitingPancreatic Acinar Cell Carcinoma152PMID 37222189
MOST plusNCT02029001P2recruitingMalignant Solid Neoplasms900PMID 37444551
COBRANCT04038502P2recruitingMetastatic Castrate Resistant Prostate Cancer100
DOLAFNCT04053322P2active not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer172PMID 40986529
GUIDE2REPAIRNCT04169841P2active not recruitingImmunotherapy270PMID 32778095
THORNCT05623319P2recruitingSCLC,Extensive Stage60
NSCLCNCT05568212P2recruitingNon-small-cell Lung Cancer Patients176PMID 18500231
IDHNCT03953898P2active not recruitingAcute Myeloid Leukemia14
TNBCNCT05203445P2active not recruitingBreast Cancer6
CAPTURNCT03297606P2recruitingLymphoma, Non-Hodgkin720
DAPPERNCT03851614P2active not recruitingMismatch Repair Proficient Colorectal Cancer90
GUIDANCENCT06419179P2enrolling by invitationSmall Cell Lung Carcinoma29
NePtuneNCT05498272P2recruitingProstate Cancer32PMID 36710203
OlympiaNNCT05498155P2active not recruitingBreast Cancer50
BAYOUNCT03459846P2active not recruitingUrinary Bladder Neoplasms154PMID 35737919
OPTIMUMNCT05222971P2recruitingBiliary Tract Cancer62PMID 20375404
ORIONNCT03775486P2active not recruitingNon-small Cell Lung Cancer NSCLC401PMID 37390980
HUDSONNCT03334617P2active not recruitingNon-Small Cell Lung Cancer528PMID 38351187
OPEB-01NCT04361370P2enrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer44PMID 33559413
ATARINCT04065269P2active not recruitingGynaecological Cancers174PMID 34904813
PALBOLANCT06078787P2recruitingAdvanced Pancreatic Cancer16
MK-7339NCT03742895P2active not recruitingAdvanced Solid Neoplasms329
MK-7339NCT04123366P2active not recruitingSolid Tumors300PMID 35567913
MEDI4736NCT05659914P2active not recruitingMetastatic Pancreatic Cancer40
ADTNCT04748042P2active not recruitingProstate Cancer21
COMICENCT04487587P2active not recruitingCervical Cancer79
COMPRENDONCT05033756P2active not recruitingMalignant Neoplasm of Breast11
MITO 35aNCT05233982P2unknownOvarian Cancer200
Post-CDKNCT05536128P2recruitingAdvanced Breast Cancer64
MAZEPPANCT04348045P2active not recruitingMetastatic Pancreatic Adenocarcinoma307
1-2018 BSMONCT03967938P2active not recruitingAdvanced Cancers Harbouring Mutations in HRG540
NEONCT02489006P2unknownOvarian Cancer71
SAFIR02_BreastNCT02299999P2active not recruitingMetastatic Breast Cancer1,460PMID 32067679
WIRENCT03741426P2unknownRenal Cell Cancer60PMID 34794412
TNBCNCT04191135P2completedTriple Negative Breast Neoplasms462PMID 41405563
STROBENCT06377267P2unknownOvarian Cancer100
CAPRINCT03462342P2completedHigh Grade Serous Carcinoma123
PEMBROLANCT05201612P2unknownMetastatic Colorectal Cancer40
SOLIDNCT03991832P2recruitingGlioma58
RADIOLANCT05340413P2completedHER2-negative Breast Cancer65
HRNCT04633902P2unknownMetastatic Melanoma41
FABNCT04780945P2terminatedOvarian Neoplasm Epithelial27
MEDI4736NCT03579784P2unknownAdvanced Gastric Cancer40
AMTEC IITNCT03801369P2terminatedAnatomic Stage IV Breast Cancer AJCC v824
TOMAS2NCT03838744P2completedAdvanced Soft Tissue Sarcoma130PMID 36110934
CUPISCONCT03498521P2completedCancer of Unknown Primary Site529PMID 39096924
UTOLANCT03745950P2completedEndometrial Carcinoma147
PROspectNCT05262608P2unknownProstate Cancer30
LYNPARZANCT04538378P2terminatedEGFR-Mutated Non-Small-Cell Lung Carcinoma4
BOLDNCT04015739P2unknownEpithelial Ovarian Cancer74
OCTOVANCT03117933P2completedOvarian Cancer139PMID 33452192
SAFIR02_LungNCT02117167P2completedNon-small Cell Lung Cancer Metastatic999PMID 26410619
NCT-PMO-1603NCT03127215P2completedCancers With DNA Repair-Deficiency102
MEDI4736NCT05245994P2unknownLung Cancer60
plasmaMATCHNCT03182634P2unknownAdvanced Breast Cancer1,150PMID 32919527
SUKSES-B2NCT04939662P2completedLung Cancer25
ANLOLANCT04566952P2unknownOvarian Cancer68
MITO 31NCT04091204P2unknownBRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer200
CLIONCT02822157P2unknownOvarian Epithelial Cancer160
OLAPemNCT04417192P2completedOvarian Cancer30
COPELIANCT03570437P2unknownCarcinosarcoma124
ROLANDONCT03161132P2completedAdvanced Ovarian Cancer32PMID 34329939
ICEBERG 1NCT00494234P2completedBreast Neoplasms54PMID 20609467
COMETABreastNCT03205761P2completedAdvanced Breast Cancer11
NUVOLANCT04261465P2unknownHigh Grade Serous Ovarian Cancer35PMID 34131041
AMBITIONNCT03699449P2unknownPlatinum-resistant Recurrent Ovarian Cancer104PMID 31671191
DORANCT03167619P2completedTriple Negative Breast Cancer45PMID 38236575
IMANOLNCT03434158P2completedProstate Cancer Metastatic16
PIPSeNNCT02679963P2terminatedNon Small Cell Lung Cancer180PMID 38097741
OPHELIANCT03931551P2terminatedAdvanced Breast Cancer5
SOLARNCT03829345P2unknownOesophageal Cancer54
NOBROLANCT03367689P2terminatedBreast Cancer7PMID 39520738
337NCT03432897P2terminatedProstate Cancer1PMID 33084183
OLAGLINCT03561870P2completedRecurrent IDH35PMID 38855053
10NCT02511223P2completedPancreatic Cancer24
BAROCCONCT03314740P2completedOvarian Neoplasms123PMID 35170751
CONCERTONCT02889900P2completedRecurrent Platinum Resistant Ovarian Cancer62
SUKSES-BNCT03009682P2completedSmall Cell Lung Cancer15
DUETTENCT04239014P2withdrawnOvarian Cancer0PMID 32878963
NEODURVARIBNCT03534492P2completedBladder Cancer29
TOPARPNCT01682772P2unknownAdenocarcinoma of the Prostate148PMID 31806540
OPHELIANCT02882308P2completedSquamous Cell Carcinoma of the Head and Neck41PMID 33714009
PINNCT01788332P2unknownNon-small Cell Lung Cancer70PMID 35990583
MSINCT00912743P2completedColorectal Cancer33

Terminated and withdrawn Olaparib trials (52)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

All Olaparib trials (409)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT03486873MK-3475Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)P3recruiting3,500Merck Sharp & Dohme LLCAug 2018
NCT07486687PLANETPembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus ChemotherapyP3not yet recruiting1,000The Netherlands Cancer InstituteApr 2026
NCT06797635Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)P2recruiting372Merck Sharp & Dohme LLCMar 2025
NCT06580314Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerP3recruiting880NRG OncologyMar 2025
NCT06966700MK-2870-032A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)P3recruiting2,400Merck Sharp & Dohme LLCJun 2025
NCT03150576PARTNERPlatinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast CancerP2/P3recruiting780Cambridge University Hospitals NHS Foundation TrustMay 2016
NCT02810743SubitoSubstantially Improving the Cure Rate of High-risk BRCA1-like Breast CancerP3active not recruiting174The Netherlands Cancer InstituteJan 2017
NCT06915025OVATION-3Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerP3recruiting500ImunonJul 2025
NCT06112379A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerP3active not recruiting1,902AstraZenecaNov 2023
NCT07460180PROOVThe PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian CancerP1/P2recruiting55The Netherlands Cancer InstituteMay 2025
NCT07382544Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP LossP1recruiting36M.D. Anderson Cancer CenterFeb 2026
NCT06712472RAINBO-REDRandomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial CancerP3recruiting554Gustave Roussy, Cancer Campus, Grand ParisJun 2024
NCT01042379I-SPYI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerP2recruiting5,000QuantumLeap Healthcare CollaborativeMar 2010
NCT07151911ROYALReal wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patientsrecruiting100Azienda Ospedaliero-Universitaria di ModenaAug 2024
NCT05522491Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast CancerP2not yet recruiting30Hebei Medical University Fourth HospitalSep 2026
NCT06829199MK-5890A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)P2withdrawn0Merck Sharp & Dohme LLCMar 2025
NCT02813135ESMARTEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsP1/P2recruiting472Gustave Roussy, Cancer Campus, Grand ParisAug 2016
NCT05887609An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and OlaparibP2recruiting53University of Colorado, DenverOct 2023
NCT05255653RAINBORefining Adjuvant Treatment IN Endometrial Cancer Based On Molecular FeaturesP2/P3recruiting1,615Leiden University Medical CenterNov 2021
NCT05332561COGNITION-GUIDEGenomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)P2recruiting240German Cancer Research CenterJun 2023
NCT04742075DOVACCOlaparib, Durvalumab and UV1 in Relapsed Ovarian CancerP2active not recruiting188Nordic Society of Gynaecological Oncology - Clinical Trials UnitDec 2021
NCT05952453Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/PembroP2recruiting20University of Alabama at BirminghamFeb 2025
NCT05366166Pembrolizumab Plus Olaparib in LA-HNSCCP2active not recruiting45UNC Lineberger Comprehensive Cancer CenterSep 2022
NCT05209529Chemo-free BRCA-targeted Neoadjuvant StrategyP2withdrawn0European Organisation for Research and Treatment of Cancer - EORTCFeb 2024
NCT05564377Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialP2recruiting2,900National Cancer Institute (NCI)Apr 2023
NCT06245889NeoADAPTPET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBCP2recruiting30Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMay 2024
NCT02624973PETREMACPErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC TrialP2active not recruiting200Haukeland University HospitalApr 2016
NCT07005583Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast CancerP2not yet recruiting46Tianjin Medical University Cancer Institute and HospitalJun 2025
NCT06607692LUPARPEDStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).P1/P2recruiting25Fundación de investigación HMSep 2024
NCT06120972Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination DeficiencyP2withdrawn0Alexander B Olawaiye, MDJan 2024
NCT05932862ISM3091A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsP1recruiting429ExelixisApr 2024
NCT06856499Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian CancerP1recruiting50University of Colorado, DenverDec 2025
NCT04380636NSCLCStudy of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)P3active not recruiting870Merck Sharp & Dohme LLCJul 2020
NCT05568550Pembro With Radiation With or Without OlaparibP2recruiting64Zin W MyintJul 2023
NCT06116578NeoSarcStudy Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant PembrolizumabP2withdrawn0Gustave Roussy, Cancer Campus, Grand ParisJan 2025
NCT06298084ICARUSBREAST02Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXdP1/P2recruiting152Gustave Roussy, Cancer Campus, Grand ParisMar 2024
NCT03740893PHOENIXPHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast CancerP2recruiting119Institute of Cancer Research, United KingdomOct 2019
NCT02032823OlympiAOlaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerP3active not recruiting1,837AstraZenecaApr 2014
NCT06785636P300A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPCP1/P2recruiting120Pathos AI, Inc.Feb 2025
NCT07113964HRDQL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)P2not yet recruiting79The First Affiliated Hospital with Nanjing Medical UniversityAug 2025
NCT06488378Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast CancerP1recruiting20Dana-Farber Cancer InstituteAug 2024
NCT07453394QLS5132 Combination Therapy in Advanced Solid TumorsP1/P2not yet recruiting626Qilu Pharmaceutical Co., Ltd.Apr 2026
NCT07156253Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid TumorsP1recruiting110Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdAug 2025
NCT06353386MK-5684Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)P1/P2recruiting220Merck Sharp & Dohme LLCMay 2024
NCT07407452QL1706Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian CancerP2not yet recruiting50Jiangsu Cancer Institute & HospitalFeb 2026
NCT07187674The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and PaclitaxelN/Anot yet recruiting20Harbin Medical UniversityDec 2025
NCT06201234ELEMENTEvaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast CancerP2recruiting176GBG Forschungs GmbHDec 2024
NCT05900895PHOEBEEstradiol Plus Olaparib for Breast Cancer (PHOEBE)P1recruiting6Mary D ChamberlinJul 2024
NCT02693535TAPURTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerP2recruiting4,200American Society of Clinical OncologyMar 2016
NCT06686745Study of SIM0508 Alone and in Combination in Patients With Advanced Solid TumorsP1recruiting130Jiangsu Simcere Pharmaceutical Co., Ltd.Dec 2024
NCT07090369LumOnatePhase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate CancerP1not yet recruiting20Peter MacCallum Cancer Centre, AustraliaNov 2025
NCT06746116DUoENDEA Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in SpainP3active not recruiting45AstraZenecaDec 2024
NCT06650709NEOCATSNEoadjuvant Olaparib Combination OvArian Cancer Targeted StudyP2not yet recruiting40British Columbia Cancer AgencyNov 2024
NCT06217757Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLCP1/P2recruiting45Sichuan UniversityApr 2024
NCT04643379Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell CarcinomaP2active not recruiting30Washington University School of MedicineAug 2021
NCT05554328Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialP2recruiting165National Cancer Institute (NCI)Apr 2023
NCT05485766Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerP2recruiting23Okayama UniversityJul 2024
NCT05898399POLKAStudy of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)P1/P2recruiting181Artios Pharma LtdJun 2023
NCT04209686Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric AdenocarcinomaP2active not recruiting36Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJul 2020
NCT06441747MEDI4736Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)P2recruiting40Australasian Gastro-Intestinal Trials GroupSep 2024
NCT03787680Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)P2active not recruiting49University of Michigan Rogel Cancer CenterOct 2019
NCT01844986SOLO-1Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.P3active not recruiting450AstraZenecaAug 2013
NCT06686030Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian CancerP2recruiting150AkesoFeb 2025
NCT02861573MK-3475Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)P1/P2recruiting1,200Merck Sharp & Dohme LLCNov 2016
NCT05128734TNBCTemozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)P2not yet recruiting40AHS Cancer Control AlbertaApr 2026
NCT05411094Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic CancerP1suspended18National Cancer Institute (NCI)May 2023
NCT04644289WoOWoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOCP2recruiting60AGO Research GmbHMay 2022
NCT04931342BOUQUETA Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian TumorsP2active not recruiting176Hoffmann-La RocheOct 2021
NCT04515836Olaparib in Patients With HRD Malignant MesotheliomaP2recruiting56University of ChicagoFeb 2021
NCT04550104CONCORDEA Platform Study of Novel Agents in Combination With Radiotherapy in NSCLCP1recruiting200University of LeedsMar 2021
NCT03786796ORCHIDStudy of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene MutationsP2recruiting20Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJun 2019
NCT03682289AZD6738Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsP2active not recruiting83Rahul AggarwalJan 2019
NCT04394858Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerP2active not recruiting46National Cancer Institute (NCI)Mar 2021
NCT07024784A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesP2recruiting377AbbVieJul 2025
NCT04005690Targeted Pathway Inhibition in Patients With Pancreatic CancerEarly P1recruiting90OHSU Knight Cancer InstituteAug 2019
NCT06160843POLARPembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell LymphomaP2recruiting24National Cancer Centre, SingaporeJul 2024
NCT06177171HRDOlaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated TumorsP1recruiting18Varun Monga, MBBSFeb 2024
NCT05255471MITO 35BMITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.P3recruiting200National Cancer Institute, NaplesJan 2022
NCT05093231Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic CancerP2recruiting20Cambridge University Hospitals NHS Foundation TrustFeb 2025
NCT04086485GEP-NETLu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)P1/P2recruiting56National Cancer Institute (NCI)Oct 2022
NCT06525298EIS-12656 as Single Agent and in Combination in Patients With Specified Solid TumorsP1/P2recruiting144Eisbach Bio GmbHSep 2024
NCT05524935Olaparib in Combination With Pembrolizumab for Advanced Uveal MelanomaP2recruiting37H. Lee Moffitt Cancer Center and Research InstituteOct 2022
NCT04728230Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO TrialP1/P2active not recruiting63M.D. Anderson Cancer CenterJan 2021
NCT04090567Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerP2recruiting60M.D. Anderson Cancer CenterJul 2020
NCT02925234DRUPThe Drug Rediscovery Protocol (DRUP Trial)P2recruiting1,550The Netherlands Cancer InstituteAug 2016
NCT05432518Pilot Trial for Treatment of Recurrent GlioblastomaEarly P1recruiting10AHS Cancer Control AlbertaJun 2023
NCT06545942Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsP1active not recruiting220MOMA TherapeuticsAug 2024
NCT04858334APOLLOAPOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationP2recruiting152National Cancer Institute (NCI)Jun 2021
NCT02029001MOST plusAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentP2recruiting900Centre Leon BerardMar 2014
NCT02484404MEDI4736Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...P1/P2active not recruiting268National Cancer Institute (NCI)Jun 2015
NCT04624204LS-SCLCPlacebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)P3active not recruiting672Merck Sharp & Dohme LLCDec 2020
NCT06121401IOLANTHEFirst Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive PatientsP4active not recruiting190Mario Negri Institute for Pharmacological ResearchSep 2023
NCT05238922Study of INCB123667 in Subjects With Advanced Solid TumorsP1recruiting604Incyte CorporationJul 2022
NCT04038502COBRACarboplatin or Olaparib for BRcA Deficient Prostate CancerP2recruiting100VA Office of Research and DevelopmentOct 2019
NCT04053322DOLAFDurvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.P2active not recruiting172UNICANCERAug 2019
NCT04169841GUIDE2REPAIRStudy Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib TreatmentP2active not recruiting270Centre Georges Francois LeclercFeb 2020
NCT05623319THORPembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)P2recruiting60Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSMar 2023
NCT04884360MONO-OLA1D9319C00001- 1L OC Mono Global RCTP3active not recruiting366AstraZenecaMay 2021
NCT02571725PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian CancerP1/P2active not recruiting50New Mexico Cancer Research AllianceFeb 2016
NCT03943173Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before SurgeryEarly P1active not recruiting15M.D. Anderson Cancer CenterJun 2019
NCT03598257Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast CancerP2active not recruiting300National Cancer Institute (NCI)Jan 2019
NCT06909825FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)P2active not recruiting85Fusion Pharmaceuticals Inc.Feb 2025
NCT05568212NSCLCRandomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and DurvalumabP2recruiting176Fondazione Ricerca TraslazionaleMay 2022
NCT02893917Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate CancerP2active not recruiting90National Cancer Institute (NCI)Aug 2017
NCT06739395Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment ExhaustionP2recruiting300Tianjin Medical University Second HospitalNov 2024
NCT05482074Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2P2withdrawn0Dana-Farber Cancer InstituteOct 2022
NCT03047135Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker AnalysisP2active not recruiting51Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMar 2017
NCT02498613A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsP2active not recruiting122National Cancer Institute (NCI)Aug 2016
NCT04421963ROSY-ORoll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibP3active not recruiting185AstraZenecaAug 2020
NCT04269200DUO-EDurvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerP3active not recruiting805AstraZenecaMay 2020
NCT07371104Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian CancerP1recruiting40Daewoong Pharmaceutical Co. LTD.Apr 2026
NCT04739800Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsP2active not recruiting120National Cancer Institute (NCI)Jun 2021
NCT03953898IDHUsing the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) MutationP2active not recruiting14National Cancer Institute (NCI)Aug 2020
NCT03660826Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneP2active not recruiting288National Cancer Institute (NCI)Sep 2018
NCT02345265Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian CancerP2active not recruiting70National Cancer Institute (NCI)May 2016
NCT02502266Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian CancerP2/P3active not recruiting582National Cancer Institute (NCI)May 2016
NCT02446600Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerP3active not recruiting579National Cancer Institute (NCI)Mar 2016
NCT01116648Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerP1/P2active not recruiting155National Cancer Institute (NCI)Apr 2010
NCT05463848Surgical Pembro +/- Olaparib w TMZ for rGBMP2recruiting78L. Nicolas Gonzalez Castro, MD, PhDOct 2022
NCT04034927Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal CancerP2active not recruiting61National Cancer Institute (NCI)Dec 2019
NCT03317392Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisP1/P2active not recruiting132National Cancer Institute (NCI)Feb 2019
NCT03732820Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerP3active not recruiting895AstraZenecaOct 2018
NCT05203445TNBCA Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast CancerP2active not recruiting6Memorial Sloan Kettering Cancer CenterJan 2022
NCT05188508Pembrolizumab, Olaparib, and Temozolomide for People With GliomaP2recruiting57Memorial Sloan Kettering Cancer CenterJan 2022
NCT04683679A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerP2recruiting34Memorial Sloan Kettering Cancer CenterApr 2021
NCT04666740A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based TherapyP2active not recruiting63Memorial Sloan Kettering Cancer CenterDec 2020
NCT03297606CAPTURCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)P2recruiting720Canadian Cancer Trials GroupMar 2018
NCT05432791Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped WorkingP2/P3active not recruiting74National Cancer Institute (NCI)Mar 2023
NCT03012321Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsP2active not recruiting70Northwestern UniversityJan 2017
NCT03155620Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)P2active not recruiting1,377National Cancer Institute (NCI)Jul 2017
NCT05870423PRRT-PARPiImproving Peptide Receptor Radionuclide Therapy With PARP InhibitorsP1recruiting24Erasmus Medical CenterJun 2022
NCT03851614DAPPERStudy of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid TumorsP2active not recruiting90University Health Network, TorontoApr 2019
NCT06419179GUIDANCEMaintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)P2enrolling by invitation29University of CologneOct 2024
NCT05498272NePtuneStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsP2recruiting32Rana McKay, MDFeb 2023
NCT06783127COROSClinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancerrecruiting3,000Santa Chiara HospitalJan 2023
NCT05498155OlympiaNStudy of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast CancerP2active not recruiting50AstraZenecaNov 2022
NCT05457257Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 MutationsP4active not recruiting43AstraZenecaJul 2022
NCT04585958Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian CancerP1recruiting55National Cancer Institute (NCI)May 2021
NCT04197713AZD1775Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR StudyP1active not recruiting13National Cancer Institute (NCI)Jun 2020
NCT03842228CODTesting the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected MutationsP1active not recruiting39National Cancer Institute (NCI)Nov 2019
NCT03923270Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung CancerP1active not recruiting25H. Lee Moffitt Cancer Center and Research InstituteJun 2019
NCT03579316Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerP2active not recruiting96M.D. Anderson Cancer CenterDec 2018
NCT03772561MEDIPACPhase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor MalignanciesP1recruiting40National University Hospital, SingaporeDec 2018
NCT03459846BAYOUA Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)P2active not recruiting154AstraZenecaMar 2018
NCT03212742OLA-TMZ-RTE-01Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas PatientsP1/P2active not recruiting91Centre Francois BaclesseSep 2017
NCT01081951Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian CancerP2active not recruiting162AstraZenecaFeb 2010
NCT05222971OPTIMUMOlaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based ChemotherapyP2recruiting62Asan Medical CenterApr 2022
NCT03737643DUO-ODurvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsP3active not recruiting1,407AstraZenecaJan 2019
NCT03375307Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic ChangesP2active not recruiting60National Cancer Institute (NCI)Nov 2020
NCT05807126Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA MutationsP1withdrawn0National Cancer Institute (NCI)Mar 2024
NCT03742245Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerP1active not recruiting28The Methodist Hospital Research InstituteJun 2019
NCT04711824SOLARAStudy of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesP1/P2recruiting41Colette ShenMar 2022
NCT03880019A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine LeiomyosarcomaP2active not recruiting23National Cancer Institute (NCI)Aug 2019
NCT04633239Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian CancerP1recruiting42National Cancer Institute (NCI)Jul 2021
NCT03641755Olaparib + Sapacitabine in BRCA Mutant Breast CancerP1active not recruiting10Dana-Farber Cancer InstituteOct 2018
NCT04548752Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA MutationsP2active not recruiting88National Cancer Institute (NCI)Feb 2021
NCT03775486ORIONStudy of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)P2active not recruiting401AstraZenecaDec 2018
NCT02734004MEDIOLAA Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.P1/P2active not recruiting264AstraZenecaMar 2016
NCT03334617HUDSONPhase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing TherapyP2active not recruiting528AstraZenecaDec 2017
NCT03330847To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.P2active not recruiting273AstraZenecaMar 2018
NCT04361370OPEB-01Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian CancerP2enrolling by invitation44Yonsei UniversityOct 2020
NCT04065269ATARIATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no LossP2active not recruiting174Institute of Cancer Research, United KingdomNov 2019
NCT02849496Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast CancerP2active not recruiting81National Cancer Institute (NCI)Mar 2017
NCT04042831Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene MutationsP2active not recruiting32Academic and Community Cancer Research UnitedJun 2020
NCT03162627Selumetinib and Olaparib in Solid TumorsP1active not recruiting90M.D. Anderson Cancer CenterAug 2017
NCT06078787PALBOLAOlaparib in PALB2 Advanced Pancreatic CancerP2recruiting16Azienda Ospedaliero-Universitaria di ModenaAug 2023
NCT03085147A Dye for the Detection of Cancer of the Tongue and MouthP1/P2active not recruiting23Memorial Sloan Kettering Cancer CenterMar 2017
NCT05933265Study of LP-184 in Patients With Advanced Solid TumorsP1/P2active not recruiting64Lantern Pharma Inc.Jun 2023
NCT03212274Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 MutationsP2active not recruiting89National Cancer Institute (NCI)Jan 2019
NCT02974621Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent GlioblastomaP2active not recruiting70National Cancer Institute (NCI)Dec 2017
NCT03878095Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant TumorsP2active not recruiting24National Cancer Institute (NCI)Jan 2020
NCT04753879Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.P2active not recruiting38Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSep 2021
NCT03874884LuPARP177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate CancerP1active not recruiting70Peter MacCallum Cancer Centre, AustraliaJul 2019
NCT03742895MK-7339Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)P2active not recruiting329Merck Sharp & Dohme LLCDec 2018
NCT03344965Olaparib In Metastatic Breast CancerP2active not recruiting114Beth Israel Deaconess Medical CenterApr 2018
NCT03263650Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCP2active not recruiting96M.D. Anderson Cancer CenterOct 2017
NCT02208375mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianP1active not recruiting159M.D. Anderson Cancer CenterNov 2014
NCT02264678Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsP1active not recruiting354AstraZenecaOct 2014
NCT04123366MK-7339Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)P2active not recruiting300Merck Sharp & Dohme LLCNov 2019
NCT05659914MEDI4736Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes AlterationsP2active not recruiting40Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Nov 2022
NCT04417062Olaparib With Ceralasertib in Recurrent OsteosarcomaP2active not recruiting63Dana-Farber Cancer InstituteNov 2020
NCT05238831ACTSMMART Adaptive Clinical Treatment (ACT) TrialEarly P1withdrawn0OHSU Knight Cancer InstituteJan 2023
NCT04592211GEJPembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) CancerP1/P2recruiting71Yonsei UniversityOct 2021
NCT04748042ADTFocal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)P2active not recruiting21University of Michigan Rogel Cancer CenterMay 2021
NCT07069335A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian CancerP1recruiting24Boryung Pharmaceutical Co., LtdJun 2025
NCT05171816Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)P3active not recruiting110AstraZenecaJun 2021
NCT05156268A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial CarcinosarcomaP2completed26Memorial Sloan Kettering Cancer CenterJan 2022
NCT02308072ORCA-2Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck CancerP1completed16University College, LondonSep 2015
NCT03740165MK-3475Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)P3completed1,367Merck Sharp & Dohme LLCDec 2018
NCT06130254MRTX849Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung CancersP1terminated1M.D. Anderson Cancer CenterJan 2024
NCT04487587COMICEA Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical CancerP2active not recruiting79The Clatterbridge Cancer Centre NHS Foundation TrustOct 2018
NCT05033756COMPRENDOComprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDOP2active not recruiting11Institut fuer FrauengesundheitJul 2022
NCT05233982MITO 35aMITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal CancerP2unknown200National Cancer Institute, NaplesDec 2021
NCT03976362MK-3475A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)P3completed851Merck Sharp & Dohme LLCJun 2019
NCT02546661BISCAYOpen-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder CancerP1active not recruiting117AstraZenecaDec 2016
NCT03976323NSCLCStudy of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)P3completed1,003Merck Sharp & Dohme LLCJun 2019
NCT05379972Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric CancersP2completed9University of Colorado, DenverJan 2023
NCT03784014MULTISARCMolecular Profiling of Advanced Soft-tissue SarcomasP3completed603Institut National de la Santé Et de la Recherche Médicale, FranceOct 2019
NCT04729387Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation DetectedP3terminated358Novartis PharmaceuticalsJul 2021
NCT05629429Olaparib Maintenance Therapy in Metastatic Breast CancerP2unknown300National Taiwan University HospitalFeb 2023
NCT05536128Post-CDKEvaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 InhibitorP2recruiting64Seoul National University HospitalDec 2022
NCT05078671PROACTIVEPharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectivenessP4recruiting160Radboud University Medical CenterDec 2021
NCT04348045MAZEPPAMaintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.P2active not recruiting307GERCOR - Multidisciplinary Oncology Cooperative GroupDec 2020
NCT039679381-2018 BSMOEfficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination GenesP2active not recruiting540Universitair Ziekenhuis BrusselFeb 2019
NCT03594396Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast CancerP1/P2active not recruiting54Seoul National University HospitalJun 2018
NCT02489006NEOA Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube CancerP2unknown71University Health Network, TorontoJul 2016
NCT02299999SAFIR02_BreastSAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerP2active not recruiting1,460UNICANCERApr 2014
NCT01874353Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyP3active not recruiting327AstraZenecaSep 2013
NCT02000622OlympiADAssessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.P3completed302AstraZenecaMar 2014
NCT01858168Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or RhabdoomyosarcomaP1completed49Massachusetts General HospitalJul 2013
NCT03685331HOPEHOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast CancerP1completed9Abramson Cancer Center at Penn MedicineOct 2020
NCT03741426WIREWIRE - Novel Treatments in Renal Cell CancerP2unknown60CCTU- Cancer ThemeJul 2020
NCT05240898A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid TumorsP1completed116Hoffmann-La RocheAug 2021
NCT04191135TNBCStudy of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)P2completed462Merck Sharp & Dohme LLCDec 2019
NCT03025035Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast CancerP2completed14Yuan YuanSep 2017
NCT03259503Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantP1completed50M.D. Anderson Cancer CenterSep 2019
NCT06560632POLARPhase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid TumorsP1terminated26Repare TherapeuticsSep 2024
NCT06377267STROBEStatus of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)P2unknown100Vall d'Hebron Institute of OncologyFeb 2024
NCT05286827Olaparib in Subjects With Advanced Pancreatic Acinar Cell CarcinomaP2terminated5National Cancer Institute (NCI)Dec 2023
NCT06331559Study of SIM0501 Alone and in Combination in Patients With Advanced Solid TumorsP1terminated13Jiangsu Simcere Pharmaceutical Co., Ltd.Mar 2024
NCT03008278Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by SurgeryP1/P2completed51National Cancer Institute (NCI)Feb 2018
NCT03462342CAPRICombination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian CancerP2completed123University of PennsylvaniaMar 2018
NCT03568656Study to Evaluate CCS1477 in Advanced TumoursP1/P2completed220CellCentric Ltd.Jul 2018
NCT05005728XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate CancerP2completed72Xencor, Inc.Oct 2021
NCT04336943Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen LoadP2terminated6University of WashingtonApr 2021
NCT05320757Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer PatientsEarly P1completed20The University of Hong KongApr 2022
NCT04614909Study of Pamiparib in Newly Diagnosed and rGBMEarly P1completed50Nader SanaiJan 2021
NCT05967286Olaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment TrialP2withdrawn0National Cancer Institute (NCI)Oct 2023
NCT05358639Combination of Olaparib and Navitoclax in Women with HGSC and TNBCP1active not recruiting36Sunnybrook Health Sciences CentreNov 2022
NCT05949424OPTI-DOSEOPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older AdultsP4unknown30University Medical Center GroningenMay 2024
NCT05201612PEMBROLAPembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).P2unknown40Grupo Espanol Multidisciplinario del Cancer DigestivoJul 2022
NCT03991832SOLIDStudy of Olaparib and Durvalumab in IDH-Mutated Solid TumorsP2recruiting58University Health Network, TorontoDec 2019
NCT02769962Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung CancerP1/P2completed45National Cancer Institute (NCI)May 2016
NCT05174832Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC PatientsP2unknown136Fudan UniversitySep 2022
NCT04236414Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid TumoursP1completed16AstraZenecaJan 2020
NCT03532880A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung CancerP1completed26Memorial Sloan Kettering Cancer CenterJul 2018
NCT05340413RADIOLAPredicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.P2completed65SOLTI Breast Cancer Research GroupMar 2022
NCT03534453L-MOCAOlaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyP3completed229AstraZenecaMay 2018
NCT05405309CORONADO CLLRP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic LeukemiaP1/P2terminated5University of UtahSep 2022
NCT05268510Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ AdenocarcinomaP2completed31Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestSep 2022
NCT05411679EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung CancerP2withdrawn0Ellipses PharmaApr 2023
NCT04633902HRPhase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) MutationP2unknown41California Pacific Medical Center Research InstituteMar 2021
NCT04298021DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract CancerP2unknown74Seoul National University HospitalJun 2020
NCT04780945FABFunctional Analysis of BRCAnessP2terminated27Leiden University Medical CenterJan 2019
NCT03579784MEDI4736Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric CancerP2unknown40Do-Youn OhNov 2018
NCT03801369AMTEC IITAMTEC IIT: Phase 2 Multiarm Study in TNBCP2terminated24Gordon Mills, MD, PhDDec 2018
NCT04306367Study of Pembrolizumab and Olaparib in Bile Duct CancerP2completed14Georgetown UniversityApr 2020
NCT04483544Pembrolizumab and Olaparib in Cervical Cancer PatientsP2terminated8Baptist Health South FloridaDec 2020
NCT05167175The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene MutationP2unknown30Hongqian GuoMar 2022
NCT05158062Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian CancerP2unknown35Kosei Hasegawa, MD, PhDApr 2022
NCT03838744TOMAS2Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.P2completed130Italian Sarcoma GroupMay 2020
NCT03498521CUPISCOA Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary SiteP2completed529Hoffmann-La RocheJul 2018
NCT03782818OPTIONOlaparib for PAH: a Multicenter Clinical TrialP1/P2terminated17Laval UniversityNov 2019
NCT05501548Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate CancerP2terminated4Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJun 2023
NCT04532645OVAL-1Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UKcompleted342AstraZenecaJan 2021
NCT04076579Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic SarcomaP2completed29University of Michigan Rogel Cancer CenterMar 2020
NCT03745950UTOLAUTOLA: UTerin OLAparibP2completed147ARCAGY/ GINECO GROUPFeb 2019
NCT02419495KPT-330Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesP1terminated221M.D. Anderson Cancer CenterJun 2015
NCT02953457Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 MutationP2completed40Roswell Park Cancer InstituteJun 2017
NCT01078662Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation PatsP2completed298AstraZenecaFeb 2010
NCT05252390NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsP1terminated82Nuvation Bio Inc.Mar 2022
NCT04375267LuPARP177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive TumoursP1completed18Vastra Gotaland RegionApr 2020
NCT03233204Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)P2completed6National Cancer Institute (NCI)Sep 2017
NCT05975944Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung CancerP1/P2unknown49Tianjin Medical University Cancer Institute and HospitalSep 2023
NCT06065059Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsP1/P2terminated7Tango Therapeutics, Inc.Dec 2023
NCT05262608PROspectThe Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene MutationP2unknown30Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityDec 2021
NCT03516812Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerP2completed36University of WashingtonAug 2018
NCT04826198REVOCANSafety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 MonthsP1/P2terminated13Gustave Roussy, Cancer Campus, Grand ParisOct 2020
NCT04538378LYNPARZAOlaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine TumorsP2terminated4National Cancer Institute (NCI)Jul 2021
NCT02229656Olaparib and Radiotherapy in Head and Neck CancerP1unknown12The Netherlands Cancer InstituteSep 2014
NCT04015739BOLDTri Association in Patient With Advanced Epithelial Ovarian Cancer in RelapseP2unknown74ARCAGY/ GINECO GROUPMar 2019
NCT03834519KEYLYNK-010Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)P3completed793Merck Sharp & Dohme LLCMay 2019
NCT04641728Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical CancerP2unknown28Saitama Medical University International Medical CenterJan 2021
NCT03278717ICON9Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer PatientsP3unknown330University College, LondonJun 2018
NCT03117933OCTOVAOlaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian CancerP2completed139University of OxfordMar 2017
NCT03239015Efficacy and Safety of Precision Therapy in Refractory TumorP2unknown300Baodong QinJan 2017
NCT02446704Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior ChemotherapyP1/P2unknown66Zofia PiotrowskaOct 2015
NCT02117167SAFIR02_LungSAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC PatientsP2completed999UNICANCERApr 2014
NCT03127215NCT-PMO-1603Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid TumorsP2completed102National Center for Tumor Diseases, HeidelbergOct 2018
NCT05245994MEDI4736An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in ChineseP2unknown60Li Zhang, MDAug 2021
NCT03182634plasmaMATCHThe UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) TrialP2unknown1,150Institute of Cancer Research, United KingdomDec 2016
NCT02937818A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung CancerP2completed72AstraZenecaNov 2016
NCT04456699MK-7339Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)P3completed335Merck Sharp & Dohme LLCAug 2020
NCT05700669Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsP1/P2completed3Valerio TherapeuticsFeb 2023
NCT04939662SUKSES-B2Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer SubjectsP2completed25Se-Hoon LeeJun 2021
NCT04951492Olaparib for the Treatment of Castration Resistant Prostate AdenocarcinomaP2terminated2University of WashingtonNov 2022
NCT04566952ANLOLAAnlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian CancerP2unknown68Xiaoxiang ChenOct 2020
NCT04091204MITO 31Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational StudyP2unknown200National Cancer Institute, NaplesJul 2019
NCT01972217Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.P2completed158AstraZenecaApr 2014
NCT02822157CLIOCirculating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian CancerP2unknown160Universitaire Ziekenhuizen KU LeuvenAug 2016
NCT03810105A Study of Olaparib and Durvalumab in Prostate CancerP2terminated5Memorial Sloan Kettering Cancer CenterMar 2019
NCT04417192OLAPemOlaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian CancerP2completed30National Cancer Center Hospital EastDec 2020
NCT03570437COPELIADoes Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?P2unknown124University of ManchesterMay 2018
NCT01063517Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer PatientsP2completed124AstraZenecaFeb 2010
NCT04166435TMZ + Olaparib for MGMT Hypermethylated Colorectal CancerP2completed11Yale UniversityJun 2020
NCT04377087Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian CancerP2terminated3Sarah E TaylorJun 2020
NCT04669002EP0057 in Combination With Olaparib in Advanced Ovarian CancerP2completed34Ellipses PharmaDec 2020
NCT01924533Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.P3completed525AstraZenecaSep 2013
NCT05295589Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor TherapyP2withdrawn0National Cancer Institute (NCI)Jun 2022
NCT02987543Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)P3completed387AstraZenecaFeb 2017
NCT02533765Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell TumorP2completed18Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSSep 2015
NCT02184195POLOOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyP3completed154AstraZenecaDec 2014
NCT03378297IMPACTIMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOCEarly P1completed26Haukeland University HospitalMay 2018
NCT05440578First-line Olaparib Combined With Bevacizumab Maintenance Therapyunknown50Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJun 2022
NCT05153603Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Settingunknown50Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityApr 2022
NCT03161132ROLANDOResistant Ovarian Cancer, Olaparib and Liposomal DoxorubicinP2completed32Grupo Español de Investigación en Cáncer de OvarioDec 2017
NCT04801966TAILORSafety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot StudyN/Aterminated3Peter MacCallum Cancer Centre, AustraliaSep 2021
NCT00494234ICEBERG 1Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast CancerP2completed54AstraZenecaJun 2007
NCT03205761COMETABreastAnalysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast CancerP2completed11Spanish Breast Cancer Research GroupOct 2017
NCT04261465NUVOLANUVOLA TRIAL Open-label Multicentre StudyP2unknown35Fondazione Policlinico Universitario Agostino Gemelli IRCCSDec 2019
NCT05258747BRCAA Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast CancerP1completed70SandozApr 2022
NCT04330040SOLIProspective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerP4completed202AstraZenecaMay 2020
NCT03699449AMBITIONAn uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)P2unknown104Yonsei UniversityNov 2018
NCT04774406Arterial Hypertension Related to PARP Inhibitors (ArteRIB)completed2,336University Hospital, CaenFeb 2021
NCT06360445Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy SubjectsP1completed102CSPC Ouyi Pharmaceutical Co., Ltd.May 2022
NCT03470805Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian CarcinomaP2completed9Grupo Español de Investigación en Cáncer de OvarioJun 2018
NCT02588105AToMStudy to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced CancerP1completed84AstraZenecaNov 2015
NCT02282020SOLO3Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum TreatmentsP3completed266AstraZenecaFeb 2015
NCT02677038Olaparib in Treating Patients With Stage IV Pancreatic CancerP2completed24M.D. Anderson Cancer CenterNov 2016
NCT03167619DORAPhase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)P2completed45Duke UniversityOct 2018
NCT02787642RADIOSARPA Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue SarcomaP1completed41Institut BergoniéJan 2016
NCT04556617PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)P1/P2terminated19Opna Bio LLCSep 2020
NCT03434158IMANOLOlaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)P2completed16Spanish Oncology Genito-Urinary GroupFeb 2018
NCT04410887LIGCNeoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)P1/P2unknown30Ruijin HospitalDec 2020
NCT02681237A Study of Cediranib and Olaparib at Disease Worsening in Ovarian CancerN/Acompleted34University Health Network, TorontoApr 2016
NCT02679963PIPSeNTrial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung CancerP2terminated180Gustave Roussy, Cancer Campus, Grand ParisFeb 2016
NCT02477644PAOLA-1Platine, Avastin and OLAparib in 1st LineP3completed806Arcagy ResearchMay 2015
NCT01921140To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid TumoursP1completed60AstraZenecaSep 2013
NCT03402841OPINIONMulticentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer PatientsP3completed279AstraZenecaJan 2018
NCT03931551OPHELIAOlaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast CancerP2terminated5MedSIRApr 2019
NCT03106987OReOA Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.P3completed220AstraZenecaJun 2017
NCT03829345SOLARA Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric CancerP2unknown54Royal Marsden NHS Foundation TrustJul 2019
NCT03924245Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersP1terminated3Vanderbilt-Ingram Cancer CenterOct 2020
NCT02898207Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerP1completed28National Cancer Institute (NCI)May 2017
NCT03367689NOBROLAA Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single AgentP2terminated7MedSIRApr 2018
NCT02855697MOLTOMulti-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian CancerEarly P1completed28The Christie NHS Foundation TrustMay 2017
NCT02476968ORZORATo Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian CancerP4completed181AstraZenecaSep 2015
NCT03925233Breast Cancer Treatment Based on Organ-like Cultureunknown300Xijing HospitalJan 2019
NCT03432897337BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair GenesP2terminated1Brown UniversityMay 2018
NCT03109080RadioPARPOlaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)P1completed24Institut CurieJul 2017
NCT03561870OLAGLIOlaparib in Recurrent IDH-mutant GliomaP2completed35Hospices Civils de LyonMar 2019
NCT03448718Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsP2completed19Matthew GalskyApr 2018
NCT03286842To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.P3completed256AstraZenecaJan 2018
NCT05860530Bioequivalence Study of Two Olaparib Tablets in Patients With CancersN/Acompleted48Qilu Pharmaceutical Co., Ltd.May 2021
NCT03955640Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall RecurrencesP1terminated3Thomas Jefferson UniversityMay 2019
NCT03057145Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid TumorsP1completed29Geoffrey Shapiro, MD, PhDMar 2017
NCT0251122310Efficacy and Safety of PARPi to Treat Pancreatic CancerP2completed24Sheba Medical CenterJul 2016
NCT03205176AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasP1completed49AstraZenecaJun 2017
NCT03314740BAROCCOBest Approach in Recurrent-Ovarian-Cancer-with Cediranib-OlaparibP2completed123Mario Negri Institute for Pharmacological ResearchJun 2017
NCT02889900CONCERTOEfficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian CancerP2completed62AstraZenecaJan 2017
NCT04579133Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical CystectomyP2terminated140Latin American Cooperative Oncology GroupMar 2021
NCT03009682SUKSES-BOlaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A MutationsP2completed15Samsung Medical CenterAug 2016
NCT04239014DUETTEA Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.P2withdrawn0AstraZenecaAug 2020
NCT03022409DDRA Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).P1completed21AstraZenecaSep 2017
NCT03428607Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]P2completed26Samsung Medical CenterOct 2018
NCT01623349Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerP1completed118Dana-Farber Cancer InstituteSep 2012
NCT03878524SMMARTSerial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialP1terminated2OHSU Knight Cancer InstituteApr 2020
NCT02983799Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor StatusP2completed272AstraZenecaDec 2016
NCT03544125Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast CancerP1completed3OHSU Knight Cancer InstituteMay 2018
NCT03531840Olaparib in People With Malignant MesotheliomaP2completed23National Cancer Institute (NCI)Jul 2018
NCT02227082Olaparib and Radiotherapy in Inoperable Breast CancerP1completed7The Netherlands Cancer InstituteOct 2013
NCT02121990IPDose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube CancerP1completed17Memorial Sloan Kettering Cancer CenterApr 2014
NCT03553108IVIVCA Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.P1completed18AstraZenecaMay 2018
NCT02755844ENDOLASafety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsP1/P2completed35Hospices Civils de LyonSep 2016
NCT02899728Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung CancerP2terminated9National Cancer Institute (NCI)Mar 2018
NCT03534492NEODURVARIBDurvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)P2completed29Spanish Oncology Genito-Urinary GroupNov 2018
NCT01562210olaparibOlaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLCP1completed28The Netherlands Cancer InstituteApr 2012
NCT02485990Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)P1terminated24Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJan 2016
NCT01682772TOPARPTOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate CancerP2unknown148Institute of Cancer Research, United KingdomJul 2012
NCT04152941RETROLAReal-life Data of Olaparib in Relapsed Ovarian Cancers Patientscompleted130ARCAGY/ GINECO GROUPOct 2018
NCT02882308OPHELIAPreoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.P2completed41Hellenic Cooperative Oncology GroupOct 2016
NCT01650376Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerP1/P2unknown52Swedish Medical CenterAug 2012
NCT01237067Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s CancersP1completed77National Cancer Institute (NCI)Feb 2011
NCT03251872OPTION-pOlaparib for PAH: a Pilot StudyEarly P1terminated6Laval UniversityOct 2018
NCT02398058TOMASTrabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)P1completed50Italian Sarcoma GroupJul 2014
NCT02684318Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid TumorsP1/P2unknown100Poveda, Andrés, M.D.Jul 2015
NCT02511795AZD1775 Combined With Olaparib in Patients With Refractory Solid TumorsP1completed128AstraZenecaAug 2015
NCT02686008Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCCP1withdrawn0Yale UniversityJan 2018
NCT03570476Olaparib Before Surgery in Treating Participants With Localized Prostate CancerP2terminated2University of WashingtonSep 2018
NCT02392676Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes MutationsP3withdrawn0AstraZenecaJul 2016
NCT02324998CaNCaP03Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before ProstatectomyP1completed20Cambridge University Hospitals NHS Foundation TrustDec 2016
NCT03575078ARQ761 + PARP Inhibitor in Refractory Solid TumorsP1withdrawn0University of Texas Southwestern Medical CenterJun 2018
NCT02093351To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid CancerP1completed79AstraZenecaSep 2014
NCT02506816PolenPreoperative Olaparib Endometrial Carcinoma Study (POLEN)completed36MedSIRFeb 2016
NCT02418624REVIVALPhase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced CancerP1completed25The Netherlands Cancer InstituteMay 2015
NCT01788332PINParp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)P2unknown70Lisette NixonJan 2014
NCT01758731Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking HistoryP1completed17University of Colorado, DenverOct 2012
NCT01460888ROCOCORadiotherapy & Olaparib in COmbination for Carcinoma of the OesophagusP1unknown36The Christie NHS Foundation TrustJul 2013
NCT02340611A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on OlaparibP2completed4University Health Network, TorontoJun 2015
NCT01390571Olaparib and Temozolomide in Treating Patients With Relapsed GlioblastomaP1completed34Cancer Research UKJul 2011
NCT01851265D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid TumoursP1completed32AstraZenecaJul 2013
NCT02430311The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.P1completed36AstraZenecaJun 2015
NCT01894243Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver ImpairmentP1completed31AstraZenecaMar 2014
NCT02338622ComPAKTTrial of Olaparib in Combination With AZD5363 (ComPAKT)P1completed60Royal Marsden NHS Foundation TrustMar 2014
NCT03079687Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.approved for marketing0AstraZeneca
NCT03063710Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japanno longer available0AstraZeneca
NCT02561832A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast CancerP1terminated15AstraZenecaNov 2015
NCT01929603Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid TumoursP1completed32AstraZenecaDec 2013
NCT01900028To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid TumoursP1completed85AstraZenecaOct 2013
NCT01813474Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid MalignanciesP1completed23AstraZenecaMar 2013
NCT01513174GOALStudy With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib AloneP1/P2completed186Spanish Lung Cancer GroupAug 2011
NCT01894256Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney FunctionP1completed56AstraZenecaNov 2013
NCT01296763Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic CancerP1completed18Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsJan 2011
NCT02681562Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer PatientsP2unknown45Istituti Ospitalieri di CremonaJan 2016
NCT00535353AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerP1completed26NCIC Clinical Trials GroupJan 2008
NCT01583543Olaparib in Adults With Recurrent/Metastatic Ewing's SarcomaP2completed12Massachusetts General HospitalMay 2012
NCT01661868Olaparib for Patients With Recurrent BRCA Deficient Ovarian CancerP2withdrawn0Dana-Farber Cancer InstituteAug 2012
NCT00912743MSIEfficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) StatusP2completed33AstraZenecaMay 2009
NCT01491139ORCAPhase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckP1withdrawn0University College, London

Olaparib clinical trials: frequently asked questions

How many Olaparib clinical trials are there?
409 Olaparib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 83 are actively recruiting participants. 125 are marked completed.
Are Olaparib clinical trials recruiting in 2026?
Yes — 83 Olaparib trials are actively recruiting in 2026, with 2053 U.S. sites across 51 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Olaparib being studied for?
Olaparib is being studied for Ovarian Cancer, Breast Cancer, Prostate Cancer, Fallopian Tube Cancer, BRCA1 Mutation and 775 more. The trials are grouped by indication on this page.
What phase is Olaparib in?
Olaparib clinical trials span 6 Phase 4, 41 Phase 3, 206 Phase 2, 88 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Olaparib clinical trials?
The lead sponsor across the most Olaparib trials is AstraZeneca, with 186 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Olaparibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai: